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Abstract 
The phosphatidylinositol-specific phospholipase C (PI-PLC) from Listeria 
monocytogenes (a monomer in solution) shows unusual kinetic properties compared to 
other well-studied phospholipases: (i) increased specific activity with decreasing protein 
concentration, (ii) activation of the phosphotransferase step by salts, and (iii) activation of 
both the interfacial phosphotransferase and water-soluble phosphodiesterase steps by 
zwitterionic and neutral amphiphiles. A variety of biophysical studies (fluorescence, 
NMR, monolayer, vesicle binding) of enzyme/lipid complexes coupled with kinetics have 
allowed us to propose a model that accounts for these features. The enzyme binds tightly 
to anionic surfaces and much more weakly to a zwitterionic interface. The tight binding 
can be reduced by adding KCl at concentrations that activate the enzyme. In the crystal 
structure of the enzyme, many basic residues are clustered on the sides and bottom of 
TIM-barrel far away from the opening to the active site. These cause the enzyme to adopt 
a non-productive orientation on negatively charged membranes that leads to a reversible 
clustering of anionic lipids and vesicle aggregation. An increased surface concentration 
of zwitterionic / neutral amphiphiles along with the salt disperses the anionic substrate, 
shields charges on the protein, and enhances productive encounters of the protein with 
substrate molecules. This model has been tested by examining the behavior of enzyme 
with citraconylated lysines and mutants of neutral surface residues at the rim of the active 
site. The unusual kinetic behavior of this PI-PLC also appears to contribute to the escape 
of L. monocytogenes from vacuoles during infection.  
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Chapter 1: 
 
Introduction 
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I. Phospholipids 
A. Structure of phospholipids 
Phospholipids are amphiphilic molecules with one variable phosphate-containing 
polar / charged group and two long, hydrophobic chains covalently linked to a glycerol 
backbone (Figure 1-1). Phospholipids may contain different hydrophobic tails but are 
classified according to their polar head group. With different phosphate-containing 
groups attached, the net charge of phospholipid varies from 0 to -2 under physiological 
conditions as shown in Figure 1-1. For bacteria and eukaryotes, two fatty acid chains, 
each typically having an even number of carbon atoms between 14 and 24, are attached to 
the first and second carbons of the glycerol molecule via a dual esterification (denoted as 
sn-1 and sn-2 chains, respectively) (Figure 1-1A). The configuration of groups on the 
second carbon of the glycerol backbone defines naturally occurring phospholipids as the 
L-configuration. Fatty acids can be saturated or unsaturated with preference for the cis 
configuration of the double bond. Both the number and positions of unsaturated bonds 
along with the number of carbon atoms of fatty acyl chains have profound effects on 
membranes fluidity. Typical phospholipids usually have a saturated fatty acid, such as 
palmitic or stearic acid, at the sn-1 position with an unsaturated fatty acid, like oleic or 
arachidonic acid, at the sn-2 position. For archaeal phospholipids, two isoprenoid chains 
are ether-linked to sn-1 and sn-2 positions of the D-glycerol backbone (Figure 1-1B). 
Because isoprene is used, the sn-1 and sn-2 chains have methyl branches along the chain 
which create some unique properties of archaeal phospholipids. Archaeal phospholipids 
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can also have two headgroups joined via two very long chains forming a ring that can 
span the thickness of a typical bilayer with headgroups oriented on each side (Gliozzi et 
al., 2002). 
B. Aggregation of phospholipids 
Due to their amphiphilic properties, phospholipids self-assemble into various 
aggregates in aqueous solution (Figure 1-2), favored by the hydrophobic effect (Chandler, 
2005), to minimize the contact of hydrophobic tails with solvent and keep the contact of 
polar headgroup with water. The structures and sizes of these aggregates are determined 
by thermodynamic laws (Horváth et al., 1976) and intermolecular forces. When dispersed 
in the aqueous solution, phospholipids at the air-water interface always form monolayers 
with their polar headgroups solvated in water and hydrophobic tails sticking into the air, 
whereas in the solution phospholipids are presented as monomers as well as aggregates if 
above their critical aggregation concentrations. The structure of the aggregate in solution 
can be predicted in terms of a ‘critical packing parameter’ (CPP) (Cullis and de Kruijff, 
1979; Israelachvili et al., 1980), v/a0lc, where v represents the volume of the hydrophobic 
chains per molecule, a0 the optimal surface area per amphiphile, lc the maximum length 
of the chains (meaning completely extended, all trans conformation chains). 
Phospholipids will form spherical micelles if CPC<1/3, globular or rod-shaped micelles 
if 1/3<CPC<1/2, vesicles if 1/2<CPC<1, and inverse micelle if CPC>1 (Goldfine, 1984; 
Cevc and Marsh, 1987; Gennis, 1989). The surface curvature of aggregates, closely 
related to the type of aggregates, can affect catalytic efficiency of many lipolytic enzymes 
such as phospholipases. 
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Figure 1-1 General structure of phospholipids in (A) bacteria and eukaryotes, and (B) 
archaea. With different polar head groups attached, the net charge of a phospholipid can 
vary from 0 to -2 under physiological conditions 
O
O
H
O
O
P
O
OR
O-O
O
O
H
O
P
O
OR
O-
sn-1
sn-2
sn-3
sn-3
A
B
sn-1
sn-2  
Lipid Name R Net Charge  at physiological pH
Phosphatidic Acid (PA) H  -2 
Phosphatidylmethanol (PMe) CH3  -1 
Phosphatidylserine (PS) CH2CHNH3
COO-  
-1 
Phosphatidylglycerol (PG) 
CH2CHCH2OH
OH  
-1 
Phosphatidylinositol (PI) 
HO
HO
HO
OH
OH -1 
Phosphatidylethanolamine (PE) CH2CH2NH3  0 
Phosphatidylcholine (PC) CH2CH2N(CH3)3  0 
 5
Figure 1-2 Various physical states of phospholipids in aqueous solution. At the air-water 
interface, phospholipids always form monolayers with polar headgroups solvated in 
water and hydrophobic tails sticking into the air. In the aqueous solution, phospholipid 
molecules are present as monomers as well as aggregates (micelles or vesicles) if above 
their critical aggregation concentrations. 
Monomer
Micelle
Monolayer
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Air
Solution
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In general, synthetic short chain phospholipids with chain length no longer than 8 
carbons form micelles containing 5 to 500 amphiphilic lipid molecules where the shape 
of micelles varies with the length of chain, the concentration of lipid and the surface area 
of the headgroup (Gennis, 1989). For instance, diC6PC (dihexanoylphosphatidylcholine) 
forms nearly spherical small micelles that only grow slightly as the diC6PC concentration 
increases; diC7PC forms larger rod-shaped micelles that grow considerably as the diC7PC 
concentration increases; while diC8PC forms extended rods or branched networks (Lin et 
al., 1986; Roberts, 1991).  
Naturally occurring phospholipids can form aggregates of different types 
depending on the preparation method used. When dispersed in aqueous solution, a dried 
phospholipid film spontaneously forms multilamellar vesicles (MLVs) consisting of 
concentric multiple alternating lipid bilayers and aqueous layers in an onion skin 
arrangement with a diameter of 1-5 µm (Bangham et al., 1965). These multilamellar 
liposomes can be further processed by other techniques to form other aggregate structures. 
Upon the addition of detergents, phospholipid MLVs can be solubilized and transformed 
into mixed micelles (Lichtenberg et al., 1983). If the detergent used has a high critical 
micelle concentration (CMC), and if it is subsequently removed by dialysis or column 
chromatography, large unilamellar vesicles (LUVs) can be generated (Brunner et al., 
1976). By sonication under an inert atmosphere, MLVs can be converted to small 
unilamellar vesicles (SUVs) with a diameter 20-50 nm (Johnson et al., 1971). Multiple 
extrusion of MLVs through membrane filters with appropriate pore sizes, will generate 
SUVs or LUVs (Olson et al., 1979; Mayer et al., 1986; Nayar et al., 1989). Other 
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techniques, such as pH-induced vesiculation (Hauser and Gains, 1982), fusion of vesicles 
by repeated freezing and thawing (Uhumwangho and Okor, 2005), or fusion of vesicles 
containing anionic phospholipids by Ca2+ mediated aggregation followed with EDTA 
treatment (Szoka and Papahadjopoulos, 1980), have also been used to transform the 
structure of lipid aggregates. Giant unilamellar vesicles (GLVs) with diameters between 5 
and 200 µm (Menger and Keiper, 1998), which are the same size as cells, have been 
prepared by several methods including gentle hydration, solvent evaporation, and 
electroformation (Bagatolli et al., 2000). Aside from micelles and vesicles, planar lipid 
bilayers (black lipid membranes) serve as a useful tool for biomembrane research and 
biosensor applications (Sackmann, 1996). These can be prepared on solid supports by 
classical Langmuir-Blodgett techniques (Kuhner et al., 1994; Beyer et al., 1996), 
liposome fusion techniques (Brian and McConnell, 1984), and a hybrid of those two 
methods (Kalb et al., 1992; Wenzl et al., 1994). 
C. Dynamic movement of phospholipids 
The modern view of biomembranes is loosely based on the “fluid mosaic” model 
in which cell membranes are considered as two-dimensional solutions of oriented 
proteins and lipids (Singer and Nicolson, 1972). Phospholipids in the membranes 
undergo several types of movements: lateral diffusion in the plane of membrane, flexing 
of acyl chains, rotational diffusion, and transverse diffusion (flip-fop) between the two 
sides of a bilayer. Those motions within the same leaflet occur at a very fast rate. The 
diffusion coefficient for lateral diffusion can range from 10-6 to 10-9 cm2/s (Jones and 
Chapman, 1995). In contrast, spontaneous “flip-flop” motion, where it is 
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thermodynamically unfavorable to pass the hydrated, polar headgroup of the lipid 
through the hydrophobic core of the bilayer, is extremely slow with half-life for the 
process ranging from several hours to days (Jones and Chapman, 1995). The rare 
occurrence of spontaneous transverse diffusion of lipids enables the asymmetry of a 
membrane to be maintained.  
D. Function of phospholipids 
It is widely recognized that phospholipids are involved at multiple levels of 
cellular organization and function. They function primarily as biological membrane 
structural elements in defining the permeability barrier of cells and organelles by forming 
a phospholipid bilayer. The hydrophobic core of the bilayer allows the passage of only 
small non-polar molecules but not charged ones, a prerequisite for the generation of 
electrochemical potentials used for ATP synthesis or active transport. By providing a 
bilayer as the matrix for the organization of various membrane proteins, phospholipids 
directly affect membrane protein structure and function (van Klompenburg et al., 1997; 
Bogdanov et al., 2002; Zhang et al., 2003; Dowhan et al., 2004; Zhang et al., 2005). 
Phospholipids were also reported to serve as molecular chaperones (Bogdanov et al., 
1996; Bogdanov and Dowhan, 1999), precursors for various second messengers (Exton, 
1994; Lennartz, 1999), donors to the synthesis of macromolecules (Becker and Lester, 
1980; Menon and Stevens, 1992; Fankhauser et al., 1993; Lester and Dickson, 1993; 
Bishop et al., 2000), surfactants (Batenburg, 1992), essential components of bile (van 
Erpecum et al., 2007), and donors in protein lipidation (Ichimura et al., 2000).  
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II. Phospholipases 
Phospholipases constitute a heterogeneous group of enzymes that hydrolyze the 
various ester linkages in glycerophospholipids. As shown in Figure 1-3, Phospholipases 
are classified into A1 (PLA1), A2 (PLA2), B (PLB), C (PLC), and D (PLD) based on their 
site of attack on phospholipids. PLA1 and PLA2 specifically hydrolyze the fatty acyl ester 
bond at the sn-1 and sn-2 position of the glycerol moiety, respectively, to generate fatty 
acid and corresponding lysophospholipid. In addition to the PLA activity, several PLA 
enzymes, such as PA-PLA1 (specific for phosphatidic acid, PA), PS-PLA1 (specific for 
phosphatidylserine, PS), cPLA2 (cytosolic PLA2), and iPLA2 (Ca2+-independent PLA2) 
also display lysophospholipase activity to remove the fatty acid from lysophospholipids 
(Wang and Dennis, 1999). PLB enzymes usually possess three kinds of activities in that 
they act as a phospholipase A to sequentially remove both the sn-1 and sn-2 acyl ester 
bonds, lysophospholipase to remove the remaining fatty acid from lysophospholipids, and 
lysophospholipase-transacylase to transfer free fatty acid to lysophospholipid to produce 
phospholipid. PLC catalyzes the cleavage of glycerophosphate ester bond to 
diacylglycerol (DAG) and phosphorylated headgroup. PLD cleaves the terminal 
phosphodiester bond to liberate phosphatidic acid (PA) and free headgroup. 
Phospholipases are ubiquitous and play important roles in a number of 
physiological processes. As phospholipids provide matrix for biomembranes, it is 
conceivable that degradation of phospholipids by phospholipases alters membrane 
composition (i.e. depletion of PC, accumulation of PA, DAG, and lysophospholipids) and 
therefore membrane physical properties (Shoemaker and Vanderlick, 2002; Larijani and 
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Dufourc, 2006). With lipolytic activities, phospholipases play roles in lipid catabolism 
and membrane remodeling during cell differentiation, cell growth and development, 
senescence, aging, and in response to stresses (Wang, 2001). Phospholipases also 
generate several important second messengers involved in cellular regulation. Of 
particular interest in signal transduction pathways are the following: (1) the unsaturated 
fatty acid generated by PLA2, arachidonic acid, is an important precursor of the 
eicosanoid family of inflammatory mediators including prostaglandins, thromboxanes, 
lipoxins, and leukotrienes (Balsinde et al., 2002); (2) DAG, either released directly via 
PLC or indirectly by the sequential action of PLD and phosphatidic acid 
phosphohydrolase (PAP-1), can activate protein kinase C (PKC) enzymes and play roles 
in cell proliferation, apoptosis, survival and migration, and perhaps tumorigenesis (Griner 
and Kazanietz, 2007); (3) inositol-1,4,5-triphosphate (IP3), generated by 
phosphatidylinositol-specific phospholipase C (PI-PLC), can mobilize the interior Ca2+ 
stores and trigger a series of calcium-sensitive activators and repressors (Berridge, 1993; 
Duncan et al., 2007); (4) PA, a product of PLD, has been implicated in a series of 
biological cellular responses regulating cell growth, proliferation, reproduction, vesicle 
trafficking, secretion, and endocytosis (Jenkins and Frohman, 2005; Wang et al., 2006). 
Besides those diverse intracellular roles, extracellular phospholipids have been implicated 
as virulence factors for bacteria and pathogenic fungi (Songer, 1997; Ghannoum, 2000). 
PLA enzymes from some protozoan species facilitates host cell penetration (Ghannoum, 
2000). 
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Figure 1-3 Action sites of phospholipases. PLA1 and PLA2 specifically hydrolyze the 
fatty acyl ester bond at the sn-1 and sn-2 position of the glycerol moiety, respectively; 
PLB enzymes can remove both the sn-1 and sn-2 acyl ester bonds; PLC catalyzes the 
cleavage of glycerophosphate ester bond; and PLD cleaves the terminal phosphodiester 
bond. 
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III. Interfacial enzyme kinetics 
The fact that phospholipases are water-soluble while naturally occurring 
phospholipids are amphiphilic and aggregated in biological membranes (Jain, 1988) 
complicates the kinetic behavior of phospholipases in that binding of enzymes to the 
interface is required to access their substrates. The model shown in Figure 1-4 (Jain and 
Berg, 1989; Berg et al., 1991), simplifying the analysis of interfacial kinetics by 
separating the contribution of the interfacial binding from the interfacial catalytic steps, is 
widely adapted to represent the Michaelis-Menten kinetics of enzyme at interfaces. Here, 
the overall catalytic process occurs in two discrete steps: the enzyme in the aqueous 
phase (E) initially binds to the interface of the aggregated substrate where the interfacial-
associated enzyme (E*) further undergoes a series of catalytic steps at the interface 
including binding and catalyzing the hydrolysis of substrate, releasing the product to 
regenerate free E* which either goes back to the aqueous phase (E) in the hopping mode 
or stays in the same interface to carry out another round of interfacial catalysis in the 
scooting mode. The overall rate of catalytic turnover is thus affected not only by the 
kinetics of those interfacial catalytic steps but also by the kinetics of binding and 
desorption of the enzyme at the interface. The relative contribution of these two factors 
clearly depends on the processivity of the reaction progress. For enzymes working in pure 
scooting mode (achieved with a suitable assay system), the enzyme always remains 
bound at the membrane interface and exhibits negligible inter-aggregate fusion or 
exchange on the time scale of the reaction progress. Scooting mode kinetics provide near 
ideal conditions for the characterization and analysis of the events of the interfacial 
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turnover cycle. Assays in pure hopping mode or with rate-limiting inter-aggregate 
exchange of substrates and products provide insights into the contribution of the kinetics 
of binding and desorption of the enzyme at the interface.  
Interfacial activation, defined as “binding of the enzyme to the membrane that 
may cause an allosteric activation that makes the enzyme a more efficient catalyst (larger 
kcat/Km for a particular substrate)” (Gelb et al., 2000), is observed for many interfacial 
enzymes. Phospholipases exhibit interfacial activation as the preference of aggregated 
versus monomeric substrates (Verheij et al., 1981). Comparing the activities of a 
phospholipase toward the same substrate in aggregated versus monomeric form, usually 
synthetic short chain phospholipids with a CMC in the mM range (i.e. diC6- or diC7-), is 
the way to check for interfacial activation behavior of phospholipases. The observed 
kinetic activation upon forming aggregated substrate, varies from 2- to 3- fold (Zhou et 
al., 1997b) to 10,000-fold (Verger et al., 1973), depending on the properties of enzyme 
and the structure and dynamics of the interface. The understanding of interfacial 
activation is mostly derived from investigating the kinetic and mechanistic bases of two 
well structurally characterized groups of interfacial enzymes: triglyceride hydrolases and 
PLA2 enzymes (Derewenda et al., 1992; Jain and Berg, 2006). Various explanations have 
been proposed to account for the interfacial activation, including an increased binding of 
the enzyme to the interface, facilitated replenishment of the substrate, opening of the lid 
on the active site, and the Ks*- and kcat*-allosteric activation (Derewenda et al., 1992; 
Berg et al., 1997; Carrière et al., 1997).  
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Figure 1-4 Scheme for interfacial catalysis (adapted from Berg et al., 1991). The species 
shown in the box are embedded in or bound to the interface. 
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Concentration is defined as “a thermodynamic term that is related to the statistical 
probability of random encounter of the reactant molecules in thermal motion” (Berg and 
Jain, 2002). It is reasonable that in a heterogeneous system, like interfacial reaction 
progress, the local concentration instead of bulk concentration is important for the overall 
kinetic rate. In diluting the substrate at the interface by adding more detergents or 
nonsubstrate lipids while keeping the total concentration of substrate constant, many 
phospholipases exhibit a lower specific activity, a phenomenon called “surface dilution”. 
Except for the decrease in surface concentration of the substrate, increase in the surface 
concentration of possible competitive lipophilic inhibitor may also account for the 
reduction in activity (Dennis, 1973; Carman et al., 1995).  
IV. Phosphatidylinositol-specific phospholipase C 
Phosphatidylinositol-specific phospholipase C (PI-PLC) enzymes are a large 
family of closely related enzymes that specifically hydrolyze phosphoinositide substrates 
(bacteria enzymes prefer PI and glycosyl-PI (GPI), while most mammalian enzymes 
prefer PI(4,5)P2 > PI(4)P, PI(5)P > PI), a minor but important class of regulatory 
phospholipids (Cockcroft and De Matteis, 2001; Martin, 2001; Stossel et al., 2001; 
Clapham, 2003; Irvine, 2003). PI-PLC activity was first identified in rat liver (Kemp et 
al., 1959). From then on, PI-PLCs have been isolated from many bacterial and eukaryotic 
sources (Flick and Thorner, 1993; Bennett et al., 1998; Griffith and Ryan, 1999; Nozaki 
et al., 1999; Katan, 2005; Pan et al., 2005). 
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A. Mammalian PI-PLC 
So far, thirteen mammalian PI-PLC isozymes have been identified and classified 
into six families based on their structure, PLC-β(1-4), PLC-γ(1,2), PLC-δ(1,3,4), PLC-
ε(1), PLC-ζ(1), and PLC-η(1,2) (Figure 1-5 and Figure 1-6) (Rhee and Bae, 1997; 
Saunders et al., 2002; Wing et al., 2003; Irino et al., 2004; Hwang et al., 2005; Nakahara 
et al., 2005; Stewart et al., 2005; Zhou et al., 2005).  
As shown in Figure 1-5, the typical PLC-δ family member is composed of a string 
of modular domains including PH (pleckstrin homology) domain, EF (elongation factor)-
hand domains, catalytic X and Y regions, and a C2 (protein kinase C conserved region 2) 
domain. Among the PLC family isozymes, PLC-δ is considered as evolutionally 
conserved (Rebecchi and Pentyala, 2000), and these four domains represent the common 
core structure of all mammalian PI-PLC isozymes, with the exception of sperm-specific 
PLC-ζ which lacks the PH domain. The X and Y regions are highly conserved with 40-
60% amino acid sequence similarity among all mammalian isozymes (Zhou et al., 2005) 
and associate tightly to form the catalytic domain (Essen et al., 1996; Essen et al., 1997). 
Two additional PLC-like proteins, PLC-L1 and –L2, or named as PRIPs (Phospholipase 
C-Related, catalytically Inactive Proteins), have been identified by searching databases 
with conserved sequences between β, γ, and δ isoforms. Despite sharing the common 
regions, PLC-Ls do not have PI-PLC activity because they lack critical catalytic residues 
(Uji et al., 2002). PH domains are found in many other proteins as adaptors or tethers to 
link their host proteins to the membrane surface (Ferguson et al., 1995; Rebecchi and 
Scarlata, 1998), mostly to phosphoinositides and βγ-subunits of heterotrimeric G proteins.  
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Figure 1-5 Domain organization of mammalian PI-PLC isoforms (adapted from 
Weerninka et al., 2007). The four domains (PH, EF-hand, catalytic, and C2) represent the 
common core structure of all mammalian PI-PLC isozymes (except sperm-specific PLC-
ζ). Other subtype-specific domains contribute to their specific regulatory mechanisms. 
The structure of bacterial PI-PLC is similar to the catalytic core of mammalian PLC-δ1. 
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Figure 1-6 Dendrogram of mammalian PI-PLC isoforms (adapted from Katan, 2005). 
Although sharing the common core structure, two PLC-like proteins (PLC-L1 and –L2) 
do not have PI-PLC activity for lack of critical catalytic residues. 
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Sequence diversity of PH domains among PLC isoforms indicates that PH domains are 
involved in subtype-specific regulation. The PLC-δ PH domain binds with high affinity 
and stereospecificity to the polar head group of PI(4,5)P2 (Garcia et al., 1995), an event 
that is essential for processive hydrolysis of substrates (Lomasney et al., 1996). PLC-γ N-
terminal PH domains bind the triply phosphorylated phosphoinositide, PI(3,4,5)P3 (Bae et 
al., 1998; Falasca et al., 1998), while PLC-β isoforms bind artificial bilayers with 
relatively little specificity for phospholipid head group (Wang et al., 1999). All 
mammalian PLC isoforms have up to four helix-loop-helix EF-hand motifs. Although 
EF-hand motifs usually bind calcium ions, some of them do not have the critical residues 
for calcium binding. The first two EF-hands of PLC-δ1 are able to bind calcium or 
magnesium ions, whereas EF3 and EF4 do not (Rebecchi and Pentyala, 2000). Recently, 
the role of EF-hands of PLC-ζ, an isozyme with high Ca2+ sensitivity of the PI(4,5)P2-
hydrolyzing activity, has been explored (Kouchi et al., 2005). EF1 and EF2 function 
primarily in a structural role to form the active conformation rather than Ca2+ binding 
sites for activation of the catalytic activity. EF3 is required for the high Ca2+ sensitivity of 
PLC-ζ although it seems the highly coordinated structure of the EF-hand region instead 
of the primary sequence in the Ca2+ binding loop accounts for the high Ca2+ sensitivity. 
All four EF-hands are prerequisites for the activity since deletion of these EF-hands 
abolished PLC-ζ activity completely. C2 domains usually play a role in calcium-
dependent membrane targeting processes (Davletov and Südhof, 1993) and are unique 
among membrane targeting domains in that they show wide range of lipid selectivity for 
the major components of cell membranes, including PS and PC. The C2 domain of PLC-
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δ1 contains three to four Ca2+ binding sites (Grobler and Hurley, 1998) and is important 
for activity by forming an enzyme-PS-Ca2+ ternary complex upon binding of calcium 
ions (Lomasney et al., 1999). For PLC-ζ, the C2 domain is a prerequisite for the activity. 
The C2 domain also has affinity for PI(3)P and PI(5)P, but not PI(4,5)P2 or acidic 
phospholipids, and thus negatively regulates PLC-ζ (Kouchi et al., 2005). However, the 
key calcium-binding residues are not conserved in all C2 domains among PLC isozymes 
(e.g. PLC-β and -γ). The C2 domains of PLC-β isozymes are unable to bind calcium; 
instead, they do interact strongly and specifically with their activator, activated α subunits 
of Gq proteins (Wang et al., 1999).  
In addition to these canonical domains, other subtype-specific domains (Figure 
1-5) contribute to specific regulatory mechanisms. PLC-β isozymes are distinguished 
from other PLCs by a ∼400 residue C-terminal extension downstream of their Y domain. 
This region interacts with GTP-bound α subunits of Gq proteins (Zhang and Neer, 2001; 
Ilkaeva et al., 2002; Singer et al., 2002) and PDZ (combination of the first letters of post 
synaptic density protein, Drosophila disc large tumor suppressor, and zonula occludens-1 
protein) domain-containing scaffold proteins (Suh et al., 2001). It bears selective 
GTPase-activating protein (GAP) activity to enhance the hydrolysis of GTP by Gq 
protein up to 50-fold (Ross and Wilkie, 2000), and triggers membrane association and 
nuclear localization (Kim et al., 1996). The unique region of PLC-γ is inserted within the 
Z region, a flexible loop linking the X- and Y- catalytic regions, and includes a second 
split PH domain, two Src homology 2 (SH2) domains and one SH3 domain. The second 
split PH domain interacts with EF-1α, a PI-4 kinase activator in mammalian cells (Chang 
 21
et al., 2002). SH2 domains mediate the association of PLC-γ with tyrosine-
phosphorylated proteins and promote the regulation of enzyme by nonreceptor and 
receptor tyrosine kinases (RTK) (Rebecchi and Pentyala, 2000). The SH3 domain 
contributes to the mitogenic properties of PLC-γ by exhibiting guanine nucleotide 
exchange factor (GEF) activity towards PIKE (PI-3-OH kinase enhancer), a nuclear 
GTPase regulating the nuclear PI3K activity (Ye et al., 2002). The SH3 domain also 
interacts with PLD2 and may couple the activity of PLC with that of PLD (Jang et al., 
2003). PLC-ε contains a N-terminal CDC25 (cell division cycle) domain with GEF 
(guanyl-nucleotide exchange factor) activity for Ras GTPases as well as two C-terminal 
Ras-association (RA) domains to bind activated Ras GTPases for upstream and 
downstream interactions of PLC-ε with Ras GTPases (Kelley et al., 2001; Lopez et al., 
2001; Song et al., 2001). PLC-η isozymes, neuron-specific enzymes identified most 
recently (Hwang et al., 2005; Nakahara et al., 2005; Stewart et al., 2005; Zhou et al., 
2005), bear a long C-terminal sequence ending with a PDZ-binding motif. Splice variants 
of PLC-η that differ at the C-terminus have been reported (Zhou et al., 2005) and further 
investigation is need to understand the roles of PLC-η C-terminal sequence. 
B. Bacterial PI-PLC 
The smallest PI-PLCs, about 35 kDa in size, are secreted by a variety of bacteria, 
including the pathogens Bacillus cereus, B. thuringiensis, B. anthracis, Listeria 
monocytogenes, L. ivanovii, Staphylococcus aureus, Clostridium novyi, Rhodococcus 
equii, and also non-pathogenic species L. seeligeri, Streptomyces antibioticus, Cytophaga 
sp., and some strains of lactic acid bacteria (LAB) such as Lactobacillus rhamnosus 
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(Griffith and Ryan, 1999; Rodriguez et al., 2001; Klichko et al., 2003; Read et al., 2003). 
While they all prefer nonphosphorylated PI as the substrate, some of these enzymes also 
have high activity towards GPI-anchors. The interest in bacterial PI-PLC arises from (1) 
their role in bacterial virulence, (2) their use as tools to investigate GPI-linked proteins, 
and (3) their structural similarity to the mammalian catalytic domain and use as a simple 
model system. PI-PLC enzymes are potential virulence factors for a number of 
pathogenic bacteria (Mengaud et al., 1991; Daugherty and Low, 1993). L. monocytogenes 
PI-PLC plays roles in the escape of bacteria from phagolysosomes (Smith et al., 1995; 
Portnoy et al., 2002) and modulation of host cell signaling pathways including Ca2+ 
signaling in macrophages (Goldfine and Wadsworth, 2002) and PI metabolism in 
endothelial cells and macrophages (Sibelius et al., 1996b; Goldfine and Wadsworth, 
2002). B. anthracis PI-PLC down-modulates dendritic cell (DC) function and T cell 
responses, possibly by cleaving GPI-anchored proteins important for TLR-mediated DC 
activation (Zenewicz et al., 2005). Without PI-PLC, B. cereus is less able to cause disease, 
although the mechanism is unclear (Callegan et al., 2002). The role for PI-PLC in other 
pathogenic bacteria has not been examined. It has been reported that PI-PLC of 
Lactobacillus rhamnosus has the ability to translocate the bacteria (Rodriguez et al., 2001) 
which could be associated with potential bacterial infectivity and pathogenic degree 
(Zhou et al., 2000). Bacterial PI-PLC enzymes also serve as useful tools for research on 
GPI-anchored proteins (Ikezawa, 2004). With the ability to cleave GPI-anchors, bacterial 
PI-PLCs can act as membrane-attacking agents to release proteins tethered to the cell 
membrane via GPI anchors. Of particular interest to our group has been the use of 
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bacterial PI-PLC enzymes as a model system for understanding the more complex and 
highly regulated eukaryotic PI-PLC. This is based on the structural similarities between 
bacterial PI-PLC and catalytic core of mammalian PLC-δ1 (Heinz et al., 1998). 
Bacterial PI-PLCs have been shown to catalyze a two-step reaction, as shown in 
Figure 1-7, that is independent of Ca2+. The first step is a phosphotransferase reaction to 
cleave phosphatidylinositol and produce DAG and D-myo-inositol 1,2-cyclic phosphate, 
(cIP). This is followed by a cyclic phosphodiesterase reaction that converts cIP to D-myo-
inositol 1-phosphate, I-1-P. For most of these enzymes the water-soluble intermediate 
product cIP accumulates because the second step is about 103-times slower than the first 
one (Volwerk et al., 1990). Bacterial PI-PLCs are extremely sensitive to the conformation 
of substrate head group which should be myo-inositol in D-configuration (Leigh et al., 
1992; Lewis et al., 1993) with a free, axial 2-OH group (Lewis et al., 1993) and free, 
equatorial 3-, 4-, and 5-OH groups (Volwerk et al., 1989). The activity of PI-PLC toward 
chiro-inositol with an axial 3-OH, which is the only allowed conformational change 
reported, reduces the rate by a factor of 103 (Bruzik et al., 1994). The GPI anchor, where 
the myo-inositol is linked via a glycosidic bond of its 6-OH group to a linear 
oligosaccharide, can also be hydrolyzed by bacterial PI-PLC. The strict conformation 
requirements also hold in the second step (Volwerk et al., 1990). In contrast to the head 
group specificity, bacterial PI-PLCs are insensitive to the conformation of the lipid 
portion of the substrate. Variations, around either the glycerol sn-2 carbon or chain 
linkages (ether- or ester-linked, saturated or unsaturated, lyso-), produce molecules that  
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Figure 1-7 Two reactions catalyzed sequentially by bacterial PI-PLC enzymes (adapted 
from Griffith and Ryan, 1999). 
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are usually good substrates (Bruzik et al., 1992; Bruzik and Tsai, 1994; Guther et al., 
1994). 
Several crystal structures of bacterial PI-PLCs have been reported (Heinz et al., 
1995; Heinz et al., 1996; Moser et al., 1997). These enzymes are folded as a single, 
distorted (βα)8-barrel or TIM (triose phosphate isomerase)-barrel (Figure 1-8) with the 
active site at the C-terminal end of the β-strands. In B. cereus PI-PLC, the α-helices 
between β-strands IV/V and V/VI are missing and replaced with a loop and an anti-
parallel strand Vb, respectively. Reduced main chain hydrogen bonds between strands V 
and VI keeps this region open compared to that of regular TIM barrels. The active site 
pocket was identified by co-crystallization with myo-inositol (Heinz et al., 1995) as well 
as with the core region of a GPI-anchor (Heinz et al., 1995; Heinz et al., 1996). As shown 
in Figure 1-9, the inositol ring binds in an edge-on orientation with the 2-, 3-, 4-, and 5- 
OH groups of the ring strongly coordinated with a network of hydrogen bonds. One or 
more hydrogen bond interactions are formed between those hydroxyl groups and the side 
chains of several residues which themselves are held in position by other residues via 
hydrogen bonds. There is also a planar stacking interaction between the apolar side of the 
myo-inositol ring and the phenol ring of Tyr-200 to position the myo-inositol ring. No 
close contact is found between the protein and O1 or O6 of the myo-inositol moiety. 
These binding patterns of myo-inositol in the active site are consistent with the exquisite 
sensitivity of enzyme to the conformation of inositol.  
Alignment of all published sequence of PI-PLCs revealed two histidines, His-32 
and His-82 in B. cereus, which are conserved in bacterial PI-PLCs and the mammalian X- 
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Figure 1-8 Side by side view of the topologies of B. cereus PI-PLC and L. 
monocytogenes PI-PLC with myo-inositol (labeled Ins in yellow) bound in the active site 
pocket (adapted from Moser et al., 1997). 
B. cereus PI-PLC L. monocytogenes PI-PLC
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Figure 1-9 Binding of (A) myo-inositol (labeled Ins, headgroup of PI substrate) and (B) 
glucosaminyl(α1→6)-D-myo-inositol (labeled GlcNIns, the central portion of a GPI 
anchor substrate) at the active site of B. cereus PI-PLC (adapted from Griffith and Ryan, 
1999). 
Ins
GlcNIns
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Figure 1-10 The catalytic mechanism for the hydrolysis of (A) PI and (B) cIP by B. 
cereus PI-PLC. His32-Asp274-inositol-2-OH and His82-Asp33-Arg69 form the catalytic 
triad (Kubiak et al., 2001; Ryan et al., 2001).  
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region and may be good candidate residues for catalysis. Combining the results of 
stereochemical approaches (Lin et al., 1990; Bruzik et al., 1992) and the solved crystal 
structures, researchers suggested that the catalysis of PI-PLC occurs via an in-line SN2 
displacement using His-32 and His-82 as general base and general acid (Heinz et al., 
1995). The importance of these residues has been confirmed by mutagenesis studies 
(Gässler et al., 1997). More recent studies have suggested that H32-D274-inositol-2-OH 
and H82-D33-R69 form the complex catalytic triad as general base and acid as shown in 
Figure 1-10 (Ryan et al., 2001; Kubiak et al., 2001).  
As interfacial enzymes, the interfacial binding region of bacterial PI-PLCs is 
important to regulate its activity. Both interfacial activation and surface dilution 
inhibition were observed for Bacillus PI-PLC enzymes (Zhou et al., 1997b). The crystal 
structure of B. cereus PI-PLC has revealed several solvent accessible hydrophobic amino 
acid residues, arranged in a semicircle around the active site cleft, that form a 
hydrophobic ridge to contact with lipid surfaces via hydrophobic interactions. These 
residues are from the short α-helix B, a loop between strand II and helix D, and the loop 
between strand VII and helix G.  
V. Listeria monocytogenes 
Listeria monocytogenes, first described by Murray and coworkers (1926) based 
on six cases of sudden death of young rabbits, is a widespread, rapidly growing Gram-
positive bacterial pathogen and the causative agent of human and animal listeriosis. 
Listeriae are acquired primarily through the consumption of contaminated foods. 
Although L. monocytogenes infection is usually limited to pregnant women, newborns, 
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and immunocompromised individuals, the high mortality rate associated with human 
listeriosis make L. monocytogenes the leading cause of death amongst foodborne 
bacterial pathogens (Paoli et al., 2005).  
L. monocytogenes has served as a model for the study of intracellular 
pathogenesis for decades, and many aspects of the pathogenic process are well 
understood (Portnoy et al., 2002; Pamer, 2004). As shown in Figure 1-11, the infection 
process of L. monocytogenes can be separated into the following steps. (1) The first step 
is the association of this microorganism with the host cell and internalization into a 
phagosome formed by fusing with early endosomal compartments of the host cell. L. 
monocytogenes enters almost all adherent cells but has a 10,000-fold higher efficiency of 
uptake by macrophages and macrophage-like cell lines compared to fibroblast cell lines 
(Camilli et al., 1993). (2) The next step is the escape from the primary vacuole into the 
cytosol of host cell. (3) Once free from the vacuole, the bacteria start intracytosolic 
replication. (4) The bacteria then gain propulsion from the rapid polar polymerization of 
host actin. (5) With a pseudopod-like structure, the bacteria are then able to reach into the 
neighbouring cell and spread cell-to-cell by forming an intermediate double-membraned 
vacuole. (6) The bacteria can then escape the secondary vacuole and continue the 
replication.  
The virulence of L. monocytogenes is directly related to its ability for intracellular 
growth and spread. Several genes encoding determinants of pathogenesis have been 
identified and found to be clustered on the chromosome (Goldfine et al., 1995). Among 
these are hly, encoding the pore-forming cytolysin listeriolysin O (LLO); plcA, encoding 
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PI-PLC; and plcB, encoding broad-range, PC-preferring PLC (PC-PLC). LLO is an 
essential determinant of pathogenicity and largely responsible for mediating escape of 
bacteria from both vacuoles (Vazquez-Boland et al., 2001). Mutants lacking LLO failed 
to escape from vacuoles in most cells, but they regain the ability to escape from a vacuole 
with the help of LLO from other organisms (Bielecki et al., 1990). The pores formed by 
LLO are too small for bacteria to cross the membrane (Palmer, 2001), instead they allow 
the bidirectional diffusion of electrolytes between the cytoplasm and the phagosome 
(Higgins et al., 1999; Repp et al., 2002). L. monocytogenes PI-PLC and PC-PLC have 
overlapping roles in the escape of bacteria from phagolysosomes (Smith et al., 1995; 
Portnoy et al., 2002) and modulation of host cell signaling pathways including Ca2+ 
signaling in macrophages (Goldfine and Wadsworth, 2002) and PI metabolism in 
endothelial cells and macrophages (Sibelius et al., 1996b; Goldfine and Wadsworth, 
2002). PI-PLC helps the bacteria to escape from the primary vacuole of macrophages 
(Camilli et al., 1993). The loss of L. monocytogenes PI-PLC by an in-frame plcA deletion 
mutation or by mutagenesis of active site histidines resulted in a significant defect in the 
ability of L. monocytogenes to escape from the primary vacuole, a slight defect in cell-to-
cell spread, and a large decrease in growth in the liver of a mouse after infection (Camilli 
et al., 1993; Smith et al., 1995; Bannam and Goldfine, 1999). The role of PI-PLC as 
virulence factor recently has been shown to be closely related to its weak GPI cleavage 
activity (Wei et al., 2005). There are other virulence factors involved in different 
infection steps, such as mediation of the internalization of bacteria by nonprofessional  
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Figure 1-11 Stages in the intracellular life-cycle of Listeria monocytogenes (adapted 
from Portnoy et al., 2002). The entry, escape from a vacuole, actin nucleation, actin-
based motility, and cell-to-cell spread of this bacteria are shown with both cartoon in the 
center and electron micrographs outside. 
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phagocytic cells (Braun and Cossart, 2000; Cossart, 2001), ActA to mediate actin 
nucleation and actin-based motility (Cameron et al., 2000). 
VI. L. monocytogenes PI-PLC 
PI-PLC from L. monocytogenes is a small 33 kDa protein. It is the most basic 
among the bacterial PI-PLC, with a pI above 9. This enzyme can be activated by salts and 
has relatively weak activity on GPI anchors, which is differ from the other well studied 
Bacillus sp. PI-PLC counterpart (Goldfine and Knob, 1992).  
The crystal structure of L. monocytogenes PI-PLC has been solved using 
molecular replacement and single isomorphous replacement with B. cereus PI-PLC as 
model despite the relative low sequence homology (∼24%) between them (Moser et al., 
1997). Similar to B. cereus PI-PLC, the L. monocytogenes enzyme folds as a TIM-barrel 
with dimensions of about 40 Ǻ × 40 Ǻ × 50 Ǻ. The TIM-barrel is also disordered due to 
missing two α-helices between strands IV and V, strands V and VI, respectively. The β-
barrel is also open between β-strands V and VI because of the lack of main-chain 
hydrogen bonding interactions. As shown in Figure 1-8 and Figure 1-12, most secondary 
structures of L. monocytogenes PI-PLC and B. cereus enzymes superimpose well except 
for the regions between strand V and VI. The strand Vb of B. cereus PI-PLC is missing in 
the L. monocytogenes enzyme, resulting in a more open active site groove and 
unfavorable binding of the oligosaccharide portion of GPI anchors (Wei et al., 2005). In 
compensation, two short strands, IIIb and IVB, are present in L. monocytogenes PI-PLC 
to stabilize this area. The α-helix B of L. monocytogenes PI-PLC, part of the expected 
interfacial region, is tilted by approximately 70˚. The regions dominated by amino acid  
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Figure 1-12 Structure-based sequence alignment of B. cereus PI-PLC (labeled BPI-PLC) 
and L. monocytogenes PI-PLC (labeled LPI-PLC) (adapted from Moser et al., 1997). L. 
monocytogenes PI-PLC is numbered from Tyr-30 of the PI-PLC precursor. Residues 
disordered in crystals are replaced by stars. α-helices, β-strands, and loops are 
symbolized by barrels, arrows, and lines, respectively. Conserved residues are in bold 
letters.  
71
63
128
128
189
179
237
243
288
298
 
 35
Figure 1-13 Side by side view of the active sites of B. cereus PI-PLC and L. 
monocytogenes PI-PLC with myo-inositol (labeled Ins in yellow) bound (adapted from 
Moser et al., 1997). 
 B. cereus PI-PLC L. monocytogenes PI-PLC
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Figure 1-14 Molecular surfaces of B. cereus PI-PLC and L. monocytogenes PI-PLC 
viewing from the C-terminal face of the ΤΙΜ-barrel (adapted from Moser et al., 1997). 
The active site pockets with bound myo-inositol (in yellow) are placed in the center. The 
hydrophobic ridge and the extended GPI-binding site are designated by A and B, 
respectively. The charges on the surface are shaded in red for negative potentials and blue 
for positive potentials. 
 B. cereus PI-PLC L. monocytogenes PI-PLC
 
 
 37
insertions and deletions are mostly in loops (Figure 1-12). Most residues of the active site 
pocket are conserved in both enzymes. These keep the inositol head group in an identical 
orientation and position (Figure 1-13). His-45 and His-93 of L. monocytogenes PI-PLC 
are found in the similar positions of His-32 and His-82, the critical catalytic residues, of 
the B. cereus enzyme. Mutagenesis studies confirmed the critical role of His-45 and His-
93 for catalysis (Bannam and Goldfine, 1999). Thus, the same reaction mechanism 
should be used by L. monocytogenes PI-PLC. Other than the structure, the differences in 
the surface charge between these two enzymes (Figure 1-14) are important for the 
regulation of activity as will be shown in our results. 
VII. Thesis directions 
The aim of this dissertation is to understand the kinetic behavior of L. 
monocytogenes PI-PLC and its biological relevance. Our interest in this enzyme arose 
because (1) this enzyme was reported as a virulence factor in the escape of bacteria from 
phagolysosomes (Smith et al., 1995; Portnoy et al., 2002) and in modulation of host cell 
signaling pathways including Ca2+ signaling in macrophages (Goldfine and Wadsworth, 
2002), and PI metabolism in endothelial cells and macrophages (Sibelius et al., 1996b; 
Goldfine and Wadsworth, 2002). (2) The preliminary studies revealed some distinct 
kinetic properties of this enzyme compared to the well studied Bacillus PI-PLC, named, 
salt activation and weak GPI activity (Goldfine and Knob, 1992). (3) The crystal 
structure of this enzyme has been solved and is very similar to that of the Bacillus PI-
PLC. This structure provided us with a straightforward starting point.  
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The first part of my project was to obtain enough L. monocytogenes PI-PLC for 
diverse kinetic and biophysical studies. After replacing TGA (the normal stop codon at 
the position of Trp-35 of PI-PLC precursor) by TGG (the normal codon for Trp) and 
getting rid of the signal sequence, we have cloned the truncated L. monocytogenes plcA 
gene from strain 10403S into the pTYB11 vector. The recombinant L. monocytogenes PI-
PLC without any extra N-terminal residues was overexpressed and purified using the 
IMPACT-CN system with a best yield of 6 mg/L. 
The kinetic behaviors of this enzyme were then studied based on the assays used 
for Bacillus enzyme with slight modifications. In general, water-soluble synthetic short 
chain phosphatidylinositol and cIP along with PI/detergent mixed micelles were used as 
substrates to understand how salts and other phospholipids affect both steps of PI 
hydrolysis by the L. monocytogenes PI-PLC. Along with the salt activation and lack of 
surface dilution inhibition, L. monocytogenes PI-PLC exhibited an added complication 
that protein concentration also affected enzyme specific activity. The results indicate that 
L. monocytogenes PI-PLC binds tightly to anionic phospholipids (e.g., PI, PG) and tends 
to form aggregated complexes with those anionic lipids. The enzymatic activity is much 
lower for those complexes. The two types of activators previously shown for this enzyme 
work by different mechanisms: (i) neutral amphiphiles, which enhance both steps of 
catalysis regardless of the aggregation state of the substrate, bind directly, though weakly, 
to the protein and enhance its catalytic ability (at sufficiently high mole fractions the 
amphiphiles can prevent the enzyme from forming the aggregated complexes), while (ii) 
moderate ionic strength (e.g., salts) only affects the phosphotransferase reaction and then 
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only when an activating interface is present. The latter is likely to be the result of altering 
the surface electrostatics and reducing the formation of aggregated complexes, and 
possibly altering the residence time of the enzyme on interfaces. A model rationalizing 
the role of both types of activators in modulating the enzyme activity in situ is presented. 
Based on the important interfacial regions (α-helix B and a particular loop) 
explored for the B. thuringiensis PI-PLC, we constructed several surface mutants (Trp-49, 
Thr-50, Leu-51, Leu-235, Thr-236, and Phe-237) in similar interfacial regions of L. 
monocytogenes PI-PLC to assess their contributions to surface binding and PI-PLC 
kinetics. The results suggest both α-helix B and the loop are kinetically important, 
particularly for the unusual kinetic traits of L. monocytogenes PI-PLC. Under our assay 
conditions, removal of just single hydrophobic residue (Leu-51, Leu-235, and Phe-237) at 
in these regions perturbed the unusual kinetic profile of L. monocytogenes PI-PLC in that 
none of the mutant enzymes showed the dramatically increased specific activity with 
decreasing enzyme concentration or with increasing TX-100 above Xdet=0.8 as observed 
for wild type recombinant PI-PLC. Trp-49 appeared to be important for catalysis as 
W49A PI-PLC exhibited dramatically reduced phosphotransferase and cyclic 
phosphodiesterase activities. The fluorescence studies of Trp-49 and Phe-237 mutants 
together with the FRET assays of T50C and T236C with fluorophores covalently attached 
revealed the connection between the affinity of enzyme for the interface and its kinetic 
profile. However, lacking a way to quantify the interfacial binding affinities of mutants to 
various lipid surfaces prevents us from looking further into this issue at this time. The 
relevance of kinetic modes of activation to the role of PI-PLC in helping L. 
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monocytogenes escape from primary phagosomes is also discussed. One interesting 
mutant, F237W, although still having high activity, showed reduced plaque sizes in 
fibroblast infection, strongly suggesting that the high affinity of enzyme for the anionic 
phospholipids is linked to its role in infectivity. 
Anther project addressed in this thesis is to explore the interactions of D-3-deoxy-
diC8PI molecules, designed to inhibit the PI3K/Akt pathway, with two different enzymes 
in the PI3K/Akt pathway. In vitro, these compounds were poor substrates and not 
inhibitors of the PLC. There was also little inhibition of PI3K observed except for 3-
deoxy-diC8PI enantiomers, suggesting that the 3-deoxy-diC8PI molecules are unlikely to 
have a significant effect on PI3K in vivo. 
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Chapter 2: 
 
Materials and methods 
 42
I. Materials 
A. Molecular biology reagents 
The pET-23a(+) vector, T4 DNA ligase, BL21(DE3), BL21(DE3)pLysS and 
NovaBlue E. coli strains were obtained from Novagen. Restriction enzymes and 
IMPACT-CN kit (including pTYB11 vector and ER2566 E. coli strains) were purchased 
from New England BioLabs. BL21-CondonPlus competent cells and Taq PCR Core Kit 
were from Stratagene. The oligonucleotide primers were ordered from Operon 
Biotechnologies. QIAprep Spin Miniprep Kit, QIAquick PCR Purification Kit, QIAquick 
Gel Extraction Kit, and QuikChange Site-Directed Mutagenesis Kit were from 
QIAGENE. 1 Kb Plus DNA Ladder and protein ladder for SDS-PAGE were from 
Molecular Probes, Inc. TEMED (N,N,N’,N’-tetramethylethylenediamine) and basic 
proteins used as standards for the acidic native PAGE were ordered from Sigma. IPTG 
(isopropyl-β-D-thiogalactopyranoside) and antibiotics were from American Bioanalytical. 
The 30% acrylamide/bis solution, SDS (sodium dodecyl sulfate), ReadyStrip IPG gel 
strips, and 4-20% Criterion Tris-HCl gradient Precast Gels were from Bio-Rad. All other 
reagents for media, plates, and gel electrophoresis were obtained from Fisher Scientific. 
Recombinant p110α/p85α PI-3-kinase was purchased from Upstate Biotechnology, and a 
chimeric rat PLC, with the catalytic domain of phospholipase Cδ1 and the N-terminal PH 
domain of phospholipase Cβ1, was the gift of Dr. Suzanne Scarlata, University of New 
York at Stony Brook. 
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B. Resins 
Resins purchased from Amersham Pharmacia Biotech include SP Sepharose fast 
flow, Sephadex G-100, and Sephadex G-10. AG 1-X8 (formate form, 100-200 mesh) was 
obtained from Bio-Rad and chitin bead resin was from New England BioLabs. 
C. Phospholipids 
Most of the lipids used in this work were purchased from Avanti Polar Lipids, 
Inc., and used without further purification. These included the long chain lipids 1-
palmitoyl-2-oleoyl-phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl-phosphatidyl-
serine (POPS), 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG), 1-palmitoyl-2-oleoyl-
phosphatidic acid (POPA), 1,2-dioleoyl-sn-glycero-3-phosphatidylmethanol (DOPMe), 
L-α-phosphatidylinositol (PI) from bovine liver, and the short chain phospholipids 
diheptanoylphosphatidylcholine (diC7PC) and dihexanoylphosphatidylcholine (diC6PC). 
Crude phosphatidylinositol (PI) was purchased from Sigma and short chain dibutyroyl-
phosphatidylinositol (diC4PI) was from Echelon Biochemicals. All the 3-deoxy-
phosphatidylinositol derivatives used were gifts of Dr. Yingju Xu and Dr. Scott Miller, 
Boston College. 
D. Fluorophore probes 
Most of the fluorophore probes were purchased from Molecular Probes, Inc, 
including β-Pyr-C10-PG (1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-
phosphoglycerol, ammonium salt), β-BODIPY FL C5-HPC (2-(4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-
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phosphocholine), and CPM (7-diethylamino-3-(4’-maleimidylphenyl)-4-methylcoumarin). 
Carboxyfluorescein (a mixture of 5- and 6-carboxyfluorescein) was ordered from 
Eastman Kodak Co. 
E. Other chemicals 
Isopropanol, DMSO, chloroform, ethanol, D2O, Trizma base, HEPES, boric acid, 
glycerol, Triton X-100, myo-inositol, EDTA, sodium phosphate, NaOH, NaCl, and HCl 
were purchased from Sigma. Chemical cross-linking reagents, including EDC (1-ethyl-3-
[3-dimethylaminopropyl]carbodiimide hydrochloride), DMS (dimethyl 
suberimidate·2HCl), APG (p-azidophenyl glyoxal monohydrate), and lysine blocking 
reagent citraconic anhydride (2-methylmaleic anhydride) were purchased from Pierce. 
II. Methods 
A. Molecular biology techniques 
1. Cloning and overexpression systems 
Two cloning and overexpression systems (pET and IMPACT-CN) were used in 
this thesis to clone the plcA gene for L. monocytogenes PI-PLC.  
Both pET and IMPACT-CN systems are based on the T7 promoter-driven system 
originally developed by Studier and colleagues (Studier and Moffatt, 1986; Rosenberg et 
al., 1987; Studier et al., 1990). Figure 2-1 illustrates how the overexpression of the 
recombinant gene is regulated in the pET system. In pET vectors, the multiple cloning 
sites are placed downstream of a bacteriophage T7 transcription promoter, which is not 
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recognized by the E. coli RNA polymerase, and upstream of T7 terminator. For 
overexpression, T7 RNA polymerase (encoded by T7 gene 1) is provided by DE3 
lysogen host strains. Because sequences of both T7 promoter and terminator are rare in E. 
coli and T7 RNA polymerase is about 5 times faster that E. coli RNA polymerase, the 
genes controlled by T7 promoter can be overexpressed in E. coli. The engineered DE3 
phage fragment also contains lacUV5 promoter and lacI gene for lac repressor. A 
lacUV5 promoter-lac operator fragment precedes the T7 gene 1 as the transcriptional 
control switch for production of T7 RNA polymerase. The lac repressor protein binds 
tightly to the lac operator as a tetramer and specifically in the absence of IPTG, causing 
transcriptional repression by interfering with the binding of RNA polymerase to the 
lacUV5 promoter. In the presence of IPTG, this inducer binds to the lac repressor protein, 
dissociating it from lac operator and turning on the transcription of T7 RNA polymerase 
in the host cell. The translated T7 RNA polymerase then binds the T7 promoter in the 
vector and initiates the transcription of the cloned gene. Most pET vectors also contain 
lac operator immediately downstream of T7 promoter (named T7lac promoter) and lacI 
gene for stringent transcription control. With a high number of genetic backgrounds 
modified for various expression purposes, the pET system has been greatly expanded and 
proved to be a powerful system for the cloning and expression of recombinant proteins in 
E. coli (the desired product can comprise more than 50% of the total cell protein a few 
hours after induction).  
 Figure 2-1 Expression of the target gene is regulated with T7/lac promoter in pET expression system (adapted from Sørensen 
and Mortensen, 2005). Without IPTG, LacI binds to lac operator as a tetramer to prevent the transcription of both T7 gene 1 
and target gene. IPTG can bind to the LacI tetramer to dissociate it from lac operator and turn on the transcriptions.  
transcription
transcription
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Novagen’s pET system offers a wide selection of cloning and expression 
strategies. Target protein expressed in a pET system could be native or with fusion 
partner which may optionally be removed via protease cleavage. Using the inducible 
protein self splicing activity of an intein to remove a purification tag and give pure 
isolated protein in single chromatography step, the IMPACT-CN system provides a novel 
cloning and expression strategy for taking advantage of the power of the T7 promoter. 
Protein splicing is a post-translational processing event involving the excision of an 
internal protein segment, the intein, from a precursor protein and the concomitant ligation 
of the flanking N- and C-terminal regions (the exteins) (Perler et al., 1994). Studies 
revealed that the protein splicing of intein from the Saccharomyces cerevisiae VMA1 
gene follows four chemical reaction steps (Xu et al., 1993; Chong et al., 1996; Xu and 
Perler, 1996; Chong et al., 1998): (1) formation of a linear thioester intermediate by an N-
S acyl rearrangement at Cys-1 of intein; (2) formation of a branched intermediate by 
transesterification of the N-terminal extein from the Cys-1 to Cys-455 (the first residue of 
C-terminal extein); (3) release of the transitory extein ligation product (linked via 
thioester bond) through peptide cleavage coupled to succinimide formation at Asn-454 of 
intein; (4) formation of a stable spliced extein (linked by amide bond) by spontaneous S-
N acyl rearrangement at Cys-455. Based on these studies, IMPACT-CN vectors have 
been developed to overexpress the target protein fused with N- or C-terminal of a 
modified VMA intein protein carrying a chitin binding domain (CBD) (Figure 2-2). In 
the C-terminal fusion vectors (pTYB1 and pTYB2), the Asn-454 of intein has been  
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Figure 2-2 The chemical mechanism of the thiol-inducible cleavage reactions catalyzed 
by the modified VMA intein (adapted from the IMPACT-CN manual). In the N-terminal 
fusion IMPACT-CN vectors, the CBD is inserted in a loop region of the intein without 
affecting its splicing and cleavage activity. N-extein contains partial maltose-binding 
protein to facilitate the translation start for the fusion precursor. 
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Figure 2-3 A schematic illustration of the IMPACT-CN system (adapted from the 
IMPACT-CN manual). 
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mutated to Ala to block the splicing reaction but still allowing the N-S acyl shift at Cys-1 
of the intein. In the N-terminal fusion vectors (pTYB11 and pTYB12), the penultimate 
His-453 has been changed to Gln to attenuate the succinimide formation at Asn-454. 
With these modifications, the protein splicing activity of the intein has been converted 
into efficient, controllable peptide bond cleavage at both termini of the intein. As shown 
in Figure 2-3, the fusion precursor can specifically bind to the chitin beads while other E. 
coli host proteins are washed away. Soaking with cleavage buffet containing thiols such 
as DTT, β-mercaptoethanol or cysteine, the intein undergoes specific self-cleavage and 
releases the target protein. The purity of the recombinant protein from the affinity 
chromatography is usually very high and no further purification is required. 
2. PCR cloning 
The procedure for cloning PCR products is shown in Figure 2-4. To direct the 
insert orientation of target genes, different restriction endonuclease recognition sites 
allowing generation of sticky ends were incorporated into the PCR forward and reverse 
primers. The selected restriction sites should be uniquely located in the polycloning sites 
of the desired vector but not in the target genes. There should be at least 3 bases between 
the two chosen restriction sites in the desired vector to ensure the cleavage efficiency 
because many restriction enzymes cleave DNA much less efficiently towards the end of a 
fragment. Two restriction sites that have comparable digestion conditions (buffer and 
temperature) are preferred for performing the convenient double digestion of the PCR 
product. To clone the truncated plcA gene for mature PI-PLC into pET-23a(+), an NdeI  
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Figure 2-4 PCR cloning procedure. 
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PCR product
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restriction site (catatg) was used in the forward primers as it conveniently contains the 
start codon (ATG). Primers were designed based on the following guidelines. (1) The 3’-
end of primer overlaps with the 5’-end of target gene for forward primer or the antisense 
strand for reverse primer. The overlap should be long enough (more than 17 bases) to 
provide specificity of PCR. Although a primer ending in G or C is preferred to increase 
the efficiency of priming, it is recommended not to have more than three G or C bases at 
the 3’-end of primer which could stabilize the nonspecific annealing of the primer. A 3’-
T should also be avoided as it is more prone to mispriming than other nucleotides. (2) 
Non-annealing overhang (like a restriction site) can be added to the 5’-end of primer 
since 5’ terminal bases are less critical for primer annealing. A 5’ extension of the 
restriction site with 2-10 bases greatly increases the cleavage efficiency of most enzymes. 
(3) The GC content of the primer is usually between 40 and 60%. (4) One should make 
sure the forward and reverse primers do not form a primer dimer (especially no 
complementary sequences at the 3’-end) or form significant secondary structure. (5) The 
primer pair should have similar melting temperatures (Tm). The primers used in all of the 
PCR cloning presented in this thesis are listed in Table 2-1. 
Using the designed primers, the target genes were amplified from the pBS1462 by 
DNA polymerase chain reaction according to Taq PCR handbook (annealing temperature 
was set at 55°C). The PCR result was checked by electrophoresis of 10 µl of the product 
on a 1% agarose gel. The remaining PCR product was purified directly with a QIAquick 
PCR Purification Kit and doubly digested at 37°C for 4 hours with two restriction 
enzymes corresponding to the restriction sites incorporated in the primer pair. Because 
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the same selective marker (ampicillin resistance) is used in both parent vector 
(pBluescript II KS) and destination vector (pET-23a(+) or pTYB11), it is necessary to 
gel-purify the DNA fragment of interest to remove the original plasmid which will 
transform very efficiently. The desired vector was also doubly digested with the same set 
of endonucleases. Following vector digestion, it is usually worthwhile to gel-purify the 
digestion reaction mixture prior to ligation to remove residual nicked and supercoiled 
plasmid, which transform more efficiently compared to the desired ligation products. The 
digestion reaction mixtures of PCR product and vector were then electrophoresed on 1% 
agarose gel containing 1 µg/ml ethidium bromide. The bands with the expected size on 
the gel were cut and purified using the QIAquick Gel Extraction Kit. T4 DNA ligase was 
used to perform the ligation of digested-PCR product and digested-plasmid. After 
incubation at 16°C for 16 hours, the ligation mixture was transformed into NovaBlue E. 
coli competent cells for plasmid propagation and preparation. Positive colonies could be 
identified by restriction digestion and confirmed by double strand DNA sequencing. The 
constructed plasmids were then ready for being transformed into the expression 
competent cells for overexpression. 
3. Site-directed mutagenesis  
A series of PI-PLC mutants were constructed using Quik-ChangeTM Site-Directed 
Mutagenesis Kit. The QuikChange mutagenesis method (Braman et al., 1996) relies on 
linear amplification of both strands of plasmid template (isolated from dam+ E. coli 
strains) by thermostable, nonstrand-displacing PfuTurbo® DNA polymerase. Extension of 
mutagenic oligonucleotide primers by the PfuTurbo® DNA polymerase generates 
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Tm = 81.5 + 0.41 (% GC) - 675 / (primer length in bases) – (% mismatch) 
mutated plasmid containing staggered nicks. Thus, DNA synthesis always uses the 
parental plasmid as template, not the newly synthesized strands. The parental plasmid 
template is eliminated by incubation with Dpn I endonuclease which specifically digests 
DNA methylated at the sequence 5’-Gm6ATC-3’. Because DNA isolated from dam+ E. 
coli strains is dam (DNA-[N6-adenine] methyltransferase) methylated, but DNA 
synthesized in vitro is not, Dpn I digestion enriches for the mutant plasmid (Nelson and 
McClelland, 1992). The resulting nicked mutagenic strands are transformed into XL1-
Blue supercompetent cells where bacterial ligase repairs the nick and allows normal 
replication to occur. The four-step procedure of QuikChange mutagenesis method is 
displayed in Figure 2-5.  
Mutagenic primers were designed according to the guidelines provided in 
QuikChangeTM Site-Directed Mutagenesis instructions. (1) Two primers containing the 
desired mutation (deletion or insertion) are located at the same sequence on opposite 
strands of the plasmid. (2) The desired mutation should be in the middle of the primer 
and flanked with more than 10 bases of unmodified nucleotide sequence. (3) The optimal 
primer should have 25-45 bases in length, at least 40% GC content, and terminal G or C 
bases. The Tm of primer, calculated with the formula below, is required to be no lower 
than 78°C. However, primers with lower melting temperature (70°C in our case) also 
worked. (4) The primer must be purified by polyacrylamide gel electrophoresis (PAGE) 
or liquid chromatography (e.g. HPLC or FPLC). The primers used in mutations are listed 
in Table 2-2. 
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Table 2-1 Primers used for cloning with restriction endonuclease recognition sites in 
capital letters and DNA fragments from the target gene underlined. Plasmid marked with 
∗ contains a stop codon (TGA) in the place of the codon for Trp-35 of PI-PLC precursor. 
 
 
Template Primers Plasmid 
XbaI forward primer 
5’-ggTCTAGAttctagtcctgctgtcc-3’ 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
pET1339* 
XbaI forward primer 
5’-ggTCTAGAttctagtcctgctgtcc-3’ 
SalI reverse primer 
5’-ggaataatatGTCGACcagctcttcttggtgaag-3’ 
pET1462* 
NdeI forward primer 
5’- ttttatactttCATATGttcccattaggcggaaaagcatattc-3’ 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
pET-F* 
NdeI forward primer 
5’-ttttatactttCATATGtattcgcttaataactgaaataag-3’ 
pBS1462* 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
pET-Y* 
NdeI forward primer 
5’- ttttatactttCATATGttcccattaggcggaaaagcatattc-3’ 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
pET-F-1w 
NdeI forward primer 
5’-ttttatactttCATATGtattcgcttaataactggaataag-3’ 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
pET-Y-1w 
SapI forward primer 
5’-ggtggttGCTCTTCcaacttcccattaggcggaaaag-3’ 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
IMPACT-F 
SapI forward primer 
5’-ggtggttGCTCTTCcaactattcgcttaataactggaataag-3’ 
pBS1462-1w 
EcoRI reverse primer 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’ 
IMPACT-Y 
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Figure 2-5 QuikChange site-directed mutagenesis method (adapted from manufacturer’s 
instructions). The annealing temperature was set as 68°C for L. monocytogenes PI-PLC. 
 
For L. monocytogenes PI-PLC: 
Denaturation (95ºC for 30 s) 
Annealing (68ºC for 1 min) 
Extension (68ºC for 16.6 min) 
12-18 cycles 
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Table 2-2 Primers used for mutagenesis with the codon for desired mutations in capital 
letters and substitution bases underlined. Mutants are numbered from Tyr-30 of the PI-
PLC precursor. 
 
 
Template Primers Plasmid 
5’-ggcggaaaagcatattcgcttaataacTGGaataagccaat-3’ 
pBS1462 
5’-attggcttattCCAgttattaagcgaatatgcttttccgcc-3’ 
pBS1462-1w 
∗6W 
5’-cggagacatgacgGCGacattaaccaaaccactgg-3’ 
IMPACT-Y 
5’-ccagtggtttggttaatgtCGCcgtcatgtctccg-3’ 
IMPACT-Y 
W49A 
5’-ggagacatgacgtggGGAttaaccaaaccactgg-3’ 
IMPACT-Y 
5’-ccagtggtttggttaaTCCccacgtcatgtctccg-3’ 
IMPACT-Y 
T50G 
5’-ggagacatgacgtggTGCttaaccaaaccactgg-3’ IMPACT-Y 
T50G 5’-ccagtggtttggttaaGCAccacgtcatgtctccg-3’ 
IMPACT-Y 
T50C 
5’-ggagacatgacgtggacaGCAaccaaaccactgg-3’ 
IMPACT-Y 
5’-ccagtggtttggtTGCtgtccacgtcatgtctcc-3’ 
IMPACT-Y 
L51A 
5’-gcgccacttcaGCAacattcacacctcgtcag-3’ 
IMPACT-Y 
5’-ctgacgaggtgtgaatgtTGCtgaagtggcgc-3’ 
IMPACT-Y 
L235A 
5’-gcgccacttcattaGGAttcacacctcgtcag-3’ 
IMPACT-Y 
5’-ctgacgaggtgtgaaTCCtaatgaagtggcgc-3’ 
IMPACT-Y 
T236G 
5’-gcgccacttcattaTGCttcacacctcgtcag-3’ IMPACT-Y 
T236G 5’-ctgacgaggtgtgaaGCAtaatgaagtggcgc-3’ 
IMPACT-Y 
T236C 
5’-gcgccacttcattaacaTGGacacctcgtcag-3’ 
IMPACT-Y 
5’-ctgacgaggtgtCCAtgttaatgaagtggcgc-3’ 
IMPACT-Y 
F237W 
5’-gcgccacttcattaacaGCCacacctcgtcag-3’ 
IMPACT-Y 
5’-ctgacgaggtgtGGCtgttaatgaagtggcgc-3’ 
IMPACT-Y 
F237A 
5’-gcgccacttcattaacaGCCacacctcgtcag-3’ IMPACT-Y 
W49A 5’-ctgacgaggtgtGGCtgttaatgaagtggcgc-3’ 
IMPACT-Y 
W49A/F237A 
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The mutagenesis was performed following the protocol in the manual with 
modifications. Briefly, 5-50 ng of the double-stranded, supercoiled plasmid template and 
125 ng of mutagenic sense and antisense primers (an excess concentration of primers 
should be used during the temperature cycling) were added in a 50 µl reaction mixture 
containing deoxyribonucleotides, reaction buffer, and PfuTurbo® DNA polymerase. The 
cycling parameters were set according to the manufacturer’s recommendations except the 
suggested annealing temperature (55°C) was increased to that used in extension (68°C) to 
avoid the effect of primer dimer formation. The cycling condition used was denaturation 
at 95°C for 30 s, annealing at 68°C for 1 min and extension at 68°C for 16.6 min, with 
12-18 cycles. The linear amplification product was treated with Dpn I for 1 h at 37°C and 
transformed into XL1-Blue supercompetent cells for plasmid propagation and preparation. 
The QuikChangeTM Site-Directed Mutagenesis Kit works for simultaneously changing at 
most two bases of IMPACT-Y may be due to the large size of IMPACT-Y (8243 bp). 
Stepwise mutagenesis was applied if all three bases of a codon had to be changed (the 
revised manual suggests QuikChange® XL Site-Directed Mutagenesis Kit for large 
targets ∼8 kb). By using high fidelity PfuTurbo® DNA polymerase, low cycle number 
(12-18), and primers designed only to copy the parental strands in a linear fashion, 
unwanted mutations were minimized. All mutants were confirmed with double strand 
DNA sequencing (done by Sequegen Company).  
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4. Transformation 
The CaCl2 method was used for transformation of E. coli cells. 1 µl plasmid 
(isolated with QIAprep Spin Miniprep kit) or 1 µl Dpn I-treated mutagenesis reaction 
mixture or 10 µl ligation reaction mixture was mixed gently with 50-100 µl competent 
cells and incubated on ice for 30 min. The transformation mixture was then heat shocked 
at 42°C for 30-45 sec according to the competent cell used and the incubated on ice for 2 
min. 500 µl fresh LB or NZY+ media without antibiotics was added and the cells were 
grown at 37°C in a Rollerdrum for 1 hour. After incubation, 200 µl of the mixture was 
spread on LB agar plate containing appropriate antibiotics and incubated overnight at 
37°C. 
5. Plasmid DNA isolation 
Plasmid preparations were performed with QIAprep Spin Miniprep Kit following 
the protocol using a microcentrifuge. DNA was eluted with water at the final step, 
quantified via spectrophotometric measurement of UV absorption at 260 nm, and stored 
at -20°C.  
B. Overexpression and purification of recombinant L. monocytogenes PI-PLC 
1. Expression of recombinant PI-PLC cloned in pET-23a(+) 
The recombinant plasmid pET1339 (or pET1462, pET-F-1w, and pET-Y-1w) was 
transformed into several BL21 E. coli host strains (BL21(DE3), BL21(DE3)pLYsS, 
BL21-CondonPlus(DE3)-RIL, or BL21-CodonPlus(DE3)-RP) for expression. A single 
colony of transformed BL21 E. coli cell was grown in 5 ml of LB medium in the 
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presence of 100 µg/ml ampicillin and 34 µg/ml chloroamphenicol (not added for 
transformed BL21(DE3) cells) overnight at 37°C. An aliquot (2 ml) of the overnight 
culture was used to inoculate 2 L fresh LB medium with the antibiotics in a rotary shaker 
(200 rpm) at 37°C. Expression of recombinant PI-PLC was induced by adding IPTG at a 
final concentration of 0.4 mM when the growing culture reached an optical density 
between 0.6 and 0.8 at 600 nm. The culture was incubated at 37°C for 3 h or 30°C for 8 h 
after induction.  
To check the expression of recombinant PI-PLC in BL21 E. coli strains, cells 
were harvested by centrifugation at 5,000 rpm for 10 min, resuspended in 20 ml ice-cold 
buffer containing 20 mM Tris-HCl, pH 7.0, and lysed by sonication on ice for 10 × 30 s. 
Cell debris was separated from the supernatant by centrifugation at 15,000 rpm for 30 
min and dissolved in 10 ml ice-cold Tris-HCl buffer containing 1% SDS (pH 7.0). 200 ml 
of cell culture medium (with the cells removed) was concentrated to ∼1 ml using a 
Millipore Centriprep YM-10. No PI hydrolysis activity was detected in the cell extract 
supernatant, solubilized cell debris, or concentrated culture medium. SDS-PAGE analysis 
of them did not show obvious overexpression of a protein band with 33 kDa molecular 
mass. So we abandoned further attempts on purification.  
2. Overexpression and purification of recombinant PI-PLC cloned in pTYB11 
The recombinant plasmid IMPACT-F or IMPACT-Y was transformed into 
ER2566 competent cells for expression. A single colony of ER2566 containing the 
recombinant plasmid was grown in 5 ml of LB medium in the presence of 100 µg/ml 
ampicillin overnight at 37°C. An aliquot (5 ml) of the overnight culture was used to 
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inoculate 2 L fresh LB medium with the antibiotic in a rotary shaker (200 rpm) at 37°C. 
Expression of recombinant PI-PLC was induced by adding IPTG at a final concentration 
of 0.8 mM when OD600 of growing culture was between 0.7 and 0.8. After induction, the 
culture was incubated at 16°C for 20 h. The expression of recombinant PI-PLC in 
ER2566 was checked in the same way used to test that in BL21 E. coli strains. The cell 
extract supernatant of ER2566 harboring IMPACT-Y had high PI-PLC activity, albeit no 
obvious band of 88 kDa on SDS-PAGE gel. To obtain the homogeneous PI-PLC, the 
ER2566 cells containing IMPACT-Y were harvested by centrifugation (5,000 rpm for 10 
min) and stored at -80°C until needed.  
The frozen cell pellets from 2 L culture were thawed at room temperature, 
resuspended in 50 ml ice-cold column buffer (20 mM Tris-HCl, 0.5 M NaCl, pH 8.4), 
sonicated for 10 × 30 s on ice, and centrifuged at 15,000 rpm for 30 min to remove the 
cell debris. The cell extract supernatant was loaded slowly (0.4 ml/min) onto an affinity 
column of chitin beads (∼20 ml) equilibrated with 200 ml column buffer. After loading, 
the chitin column (2.5 cm × 20 cm) was washed sequentially with 20 ml column buffer at 
1 ml/min, at least 200 ml washing buffer (20 mM Tris-HCl, 1 M NaCl, pH 8.0) at 2 
ml/min to thoroughly remove the unbound contaminants, and 60 ml cleavage buffer (20 
mM Tris-HCl, 0.5 M NaCl, 50 mM DTT, pH 8.4) at 2 ml/min. The on-column cleavage 
of fusion protein was allowed to proceed at room temperature for 20 h. Cleaved PI-PLC 
protein was eluted from the column with 200 ml dialysis buffer (20 mM Tris-HCl, pH 
7.0). Fractions containing PI-PLC activity (usually the first 50 ml) were pooled, dialyzed 
twice at 4°C to remove co-eluted DTT, salts and a small peptide (1.6 kDa), passed 
 62
through a 0.22 µm filter, and concentrated using Millipore Centriprep YM-10 to 1-10 
mg/ml. All protein concentrations were determined by Lowry assay (Lowry et al., 1951). 
The best yield for recombinant L. monocytogenes PI-PLC was about 6 mg/L. The stock 
solution can be stored at 4°C without activity loss for ∼1 month. 
The SDS-PAGE analysis (Figure 3-11) showed that the purity of PI-PLC after the 
chitin column was more than 85% and that PI-PLC was contaminated with a band around 
50 kDa, which should be the intein tag judging from the SDS-PAGE gel of chitin beads 
after elution of PI-PLC. If needed, a SP Sepharose Fast Flow column (1.5 cm × 15 cm) 
was used to further purify PI-PLC right after dialysis. The dialyzed eluate from the chitin 
column was applied at 2 ml/min onto the strong cation exchange column (∼25 ml) 
equilibrated with 100 ml starting buffer (50 mM sodium phosphate buffer, pH 7.0). The 
protein was eluted using a NaCl gradient ranging from 0 to 0.5 M in 50 mM sodium 
phosphate (pH 7.0) at rate of 2 ml/min, dialyzed to remove the high salts, filtered and 
concentrated. Only the PI-PLC band was observed on the SDS-PAGE gel after these two 
columns.  
C. Chemical modification of lysine residues of L. monocytogenes PI-PLC 
1. Citraconic Anhydride modification 
Modification was carried out using citraconic anhydride as a specific blocking 
agent for lysine residues. As depicted in Figure 2-6, chemical modification of PI-PLC 
with citraconic anhydride changes the positive charges of lysine residues on the protein  
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Figure 2-6 The reaction of citraconic anhydride with an amine-containing molecule at 
pH 8 and followed by deblocking of the amine at pH 3-4 (adapted from manufacturer’s 
instructions).  
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surface to negative ones. Sodium phosphate, 0.5 M at pH 8.5, was used to provide 
adequate buffer capacity. The PI-PLC to be modified was purified with two columns 
(chitin column and SP Sepharose Fast Flow column), dialyzed against reaction buffer, 
and concentrated. 200 µl PI-PLC (6.5 mg/ml) was incubated with 1 µl to 50 µl citraconic 
anhydride (113 mM, diluted with reaction buffer) in 1 ml of reaction buffer at room 
temperature for 3 h. The pH of the reaction mixture was monitored and remained stable at 
8.5 during the reaction. The reaction mixture was then dialyzed extensively against 20 
mM Tris-HCl (pH 7.0) to quench the reaction. The Tris containing a primary amino 
group, reacts with the excess citraconic anhydride, and changes the stock buffer for PI-
PLC. 
2. Two-dimensional gel electrophoresis 
The charge heterogeneity of citraconic anhydride modified PI-PLC was checked 
using two-dimensional polyacrylamide gel electrophoresis with immobilized pH 
gradients (IPG-Dalt) (Görg et al., 1988; Görg, 1998). The first dimension, isoelectric 
focusing (IEF), was performed in ReadyStrip IPG gel strips (pH gradient 3-10, 11 cm) 
using sample in-gel rehydration. Protein, 200 µl in rehydration buffer (9M urea, 4% 
CHAPS, 15 mM DTT, 0.2% Bio-Lyte, and traces of bromophenol blue crystals) was 
loaded onto the middle of an IPG strip which was then covered with mineral oil and 
rehydrated on a Bio-Rad Protean IEF cell under active condition at 20°C for 12 h. The 
strips were run with the following 4-step program (all steps with a current limit of 50 µA 
per gel): 250 V, linear ramp for 15 min; 8,000 V, linear ramp for 2.5 h; 8,000 V, for a 
total of 35,000 V-hr; and 500 V, for hold. To prepare for the second dimension, the strips 
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were removed from the focusing tray, equilibrated with buffer containing 6 M urea, 2% 
SDS, 0.375 Tris-HCl, pH 8.8, 20% glycerol, and DTT or β-mercaptoethanol, washed 
with electrophoresis running buffer (25 mM Tris-base, 200 mM glycine, 0.1% SDS), 
layered on 4-20% Criterion Tris-HCl gradient Precast Gels, and embedded in place with 
0.5% agarose melted in the electrophoresis running buffer. Electrophoresis was 
performed at 90 V for ∼2.5 h until the dye front ran off the gel. Gels were then stained 
overnight with Coomassie Brilliant Blue. 
D. Determination of L. monocytogenes PI-PLC native molecular weight 
1. Gel filtration 
Gel filtration was carried out at room temperature on a Sephadex G-100 column 
(1.5 cm × 75 cm). Sephadex G-100 resin (∼ 8 g of 40-120 µm particle size, 15-20 ml/g 
bed volume, 4-150 kDa fractionation range) was hydrated with boiling deionized water 
(passed through a 0.2 µm filter) for 3 h, degassed gently after decanting the very fine 
particles, and packed at 1 ml/min. The column was equilibrated with 50 mM Tris-HCl, 
pH 7.0 and 0 or 500 mM NaCl buffer. The void volume was measured with Blue Dextran 
(2,000 kDa), and the column was calibrated with sweet potato β-amylase (200 kDa), 
yeast alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), bovine 
erythrocyte carbonic anhydrase (29 kDa), and horse heart cytochrome c (12.4 kDa). The 
protein sample (0.5 ml) was loaded onto the column and eluted with the same buffer used 
for equilibration at a flow rate of 0.3 ml/min. The eluate was monitored with an on-
column UV detector at 280 nm and collected in 1 ml fractions. A plot of log molecular 
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mass vs. elution volume should be linear over the useful fractionation range of gel for 
roughly spherical proteins.  
2. Acidic nondenaturing acrylamide gel electrophoresis 
Standards and L. monocytogenes PI-PLC (∼5µg of each) mixed with 64 mM 
acetate-KOH buffer (pH 6.8) containing 37% glycerol and traces of methyl green were 
electrophoresed on polyacrylamide mini slab gels based on an acidic-native gel protocol 
for basic proteins (http://wolfson.huji.ac.il/purification/Protocols/PAGE_Acidic.html) in 
which the acetate-KOH buffer was used to prepare the gels. The pH of the separating gel 
was 4.3 while that of stacking gel was 6.8. The electrophoresis running buffer (pH 4.3) 
consisted of 0.35 M β-alanine and 0.14 M acetate. Three commercially available basic 
proteins, lentil lectin (98 kDa), chicken egg white lysozyme (14.3 kDa), and bovine 
pancreas α-chymotrypsinogen (25.6 kDa), were used as standards. With the power 
polarity reversed, the electrophoresis was conducted at a constant voltage of 120 V in the 
cold room (4°C) until the dye front approached the bottom of the gel (∼1 h). The 
positions of methyl green were marked and the gels were stained with Coomassie 
Brilliant Blue overnight. Plots of protein relative mobility versus acrylamide 
concentration (7, 10, 12 and 15%), provided a negative slope that varied linearly with the 
molecular weight. The standard curve from this slope was used to extract a native mass 
for L. monocytogenes PI-PLC. 
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3. Laser light scattering 
L. monocytogenes PI-PLC after the two-column purification was sent to HHMI 
Biopolymer Facility and W. M. Keck Foundation Biotechnology Resource Laboratory to 
determine native protein molecular weights by laser light scattering (LS) (Folta-Stogniew 
and Williams, 1999). The chromatography mode in which coupled size exclusion 
chromatography (SEC) serves solely as a fractionation step was first applied. Three 
detectors (LS, UV, and refractive index (RI)) are connected in series after the SEC 
column. The UV profile of the eluate (Figure 2-7) indicated that protein interacted with 
the column matrix dramatically and only a very small portion (∼2%) protein was eluted at 
a retarded time (∼20 ml, the region where small species, e.g. DTT, are normally eluted). 
The remaining protein sample was thus analyzed by micro-batch approach in which the 
sample from an injector loop was flown through the system to collect UV/LS/RI signals 
while the buffer was continuously delivered from the HPLC system. Conditions (1.1 ml 
protein sample, 500 µl sample loop, and 0.3 ml/min for 1 min 20 sec) were established to 
provide a reading “plateau” (∼0.2 ml, free of air and particle) in all three detectors 
(Figure 2-7). Transferrin with a comparable extinction coefficient to L. monocytogenes 
PI-PLC was used as a standard and the same calibration constant was applied to analyze 
the PI-PLC sample. The concentrations of PI-PLC during the reading plateau were 
measured with the UV absorbance at 280 nm (extinction coefficient=33710 M-1·cm-1, 1 
cm length). The molecular weight was determined by solving the equation (Wyatt, 1993) 
that relates the excess scattered light to the concentration of solute and the weight- 
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Figure 2-7 Light scattering analysis of L. monocytogenes PI-PLC. (A) UV trace 
(absorbance at 280 nm) of eluent from LS-SEC/UV/RI analysis; (B) UV traces of PI-PLC 
and transferrin from LS micro-bath analysis; (C) LS traces of PI-PLC and transferrin, 
detected at 90° angle, from LS micro-bath analysis. 
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average molecular weight by ASTRA calculations 
(http://info.med.yale.edu/wmkeck/6_16_98/Astra2a.htm#Calculation of MW by). 
E. Enzymatic synthesis and purification of cIP 
Crude soybean PI (50%) was used for the enzymatic generation of cIP as 
described previously (Zhou et al., 1997a) by taking the advantage of the fact that the 
phosphotransferase (PI cleavage) activity is much higher than the phosphodiesterase (cIP 
hydrolysis) activity for bacterial PI-PLC. The reaction condition was modified for L. 
monocytogenes PI-PLC. One gram of crude PI was dissolved overnight in 15 ml of 50 
mM Tris-HCl, pH 7.0, containing 220 mM Triton X-100 and 150 mM NH4Cl (this salt 
was added to activate the PI cleavage but inhibit the cIP hydrolysis by L. monocytogenes 
PI-PLC). Enzyme (20 µg) was added and the reaction progress (at 25 °C) was monitored 
using 31P NMR spectroscopy. After the PI was mostly hydrolyzed to cIP (when the height 
of the cIP peak no longer increased), further reaction (e.g., hydrolysis of cIP to I-1-P) was 
quenched by the addition of chloroform. The lipids (DAG and unhydrolyzed PI) in the 
reaction mixture were then extracted from the aqueous phase with a chloroform-methanol 
(about 4:1) solution. Typically, a clear aqueous phase could be achieved after 4 to 6 
extractions. cIP stayed in the aqueous phase and was purified using an AG 1-X8 (formate 
form, 100-200 mesh) anion exchange column (1.5 cm × 20 cm). AG 1-X8 resin, 10 g, 
was suspended in deionized water and packed in the column at 2 ml/min. The aqueous 
phase from the extraction was then applied, the column was eluted with 60 mM 
ammonium formate buffer (∼pH 7.4) at a flow rate of 1 ml/min, and 5-ml fractions were 
collected. The fractions containing cIP (detected by 31P NMR) were lyophilized to 
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remove ammonium formate. Typically, 100 mg of pure cIP could be obtained from 1 g 
crude PI.  
F. Vesicle preparation 
Lipid stock solution supplied in chloroform was placed in a 20 ml glass 
scintillation vial, and the chloroform was removed with a rotary evaporator. The resulting 
lipid film was dissolved in 5 ml water, frozen on dry ice, lyophilized overnight, and 
rehydrated with appropriate buffer. Lipids supplied as powder were dissolved in the 
buffer directly. To prepare small unilamellar vesicles, the chilled phospholipids 
suspensions were sonicated on ice using a Branson sonifier W-150 ultrasonic cell 
disruptor with a 1-cm-diameter probe until maximum clarity was achieved (with 1-min 
on, 1-min off cycle). Vesicles were centrifuged in a bench-top centrifuge (14,000 rpm for 
3 min) to remove residual titanium particles. 
G. PI-PLC activity assay 
The specific activity of PI-PLC was measured using 31P NMR spectroscopy (at 
202.3 MHz on a Varian Inova 500 spectrometer). NMR parameters were based on those 
previously reported (Volwerk et al., 1990; Zhou et al., 1997a) with some modifications. 
A 8.5 µs pulse width (90°), 14998 Hz sweep width, and variable number of transients 
were used. Two types of assays (end-point and continuous time point) were used for 
phosphotransferase activity (PI as substrate) and phosphodiesterase activity (cIP as 
substrate) respectively. Except for diC4PI, experiments were run in duplicate, the average 
specific activities were reported (typical errors <15%). 
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For long chain PI from bovine liver (8 mM) dispersed in diC7PC or Triton X-100 
micelles, or in SUVs in the absence and presence of POPC in 50 mM HEPES, pH 7.0, 
containing 0.5 mg/ml BSA, enzyme (between 0.01 and 7.2 µg/ml) was added to the 200 
µl assay mixture and incubated at 25°C. The reaction was quenched by the addition of 
400 µl chloroform at appropriate incubation times (from 1 min to a few hours) which 
were chosen so that less than 20% PI cleavage occurred. The protein concentrations were 
kept constant within the same series of assays as protein concentration also affects the 
activity of L. monocytogenes PI-PLC. The cIP content in the aqueous phase (separated 
from the organic layer using centrifugation at 14,000 rpm for 6 min) was quantified in the 
31P NMR spectrum using added glucose-6-phosphate (1 mM) as an internal standard 
(Figure 2-8A). Triton X-100 and salt effects were also measured using the water-soluble 
substrate diC4PI. In this assay, 100 µl assay mixture containing 2 mM diC4PI and 1.6 
µg/ml enzyme were used. PI-PLC activities toward diC8PI and the 3-deoxy-diC8PI 
derivatives were also measured with the end-point assay. The assay buffer for the 
recombinant L. monocytogenes PLC was 50 mM Tris-HCl, 0.5 mg/ml BSA, pH 7.0, and 
incubation was at 28˚C. For the recombinant PLCδ1, the assay buffer was 50 mM Tris-
HCl, 0.5 mM CaCl2, pH 7.5, and incubation was at 34˚C.  
In the continuous time point assay for cIP hydrolysis, the release of I-1-P product 
was monitored as a function of time until 20% of the cIP was converted to I-1-P using a 
31P NMR experiment where the pre-acquisition delay (pad) was arrayed (Figure 2-8B). A 
control spectrum was acquired prior to the addition of enzyme (t=0 min). The reaction 
was initiated by adding 3.6 or 7.2 µg/ml PI-PLC to 400 µl assay mixture in a NMR tube 
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typically containing 10 mM cIP in the absence and presence of different additives 
(diC7PC, POPC, DOPMe, POPS, salts) in 50 mM imidazole buffer (pH 7.0), incubated at 
25°C, and monitored for a period of time, typically from at least 30 minutes to a few 
hours. The rate of cIP hydrolysis was calculated from the slope of I-1-P production as a 
function of incubation time. The I-1-P concentration at various time points was calculated 
from the ratio of I-1-P to cIP since the total amount of I-1-P and cIP equals to that of 
starting cIP. 
H. PI3K activity assay 
PI3K (2 µg) was added to a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 
0.1 mg/ml BSA, 50 mM NaCl, 5 mM MgCl2, 2 mM ATP, 1 mM diC8PI and 0 to 3 mM 
of the 3-deoxy-diC8PI analogues. The reaction was incubated at 22˚C for 3 h and stopped 
by the addition of 10 mM EDTA. The phosphorylation on O-3 of PI and PI analogues 
was monitored by 31P NMR spectroscopy using the NMR resonance of the phosphate 
attached to the glycerol backbone as an internal standard. If PI(5)P was included in the 
reaction mixture, the contribution of the phosphate at O-5 (calculated from the ratio of it 
to the phosphate attached to glycerol) was considered to calibrate the activity as the 
phosphate peaks at O-3 and O-5 were not separated well under the assay condition 
(Figure 2-8C). 
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Figure 2-8 NMR spectra for the activity assays of (A) the PI-PLC phosphotransferase 
reaction, (B) the PI-PLC cyclic phosphodiesterase reaction, and (C) the PI3K reaction. 
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I. Interaction of PI-PLC with lipid surfaces 
1. Filtration/centrifugation/SDS-PAGE assay 
A simple binding assay (Stieglitz et al., 1999; Wehbi et al., 2003a) based on 
filtration and centrifugation was tried to characterize the binding of L. monocytogenes PI-
PLC to vesicle interfaces. Typically, 25 µg of PI-PLC was incubated at room temperature 
for 15 min with an aliquot of phospholipid vesicles solution (2 ml) in 10 mM Tris-HCl 
buffer, pH 7.0. The vesicle bound protein was separated from free protein using an 
Amicon centricon-100 filter with 100 kDa molecular mass cutoff. A control containing 
the same amount of PI-PLC in Tris-HCl buffer, pH 7.0, with no phospholipids present 
was used to measure the recovery efficiency of free enzyme from the 
filtration/centrifugation step. Filtrates, which contained only the free protein, were 
lyophilized, dissolved with 40 µl SDS sample loading buffer, and analyzed by SDS-
PAGE. Band intensities were quantified by NIH Image 1.61 software and used to 
calculate the amount of free protein from phospholipid containing samples by comparing 
their intensities to that of the control. The amount of vesicle bond protein was then 
evaluated as the amount difference between the total added protein and the quantified 
free protein. Binding could then be analyzed using Langmuir adsorption isotherm (Cho et 
al., 2001a) to yield the dissociate constant and number of lipid binding sites per PI-PLC 
molecule.  
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2. Monolayer penetration by PI-PLC 
Lipid monolayers have been used to characterize the ability of proteins to 
penetrate into the membrane (Verger and Pattus, 1982; Wehbi et al., 2003b). Lipid 
monolayers were formed by spreading 5 to 10 µl of the appropriate lipids (POPC, or 
DOPMe, or a mixture of 70% POPC and 30% DOPMe) dissolved in ethanol/hexane (1:9, 
v/v) onto 10 ml of 50 mM HEPES, pH 7.0, with KCl at three different concentrations (0, 
0.16, or 0.5 M) contained in a circular Teflon trough (4 cm diameter × 1 cm deep). The 
surface pressure (π) of subphase (the solution in the trough) was measured using a 
Wilhelmy plate attached to a computer-controlled tensiometer as described for the B. 
thuringiensis PI-PLC (Wehbi et al., 2003b). The subphase was gently mixed with a 
magnetic stir bar and the monolayer was allowed to equilibrate until a stable surface 
pressure (defined as the initial surface pressure, π0) was obtained. Then a protein solution 
was injected into the subphase through a small hole in the side of the trough without 
disruption of the monolayer. The change in surface pressure (Δπ) was measured as a 
function of time. Since the value of Δπ depends on the protein concentration in the low 
concentration range, protein concentration in the subphase was maintained high enough 
(above 3 µg/ml for PI-PLC) to ensure the observed Δπ represented a maximal value 
(Medkova and Cho, 1998). In general, Δπ is inversely proportional to the π0 of the lipid 
monolayer and extrapolations of the Δπ versus π0 plot to π0=0 and Δπ=0 yield the 
maximum Δπ obtainable and the critical surface pressure (πc) that specifies an upper limit 
of π0 into which a protein can penetrate respectively.  
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3. Carboxyfluorescein leakage assay of vesicle integrity 
To monitor vesicle leakage promoted by the bound L. monocytogenes PI-PLC, 
assays were performed according to literature procedure (Ravoo et al., 1999) with 
modifications. Carboxyfluorescein (Figure 2-11A), which is self-quenched at high 
concentration, was entrapped in the vesicle as a release marker. Briefly, vesicles were 
prepared by sonication of 20 mM of the appropriate lipids (POPC or DOPMe) with a 
solution of 100 mM carboxyfluorescein in 10 mM HEPES, pH 7.1, with 0 or 100 mM 
(NH4)2SO4. The nonencapsulated carboxyfluorescein was removed by rapid filtration of 
the vesicle solution through a Sephadex G-10 (fractionation range <700 Da) column (1.0 
cm × 20 cm) at room temperature using the corresponding HEPES buffer as the eluent. 
The carboxyfluorescein entrapped vesicles were used right after gel filtration. Vesicle 
integrity in the absence or presence of PI-PLC protein was monitored by the 
carboxyfluorescein fluorescence using an excitation wavelength of 490 nm and an 
emission wavelength of 520 nm. Leakage at time t was expressed in percentage relative 
to the initial fluorescence F0 and the maximum fluorescence FTX obtained after complete 
lysis of the vesicles by the addition of 25 mM Triton X-100 according to (Ft - F0) / (FTX - 
F0) × 100%. All the carboxyfluorescein assays were carried out in the dark and a narrow 
excitation slit width (1 nm) was used to minimize photobleaching of the 
carboxyfluorescein. 
4. Turbidity assay of macroscopic aggregation 
Aggregation and fusion of vesicles (POPC, POPG, DOPMe) promoted by PI-PLC 
were monitored by the increase in turbidity of the solution (Stieglitz et al., 2001) after the 
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addition of protein. The vesicle stock solutions were prepared by sonication of 
phospholipids in 50 mM HEPES, pH 7.0, and centrifuged at 15,000 rpm for 30 min with 
a bench-top centrifuge to get rid of bigger vesicles prior to the assay. The optical density 
of the vesicle solution (0.172 mM POPG / 0.62 mM POPC or 0.86 mM DOPMe / 3.1 
mM POPC or 3.1 mM POPC) was then measured at 350 nm as function as time after the 
addition of PI-PLC (protein, 4 µg to 1.5 mg, was added at t=10 min) and the baseline 
turbidity was provided by monitoring the OD350 of corresponding vesicles without 
protein. After a stable OD350 was reached, the solution was centrifuged at 15,000 rpm for 
10 min and both the precipitate (washed by buffer, dissolved with guanidine/salts, or 
dissolved with Triton X-100, or extracted with chloroform/methanol) and supernatant 
were subjected to analysis by SDS-PAGE and NMR spectroscopy. 
5. 31P NMR linewidth to monitor protein binding 
Changes in phospholipid 31P linewidths were used to monitor the binding of 
diC6PC and diC7PC to L. monocytogenes PI-PLC (2 mg/ml). The linewidth of the PC 
resonance was measured at various concentrations (0.1-20 mM) in the absence and 
presence of enzyme. Linewidth changes upon micellization of both of these short-chain 
lipids were small, so that the difference in linewidth caused by the presence of enzyme 
was initially assumed to reflect the amount of ligand bound to the enzyme in fast 
exchange with free ligand. As discussed previously (Zhou et al., 1997b), the difference in 
linewidth in the presence and absence of ligand at a given ligand concentration, (Δυobs-
Δυo), is a function of total concentration of enzyme (ET) and ligand ([PC]T), the bound 
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linewidth for the E·PC complex (Δυb), the dissociation constant (Kd), and n, the number 
of ligands bound per enzyme molecule. If there are multiple, independent binding sites 
for the PC (to form E·PCn) leading to the change in linewidth, and if the free 
[PC]>>[E·PC] complex, then the following equation holds: 
6. Chemical cross-linking of PI-PLC 
To check if L. monocytogenes PI-PLC aggregates on phospholipid interfaces, 
chemical cross-linking assays in the absence and presence of various phospholipid 
interfaces were performed. Three reagents, EDC, DMS, and APG were tried to trap any 
protein aggregates formed (Figure 2-9 and Figure 2-10). PI-PLC for cross-linking assays 
was purified by elution through two columns and dialyzed against the appropriate 
reaction buffer. The lipid surface was provided by micellar diC7PC (0.5-15 mM) or 
vesicle POPC (2 mM). Crosslinking by EDC, a carboxyl and amine-reactive zero length 
cross-linker, were carried out by incubating 300 µg/ml of PI-PLC with 50 mM of EDC in 
100 mM MES, pH at 5.0 or 7.0, at room temperature for 4 h. Reaction mixtures were then 
dialyzed against 10 mM Tris-HCl, buffer of pH 7.0 at 4°C to remove excess EDC, 
lyophilized, dissolved with SDS loading buffer, and analyzed by SDS-PAGE. 
Crosslinking by DMS, an imidoester cross-linker with an 11 Å spacer arm, were carried 
out by incubating 250 µg/ml of PI-PLC with 10 mM of DMS in 200 mM HEPES, pH 8.0,  
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Figure 2-9 Structure of (A) EDC (1-ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride) and (B) DMS (dimethyl suberimidate·2HCl) with 11.0 Å spacer arm. (C) 
EDC cross-linking reaction scheme; (D) DMS cross-linking reaction scheme. 
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Figure 2-10 (A) Structure of APG (p-azidophenyl glyoxal monohydrate) with 9.3 Å 
spacer arm; (B) APG cross-linking reaction scheme. 
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Figure 2-11 Structures of fluorescent labels: (A) (5 or 6)-carboxyfluorescein, (B) pyrene, 
(C) CPM, (D) BODIPY, and (E) CPM-PI-PLC. 
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at room temperature for 2 h. The reaction was quenched with dialysis against Tris-HCl 
buffer (pH 8.0) and checked with SDS-PAGE. Crosslinking with APG, a 
heterobifunctional cross-linker (spacer arm length 9.3 Å) with a phenylglyoxal group 
targeting the guanidium side chain of Arg residues and a nonspecific photoactivatable 
phenyl azide group, were performed in two steps: 2 mg/ml PI-PLC was incubated in the 
dark with 2.4 mM of APG in 20 mM of sodium phosphate, pH 7.5, for 6 h at room 
temperature; the subsequent photoactivation was performed with a 254 nm UV light 
source for 15 min at room temperature. Upon completion, the reaction mixture was 
dialyzed in the dark to get rid of the excess APG and checked with SDS-PAGE. 
7. Fluorescence spectroscopy 
Fluorescence spectroscopy has been widely used to monitor environmental and 
conformational changes of macromolecules. Except for self-quenching 
carboxyfluorescein, several other types of fluorophores (Figure 2-11), including the 
intrinsic tryptophanyl residues of PI-PLC, pyrene, and BODIPY-CPM fluorescence 
resonance energy transfer (FRET) pair, were tried to study the effect of interfaces on the 
PI-PLC with steady-state fluorescence. All the fluorescence studies were done at 25°C 
using a SPEX FluoroLog®-3 spectrofluorometer, typically with 1 nm excitation slit width 
and 5 nm emission slit width. Different conditions were used based on the fluorophores 
monitored. The intrinsic fluorescence (from the tryptophanyl residues) of 100 µg/ml PI-
PLC in the absence or presence of various phospholipids (diC6PC, diC7PC, POPC, POPA, 
POPS, DOPMe) in 50 mM HEPES, pH 7.0, with 2 mM EDTA, was monitored between 
300 and 380 nm using an excitation wavelength of 290 nm. (2) The fluorescence spectra 
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of β-Pyr-C10-PG in 50 mM HEPES, pH 7.0, dissolved in diC7PC micelles or co-sonicated 
with POPC / POPG, were acquired with an excitation wavelength of 350 nm and the 
emission measured between 360 and 600 nm. For clustering in micelles, 20 μM β-Pyr-
C10-PG was added to 3 mM diC7PC (ratio of micellar PC to the β-Pyr-C10-PG ~ 150/1); 
for clustering of PG in SUVs, 100 μM β-Pyr-C10-PG was added to SUVs containing 2 
mM POPC and 0.1 mM unlabeled PG (ratio of PC to total PG = 10/1). By monitoring the 
ratio of the pyrene excimer (excited-state dimer) to monomer fluorescence intensity 
versus the PI-PLC concentration, the changes in distribution of pyrene-containing acryl 
chains in the mixed micelle or vesicle induced by PI-PLC, if any, could be detected. (3) 
FRET experiments involving CPM, attached via a maleimide to a cysteine residue of 
protein, as the donor used excitation at 387 nm and with emission monitored at 472 nm 
for CPM quenching due to energy transfer to the BODIPY dye labeled on the acyl chain 
of phospholipids (β-BODIPY FL C5-HPC). The acceptor sensitization was 
simultaneously monitored at 516 nm. In these fluorescence experiments, 10 µg/ml 
labeled protein and 100 µM phospholipids (containing 2.5% BODIPY labeled lipids) 
were used. To label cysteine mutants of PI-PLC, 100 µg/ml protein was incubated with 
24 µM CPM in 3 ml 20 mM Tris-HCl, pH 7.0, at room temperature for 2 h. The reaction 
was monitored by the fluorescence intensity at 472 nm (excitation at 387 nm) as there is a 
great fluorescence increase when CPM dyes couple with thiol groups. Upon completion, 
the reaction mixture was dialyzed to remove free CPM.  
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J. Circular dichroism spectroscopy 
CD spectroscopy was used to monitor secondary structure and thermal 
denaturation of proteins. All samples used for CD experiments had protein in 10 mM 
borate buffer, pH 7.0. In wavelength scan experiments, 0.2-0.3 mg/ml PI-PLC was used 
in 1 mm cells to collect CD spectrum between 300 and 190 nm using an AVIV Circular 
Dichroism model 202 spectrometer. Secondary structure content was estimated with 
CDNN using molar ellipticity in the 200 to 260 nm range (Böhm et al., 1992; Andrade et 
al., 1993). Thermal stability of protein (0.02 mg/ml in 1 cm cells) was assessed using CD 
by following ellipticity changes at 222 nm (primarily α-helix) as temperature increased 
from 20 to 90°C with 1°C increase interval (within ±0.2°C of the set value and with 1 
min equilibration time). Tm was the temperature point at which maximum derivative of 
θ222 reached. 
K. Plaque formation assay of fibroblast infection 
The size of plaques generated as L. monocytogenes infects target mammalian cells 
was used as a measure of infectivity of the F237W mutant compared to WT PI-PLC. This 
assay, performed as described previously (Sun et al., 1990), quantifies the infection of 
mouse fibroblast L2 cells by measuring the plaque size. The wild type PI-PLC gene (plcA) 
or F237W PI-PLC gene was inserted into the pAM401, which contains the plcA gene 
promoter with the L. monocytogenes PI-PLC original signal peptide sequence. These 
pAM401 plasmids were then electroporated into strain DP-L1552 (ΔplcA, no L. 
monocytogenes PI-PLC expression). The modified L. monocytogenes strains were then 
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used to infect monolayer cultures of mouse fibroblast L2 cells. The cell monolayer was 
then washed with PBS three times, covered with 1% DMEM-containing agarose with 10 
µg/ml gentamicin, and incubated at 37°C for 3 days. Plaques formed were then visualized 
by staining the cells with neutral red. The mean plaque diameter formed by each strain 
was compared with the mean plaque diameter of strain 10403S, the L. monocytogenes 
WT strain where the PI-PLC gene is chromosomal (Bishop and Hinrichs, 1987). The 
relative plaque size is reported as a percentage of 10403S plaque size. 
 
 86
Chapter 3: 
 
Cloning and expression of 
L. monocytogenes PI-PLC 
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I. Introduction 
Since Kemp et al. (1959) showed the presence of PI-PLC enzymatic activity in rat 
liver, the observations that mammalian PI-PLC enzymes may play important roles in 
agonist-stimulated phosphoinositide metabolism and signaling (Michell, 1975; Berridge 
and Irvine, 1987; Nishizuka, 1992) greatly propelled the studies of their molecular 
characterization. Numerous eukaryotic PI-PLC isozymes from a diverse range of sources, 
including different animals tissues, filamentous fungi, yeasts, protozoan parasite, and 
plants, have been isolated and their corresponding cDNA sequences determined since the 
late 1980s (Nozaki et al., 1999; Rebecchi and Pentyala, 2000; Pan et al., 2005). The early 
studies aimed at isolating of PI-PLC from eukaryotic sources were complicated by the 
enzyme heterogeneity (the existence of more than one isozyme in the same source) in 
addition to the complex purification schemes and low yields (often in the microgram 
range). In contrast, bacterial PI-PLCs are secreted in relatively large quantities across the 
cell membrane into the culture medium. Milligram quantities of PI-PLCs were purified to 
homogeneity from cultures of Staphylococcus aureus (Low and Finean, 1977; Low, 
1981), Bacillus cereus (Ikezawa et al., 1976; Ohyabu et al., 1978; Kominami et al., 1985), 
and Bacillus thuringiensis (Taguehi et al., 1980), although the yields of these purification 
schemes still were lower than one milligram per liter of culture. By the use of 
recombinant DNA technology, PI-PLCs can be obtained with much higher yields via 
more rapid procedures (Koke et al., 1991). 
The initial plasmids pDP1462 and pBS1462 for the PI-PLC from Listeria 
monocytogenes were kindly provided by Dr. Howard Goldfine, University of 
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Pennsylvania. The construction of plasmid pDP1462 has been described (Camilli et al., 
1993). L. monocytogenes genes prfA for a positive regulatory protein and plcA for PI-
PLC, gene bases -810 to 1349 (Mengaud et al., 1989), were amplified from wild-type 
10403S strain (Portnoy et al., 1988) chromosomal DNA and ligated into E. coli-S. 
faecalis shutter vector pAM401 (Wirth et al., 1986) with XbaI and SalI sites. The 
pBS1462 plasmid was made by inserting the same genes of interest into the smaller 
pBluescript II KS phagemid vector using the same restriction sites to facilitate creating 
mutants. Goldfine and Knob transformed a similar plasmid (pAM401:: plcA prfA) into 
the 10403S strain, and purified about 1 mg homogeneous PI-PLC from the culture of L. 
monocytogenes without specifying the culture volume used (Goldfine and Knob, 1992). 
Expressing the plcA gene in L. monocytogenes strains can avoid the potential problems 
associated with heterologous gene expression, such as protein misfolding, toxicity of 
recombinant protein to the host, recognizing and cleaving the signal peptide of interest 
protein correctly, as well as different codon usage in the host system. However, 
expressing L. monocytogenes PI-PLC in an E. coli background is worth a try considering 
the relative simplicity of the protein (small protein size with 33 kDa molecular mass, and 
lack of cysteine residues) in addition to the ability of E. coli to grow rapidly and at high 
density on inexpensive medium. E. coli also lacks a PI-PLC activity. Moser et al. (1997) 
expressed and purified crystallographic qualities of L. monocytogenes PI-PLC. They 
obtained 1.2 to 1.5 mg per liter from E. coli BL21 transformed with the expression 
plasmid plcA-1, constructed by inserting the gene for predicted mature PI-PLC 
(Leimeister-Wächter et al., 1991) into NheI-XhoI digested pIT vector (Moser et al., 1997). 
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As the pIT vector (Koke et al., 1991) is not commercially available, we cloned and 
expressed L. monocytogenes PI-PLC in two cloning/expression systems (pET and 
IMPACT) using pBS1462 plasmid as template since we did not have the DNA sequence 
of the pAM401 vector. This procedure was used to generate PI-PLC for diverse kinetic 
and biophysical studies. 
II. Experiments and Results 
A. Cloning of L. monocytogenes plcA gene with or without prfA gene into pET-23a(+) 
The plcA gene in plasmids pDP1462 and pBS1462 encodes the PI-PLC precursor 
of 317 residues with an N-terminal signal sequence. If PI-PLC is secreted through the 
general secretary pathway (Sec machinery), the signal peptide targets the precursor 
protein to the cytoplasmic membrane and initiates its translocation across the membrane. 
Once translocated, the signal peptide is cleaved by signal peptidase (SPases) (Raynaud 
and Charbit, 2005). At the time we constructed plasmids for expressing L. 
monocytogenes PI-PLC, two different cleavage sites of signal sequence were reported 
(Leimeister-Wächter et al., 1991; Goldfine and Knob, 1992; Moser et al., 1997). Since 
the signal peptide may be recognized by E. coli secretion machinery, we amplified the 
entire plcA gene of L. monocytogenes containing signal sequence, bases 294 to 1349 
Mengaud et al., 1989), from pBS1462 with the forward primer used to construct 
pDP1339 (Camilli et al., 1993). The reverse primer was designed simply by taking a 
fragment of the plcA gene antisense strand (base 276 to 318) (Mengaud et al., 1989) in 
which 6 bases (288 to 293) were replaced by the EcoRI restriction site (gaattc).  
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The PCR products were purified directly by QIAquick PCR Purification Kit, 
doubly digested with XbaI and EcoRI to generate sticky ends, and purified again by 
QIAquick PCR Purification Kit. When needed, agarose gel electrophoresis combined 
with QIAquick Gel Extraction Kit was used to isolate a DNA fragment of specific 
molecular weight but with lower DNA recovery. pET-23a(+) was digested with the same 
set of endonucleases, purified and then ligated to the digested PCR products. The loss of 
ribosome binding site in XbaI-EcoRI-digested pET-23a(+) is compensated by the 
ribosome binding site of the plcA gene (aaggag, same as that of pET-23a(+) vector). 
NovaBlue E. coli competent cells were transformed with the ligation products and grown 
at 37°C on the LB-agar-plate with 100 µg/ml ampicillin. To screen the positive clones, 
four colonies were picked and inoculated into 5 ml LB medium containing 100 µg/ml 
ampicillin and grown overnight at 37°C. Plasmids were purified from these cultures with 
QIAprep Miniprep and doubly digested with XbaI and EcoRI to identify the positive 
clones. The positive clones showed a 1062-bp DNA band on the agarose gel after 
digestion and were further confirmed by double strand DNA sequencing with T7 
promoter primer and T7 terminator primer. The graphic map of constructed plasmid of 
pET1339 showing the unique restriction sites from common restriction enzyme database 
of PlasMapper (http://wishart.biology.ualberta.ca/PlasMapper) is displayed in Figure 3-1. 
BL21 E. coli host strains (BL21(DE3) and its pLysS derivative for stringent 
transcription control) were transformed with plasmid pET1339 for overexpression of 
recombinant protein. Aliquots of cell extract supernatants, solubilized cell debris  
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Figure 3-1 Graphic map of recombinant pET1339 created with PlasMapper. Using 
plasmid pBS1462 as template, L. monocytogenes plcA gene was amplified by PCR using 
primers 5’-ggTCTAGAttctagtcctgctgtcc-3’ and 5’-
ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with XbaI and EcoRI and ligated to XbaI-EcoRI digested pET-23a(+). The 
insertion of the target gene was checked by DNA sequencing with T7 promoter primer 
and T7 terminator primer. 
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(resuspended in half the supernatant volume with 1% SDS), and concentrated E. coli 
culture media were incubated respectively with an optically clear mixture of 2 mM PI and 
8 mM Triton X-100 in 25 mM HEPES buffer (pH 7.5) overnight at room temperature and 
then checked for PI-PLC activity with 31P NMR spectroscopy by monitoring the 
generation of cIP and I-1-P. No PI hydrolysis activity was detected in any of them even 
after extended incubation of up to 1 week. SDS-PAGE analysis of the concentrated 
culture media, cell extract supernatants and solubilized cell debris did not show obvious 
overexpression of a protein band with 33 kDa molecular mass. 
The entire plcA gene, inserted after the T7 promoter in pET1339, carries its own 
promoter with -10 region (tagaat) related to the E. coli consensus sequence (tataat) and a 
palindromic sequence of 14 bp (ttaacaaatgttaa) in the -40 region (Mengaud et al., 1989). 
The plcA gene promoter lacks the -35 region. PrfA protein can recognize this 14-bp 
palindrome and activate the transcription of plcA (Mengaud et al., 1991; Leimeister-
Wächter et al., 1992). Co-expression of plcA and prfA genes could enhance the 
expression of recombinant PI-PLC in E. coli. Therefore, we constructed a pET1462 
plasmid containing the plcA and prfA genes. The DNA fragment of interest, base -810 to 
1349 (Mengaud et al., 1989), was amplified from pBS1462 with the same primer pair 
used in making pDP1462 (Camilli et al., 1993). However, no colonies grew on the plate 
spread with NovaBlue cells transformed with the ligation product. The failure to subclone 
the plcA and prfA genes into the pET-23a(+) is because of the low digestion efficiency of 
PCR products by SalI. In the reverse primer, the SalI restriction site has only 2 bases (gg) 
at the 5’ end. For oligo sequences with 2 (gc) or 4 nucleotides (acgc) at the 5’ end of SalI 
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site incubated at 20°C with 20 units SalI, only 10% was reported to be cleaved after 2 
hours and 50% to 75% was cleaved after 20 hours 
(http://www.neb.com/nebecomm/tech_reference/restriction_enzymes/cleavage_olignucle
otides.asp). Therefore, we modified the reverse primer by inserting an extra non-
complementary sequence of aataatat between the SalI site and 5’-terminal gg to ensure 
the efficient cleavage of PCR products. By using the modified reverse primer, we 
obtained the plasmid pET1462 (Figure 3-2). The XbaI-SalI digested pET1462 showed a 
2166-bp DNA band on the agarose gel. Again, the attempts to express the L. 
monocytogenes PI-PLC with various BL21 strains harboring pET1462 were not 
successful. 
The failures were unexpected since the successful expressions of recombinant L. 
monocytogenes PI-PLC in E. coli have been reported (Leimeister-Wächter et al., 1991; 
Moser et al., 1997). Leimeister-Wächter et al. constructed several plasmids containing 
different combinations of plcA with neighboring genes from L. monocytogenes EGD 
strain, pLM48 (pUC18::plcAlisA), pLM48-202 (pUC18::plcA) and pLM50 
(pUC18::plcAprfA). The expression level of PI-PLC from these plasmids, checked by 
radioactive labeling with [35S]-methionine, was consistent with the level of detectable PI-
PLC activity, increasing in the order pLM48<pLM48-202<pLM50. In this 
communication, no attempt to purify the recombinant PI-PLC was mentioned. Although 
Leimeister-Wächter et al did not clarify in which cell compartment the recombinant 
protein was located, the way they detected PI-PLC activity was from the generation of a  
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Figure 3-2 Graphic map of recombinant pET1462 created with PlasMapper. Using 
plasmid pBS1462 as template, L. monocytogenes plcA gene and prfA gene were 
amplified by PCR using primers of 5’-ggTCTAGAttctagtcctgctgtcc-3’ and 5’-
ggaataatatGTCGACcagctcttcttggtgaag-3’. The 30 cycle PCR product was doubly 
digested with XbaI and SalI and ligated to XbaI-SalI digested pET-23a(+). The insertion 
of target genes was checked by DNA sequencing with T7 promoter primer and T7 
terminator primer. 
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turbid halo around the colony on PI-containing-plates, the same assay used to check PI-
PLC activity of L. monocytogenes strains and may indicate that recombinant PI-PLC was 
secreted as well. These results indicate that E. coli secretion machinery can recognize the 
signal peptide of L. monocytogenes plcA gene and direct the secretion of PI-PLC 
precursor across the cytoplasmic membrane where the protein may diffuse or leak into 
the extracellular medium due to the lack of efficient pathways for translocation through 
the outer membrane in E. coli. The expression of recombinant plcA in E. coli is also 
regulated by PrfA in the presence of plcA promoter.  
As we were not sure of the reasons for the failures, we wanted to simplify the 
transcriptional regulation of the recombinant gene by taking off the promoter of the plcA 
gene, thus eliminating the potential effect of the 14-bp palindrome on the transcription. 
Except for extracellular medium, recombinantly expressed proteins can be directed to 
cytoplasm or the periplasm with various advantages and disadvantages. Expression in the 
cytoplasm is normally preferable since production yields are high. Although PI-PLC is 
involved in lysis of host vacuoles, the fact that PI is only a minor component of E. coli 
(Ames, 1968; Cronan and Vagelos, 1972; Lechevalier, 1977; Kozloff et al., 1991) made 
us keep the expressed recombinant PI-PLC in cytoplasm of E. coli by removal of its 
signal sequence.  
B. Cloning of mature L. monocytogenes plcA gene into pET-23a(+) 
Our next attempt was to clone the gene for mature PI-PLC, i.e., protein without 
the signal peptide. The same reverse primer designed for the plasmid pET1339 was used 
to introduce an EcoRI restriction site immediately after the gene stop codon, TAA, which 
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is preferred among the three possible stop codons because it is less prone to read-through 
than TAG and TGA (Sharp and Bulmer, 1988). If needed, 2 or 3 stop codons can be 
added in series to increase the translation termination efficiency.  
To design the forward primer, we needed to know where mature L. 
monocytogenes PI-PLC starts. The signal sequence was first predicted to be 22 amino 
acids (Leimeister-Wächter et al., 1991). However, N-terminal amino acid sequence 
analysis of the homogeneous PI-PLC purified from the culture fluid of L. monocytogenes 
revealed that the signal peptide cleavage site was between Ala-29 and Tyr-30 (Goldfine 
and Knob, 1992), in agreement with the prediction results of program SignalP (Figure 
3-3). The graphic output from SignalP-NN prediction (using neural network) comprises 
three scores. The C-score is only significantly high at the first residue in the mature 
protein. S-score is high at all residues of signal peptides. And the Y-score is the 
combination of C- and S-scores, also high for the first residue of mature protein. The 
SignalP-HMM prediction is based on the hidden Markov model to tell if the submitted 
sequence contains a signal peptide and assigns scores for n-, h-, and c-regions of the 
peptide, if one is found. Both predictions are consistent with the cleavage site between 
Ala-29 and Tyr-30. The classical signal peptides contain three recognizable domains, a 
positively charged n-region, a central hydrophobic h-region, and a neutral but polar c-
region. The average signal peptides from Gram-positive bacteria are 32 amino acids, 
much longer than those from other organisms (Nielsen et al., 1997a; Nielsen et al., 
1997b). In general they have a longer h-region (von Heijine and Abrahmsen, 1989). The  
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Figure 3-3 Prediction of L. monocytogenes PI-PLC precursor signal peptide cleavage site 
with program SignalP (http://www.cbs.dtu.dk/services/SignalP/). Only the N-terminal 70 
amino acid residues of precursor are shown. Refer to text for details. 
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29-amino acid-signal peptide (LYKNYLQRTLVLLLCFILYFFTFPLGGKA) exhibits the 
signal peptide cleavage-site specificity (Perlman and Halvorson, 1983; von Heijine, 1983; 
von Heijine, 1985) including a helix-breaking residue (Pro) at the -6 position relative to 
the cleavage site, and small residues at the -3 (Gly) and -1 (Ala) positions which are all 
absent in another predicted signal peptide (LYKNYLQRTLVLLLCFILYFFT). 
Surprisingly, the later work of Moser et al. still took Phe-23(numbered from the N-
terminus of the signal peptide) as the first residue of mature PI-PLC (Moser et al., 1997). 
We thus designed two forward primers to insert into pET-23a(+) plcA genes starting 
from the codons for Phe-23 and Tyr-30 of the precursor respectively. Adding an NdeI site 
(catatg) prior to the truncated plcA gene could initiate the translation of the target gene 
with only one extra amino acid (Met) ahead of the recombinant PI-PLC. Eleven bases 
(ttttatacttt) from the plcA gene, base 50 to 60 relative to the start codon of PI-PLC 
precursor gene, were taken as the 5’ terminus for both primers before the NdeI site to 
ensure the efficient cleavage of PCR products. The graphic maps of constructed plasmids 
pET-F and pET-Y are shown in Figure 3-4 and Figure 3-5. The NdeI-EcoRI digested 
pET-F and pET-Y showed 893-bp and 872-bp DNA bands, respectively, on the agarose 
gel. 
The DNA sequencing results of pET-F and pET-Y using the T7 promoter primer 
revealed both plasmids had an unexpected stop codon, TGA, in the place of the codon for 
Trp-35 of PI-PLC precursor from EGD strain (accession number: CAA38438). Using the 
forward primer designed to clone the pET1462, we then checked this gene region of  
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Figure 3-4 Graphic map of recombinant pET-F created with PlasMapper. Using plasmid 
pBS1462 as template, L. monocytogenes partial plcA gene for PI-PLC from Phe-23 was 
amplified by PCR using primers of 5’- ttttatactttCATATGttcccattaggcggaaaagcatattc-3’ 
and 5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was 
doubly digested with NdeI and EcoRI and ligated to NdeI-EcoRI digested pET-23a(+). 
The insertion of target gene was checked by DNA sequencing with T7 promoter primer 
and T7 terminator primer. 
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Figure 3-5 Graphic map of recombinant pET-Y created with PlasMapper. Using plasmid 
pBS1462 as template, L. monocytogenes partial plcA gene for PI-PLC from Tyr-30 was 
amplified by PCR using primers of 5’-ttttatactttCATATGtattcgcttaataactgaaataag-3’ and 
5’-ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with NdeI and EcoRI and ligated to NdeI-EcoRI digested pET-23a(+). The 
insertion of target gene was checked by DNA sequencing with T7 promoter primer and 
T7 terminator primer. 
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pDP1462 and pBS1462 by DNA sequencing, the TGA codon did exist in both original 
plasmids. It is reasonable to believe that pET1339 and pET1462 also carry this stop 
codon, which may account for the failures to express recombinant PI-PLCs from E. coli. 
After rechecking the sequencing results of pET1339 and pET1462, we found this TGA 
codon in both plasmids. This stop codon, however, is unlikely an error induced by PCR 
because pDP1462 has been transformed into the L. monocytogenes 10403S strain to 
obtain PI-PLC (Goldfine and Knob, 1992). It has been reported that TGA codes at low 
efficiency for Trp in B. subtilis and, presumably in E. coli (Hatfield and Diamond, 1993).  
To optimize overexpression of the recombinant protein, we used the 
QuikChangeTM Site-Directed Mutagenesis Kit to change the TGA codon in pBS1462 to 
TGG, the codon for Trp-35 in the published plcA gene sequence from L. monocytogenes 
EGD strain (nucleotide accession number: X54618). The 41-base mutagenic primers 
containing the mutated base were designed according to the manual. The mutagenesis 
was first performed using the suggested thermal-cycle parameters (denaturation at 95°C, 
annealing at 55°C and extension at 68°C), and various false positives were obtained. 
Partial or multiple copies of mutagenic primers were incorporated into the desired mutant 
region of these false positives. These false mutants may be caused by the primer self-
annealing. The oligo plots of the mutagenic primers showed 10 short primer-dimer 
complements in the length of 4-5 bps. Either increasing the annealing temperature or 
decreasing the primer concentration can help to reduce those non-specific primer-primer 
bindings. Since excess primers concentrations are need for the mutagenesis, we thus 
modified the thermal-cycle parameters by simply increasing the annealing temperature to 
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68°C. Using this new thermal cycle (denaturation at 95°C, annealing at 68°C and 
extension at 68°C), we obtained the modified pBS1462, named pBS1462-1w, which was 
used as template for the following cloning. The gene for the PI-PLC precursor from 
10403S strain in pBS1462-1w was then screened using the primers listed in Table 3-1. 
The DNA sequence determined was translated into the amino acid sequence which was 
then aligned with that of the published EGD strain L. monocytogenes PI-PLC using the 
Blast program. As shown in Figure 3-6, the 10403S strain PI-PLC differs from the 
published one at amino acids 76 (Ile→Met), 112 (Asn→Lys), and 119 (Phe→Tyr) in the 
mature protein and 4 (Asn→Ile), 7 (Gln→Arg), 13 (Leu→Val), 19 (Tyr→Cys) in signal 
peptide. These amino acids mutants were conserved in the pDP1462 checked by DNA 
sequencing using the T7 promoter primer. The plasmids pET-Y-1w and pET-F-1w were 
cloned from pBS1462-1w with the same primers for pET-F and pET-Y except the stop 
codon in the forward primer for pET-Y was changed to TGG also. Changing of TGA to 
TGG in the plcA gene generated a new BsrI restriction site (Figure 3-7, Figure 3-8). The 
entire DNA sequence of inserted target gene was sequenced with the T7 promoter 
primers, G74 and G192, and compared with pBS1462 to prevent introduction of PCR-
induced errors. 
The pET-Y-1w and pET-F-1w plasmids should have some advantages over 
plasmids pET1339 and pET1462 in transcription and translation of the recombinant PI-
PLC. First, the target gene is only under the control of strong bacteriophage T7 
transcription as the promoter regions of the plcA gene are deleted. Second, the initiation  
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Table 3-1 Primers for sequencing plcA gene of L. monocytogenes PI-PLC in the 
constructed plasmids. 
 
 
T7 promoter 5'-TAATACGACTCACTATAGGG-3' 
G74 5’-GGAGACATGACGTGGACATTAACCAAACC-3’
G192 5’-GGAAAAATATTATTACTTTCAGAGAACC-3’ 
T7 terminator primer 5’-GCTAGTTATTGCTCAGCG-3’ 
Intein forward primer 5’-CCCGCCGCTGCTTTTGCACGTGAG-3’ 
T7 terminator reverse primer 5’-TATGCTAGTTATTGCTCAG-3’ 
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Figure 3-6 Translation of plcA gene for 10403S L. monocytogenes PI-PLC precursor 
with rare codons (in E. coli) underlined. The differences from published EGD amino acid 
sequence (UniProtKB entry: P34024) are indicated. 
 
 
ttgtataagatttatttacgacgcacattagttttagtactctgttttattttatgcttt 
 L  Y  K  I  Y  L  R  R  T  L  V  L  V  L  C  F  I  L  C  F  
          N        Q                 L                 Y 
tttactttcccattaggcggaaaagcatattcgcttaataactgaaataagccaataaag 
 F  T  F  P  L  G  G  K  A  Y  S  L  N  N  W  N  K  P  I  K  
                      
aactctgtaactacaaaacaatggatgtccgctctacctgacacaacaaacctagcagcg 
 N  S  V  T  T  K  Q  W  M  S  A  L  P  D  T  T  N  L  A  A  
 
ctctctataccaggtacacacgatacgatgagctataacggagacatgacgtggacatta 
 L  S  I  P  G  T  H  D  T  M  S  Y  N  G  D  M  T  W  T  L  
                                              I 
accaaaccactggctcaaacgcaaacgatgtcattgtatcaacaattagaagcaggaata 
 T  K  P  L  A  Q  T  Q  T  M  S  L  Y  Q  Q  L  E  A  G  I  
 
cggtacatcgatattagagcaaaggacaatctcaaaatttaccatgggccaatttattta 
 R  Y  I  D  I  R  A  K  D  N  L  K  I  Y  H  G  P  I  Y  L  
                                  N                    F 
aatgcatcactttcaggtgtattagaaacgattactcaatttttaaagaaaaatccaaaa 
 N  A  S  L  S  G  V  L  E  T  I  T  Q  F  L  K  K  N  P  K  
 
gaaaccattattatgcgtttaaaagacgagcaaaacagcaacgatagttttgattatcgg 
 E  T  I  I  M  R  L  K  D  E  Q  N  S  N  D  S  F  D  Y  R  
 
atccaaccactaatcaacatttataaagattatttttacactactcccagaactgacacg 
 I  Q  P  L  I  N  I  Y  K  D  Y  F  Y  T  T  P  R  T  D  T  
 
agcaataaaatccctacattaaaagatgtccgcggaaaaatattattactttcagagaac 
 S  N  K  I  P  T  L  K  D  V  R  G  K  I  L  L  L  S  E  N  
 
cacacaaaaaagccattagtcattaactcacgcaaattcggcatgcagttcggcgcacct 
 H  T  K  K  P  L  V  I  N  S  R  K  F  G  M  Q  F  G  A  P  
 
aaccaagtaattcaagatgactacaatggtccgagtgtgaaaacaaaattcaaagagatt 
 N  Q  V  I  Q  D  D  Y  N  G  P  S  V  K  T  K  F  K  E  I  
 
gtccagactgcttatcaagcttccaaagcggacaataaactttttcttaaccatattagc 
 V  Q  T  A  Y  Q  A  S  K  A  D  N  K  L  F  L  N  H  I  S  
 
gccacttcattaacattcacacctcgtcagtatgctgcagcattaaacaacaaagtagag 
 A  T  S  L  T  F  T  P  R  Q  Y  A  A  A  L  N  N  K  V  E  
 
caattcgtactcaacttaacatcggaaaaagttcgaggattaggcatactaatcatggac 
 Q  F  V  L  N  L  T  S  E  K  V  R  G  L  G  I  L  I  M  D  
 
ttccccgaaaaacaaacaattaaaaacatcataaaaaacaataaattcaactaa 
 F  P  E  K  Q  T  I  K  N  I  I  K  N  N  K  F  N  - 
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Figure 3-7 Graphic map of recombinant pET-F-1w created with PlasMapper. Using 
plasmid pBS1462-1w as template, L. monocytogenes partial plcA gene for PI-PLC from 
Phe-23 was amplified by PCR using primers 5’- 
ttttatactttCATATGttcccattaggcggaaaagcatattc-3’ and 5’-
ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with NdeI and EcoRI and ligated to NdeI-EcoRI digested pET-23a(+). The entire 
DNA sequence of inserted target gene was sequenced with T7 promoter primer, G74 and 
G192 and compared with pBS1462 to prevent introduction of PCR-induced errors. 
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Figure 3-8 Graphic map of recombinant pET-Y-1w created with PlasMapper. Using 
plasmid pBS1462-1w as template, L. monocytogenes partial plcA gene for PI-PLC from 
Tyr-30 was amplified by PCR using primers of 5’-
ttttatactttCATATGtattcgcttaataactggaataag-3’(TGA was replaced with TGG) and 5’-
ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with NdeI and EcoRI and ligated to NdeI-EcoRI digested pET-23a(+). The entire 
DNA sequence of inserted target gene was sequenced with T7 promoter primer, G74 and 
G192 and compared with pBS1462 to prevent introduction of PCR-induced errors. 
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codon TTG used in the plcA gene is replaced with the more popular start codon ATG. 
The start codons used in E. coli were reported as 91% ATG, 8% GTG, and 1% TTG 
(Hannig and Makrides, 1998). Also, the codon for Trp-35 was changed from TGA to 
TGG, the normal codon for Trp.  
pET-Y-1w and pET-F-1w were first transformed into BL21(DE3) and 
BL21(DE3)pLysS for overexpression. Analysis of the PI-PLC activity in cell extracts 
supernatants, solubilized cell debris and concentrated culture media detected no PI-PLC 
activity. Also no overexpressed protein band corresponding to a MW of 33 kDa could be 
detected by SDS-PAGE.  
We also tried BL21-CondonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP 
strains to provide rare codon tRNAs pool for expression because a number of rare codons 
are used in the plcA gene from L. monocytogenes 10403S strain (Figure 3-6). Several 
adjustments were tested including decreasing the incubation temperature (30°C) after 
IPTG induction and using the less degradation susceptible carbenicillin. However, none 
of theses modifications helped.  
It was also possible that L. monocytogenes mature PI-PLC was expressed in the 
cytoplasm but misfolded. It could then be segregated into inclusion bodies and then 
degraded by proteases. In either case its expression level was too low to be detected by 
SDS-PAGE. Inclusion bodies can be separated easily and solubilized using urea or 
guadinium hydrochloride, from which, native target protein may be refolded in vitro 
either by dilution, dialysis or on-column refolding methods (Middelberg, 2002). However, 
refolding requires time consuming efforts with reduction in protein yield and the resultant 
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protein does not always regain biological activity. Refolding may not be a good general 
way to obtain interesting mutants as well since refolding is never guaranteed. Several 
approaches may be taken to address such protein expression problems. One strategy, for 
example, is to generate a fusion protein of the target protein and a fusion partner. 
Alternatively, the target protein can be co-expressed with molecular chaperones to help 
protein folding. Although there have some successful reports for the latter strategy, 
unfortunately, it is a trial and error process to specify the match between target protein 
and working chaperones (Georgiou and Valax, 1996; Hannig and Makrides, 1998). A 
third way in which target protein may be expressed is through the use of a periplasmic 
leader sequence.  
C. Cloning and overexpression of mature L. monocytogenes plcA gene into pTYB11 
Fusion proteins were originally exploited to facilitate protein purification and 
immobilization by using different kinds of molecular tags that can be used for affinity 
purification (Stevens, 2000). It soon became apparent that fusion partners might protect 
passenger proteins from intracellular proteolysis (Martinez et al., 1995; Jacquet et al., 
1999), improve the solubility of passenger proteins (Davis et al., 1999; Kapust and 
Waugh, 1999), or be used as specific expression reporters (Waldo et al., 1999). High 
expression levels can often be transferred from an N-terminal fusion partner to a poorly 
expressing passenger probably as a result of mRNA stabilization (Arechaga et al., 2003). 
The IMPACT-CN appears to be an attractive protein purification system (Szweda et al., 
2001; Byun et al., 2002; Massimelli et al., 2005). It provides two interesting vectors 
(pTYB1 and pTYB11) that enable the target gene to be cloned immediately adjacent to 
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the intein cleavage site, generating a fusion protein that could be purified in a single 
chromatographic step. The native recombinant protein without modifications could then 
be released from the fusion precursor by taking advantage of thiol induced self-cleavage 
activity of inteins. The N-terminal fusion vector, pTYB11, was used since the L. 
monocytogenes PI-PLC precursor normally contains an N-terminal signal peptide. To 
obtain the “native” mature PI-PLC, a SapI restriction site must be used for cloning the 5’ 
end of target gene. Two forward primers were thus designed for cloning into pTYB11. 
5’-ggtggttGCTCTTCcaacNx-3’ (SapI site underlined) was generated by replacing the Nx 
with 5’ end of the target genes (19 or 24 bases in order to terminate the primers in base of 
G or C). The same reverse primer containing an EcoR1 restriction site was used. Target 
genes flanked with SapI and EcoRI sites were amplified by PCR. Because the SapI site 
was lost after the cloning, we screened the positive colonies by XbaI-EcoRI double 
digestion. The results showed a DNA band of 2504-bp for IMPACT-F (Figure 3-9) and 
2483-bp for IMPACT-Y (Figure 3-10) on the agarose gel. The entire DNA sequence of 
the inserted target gene was sequenced with Intein forward primer G74 and T7 terminator 
reverse primer and compared with that of pBS1462 to prevent introduction of PCR-
induced errors. 
The plasmids IMPACT-F and IMPACT-Y were transformed into ER2566 E. coli 
host cells for overexpression. LB media containing 100 µg/ml ampicillin was inoculated 
at 37°C with 5 ml freshly grown cultures and inoculated until the OD600 reached 0.7. 
IPTG was added to the final concentration of 0.4 mM for induction of PI-PLC expression.  
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Figure 3-9 Graphic map of recombinant IMPACT-F created with PlasMapper. Using 
plasmid pBS1462-1w as template, L. monocytogenes partial plcA gene for PI-PLC from 
Phe-23 was amplified by PCR using primers 5’-
ggtggttGCTCTTCcaacttcccattaggcggaaaag-3’ and 5’-
ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with SapI and EcoRI and ligated to SapI-EcoRI digested pTYB11. The entire 
DNA sequence of inserted target gene was sequenced with Intein forward primer, G74 
and T7 terminator reverse primer and compared with pBS1462 to prevent using a gene 
with the PCR-induced errors. 
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Figure 3-10 Graphic map of recombinant IMPACT-Y created with PlasMapper. Using 
plasmid pBS1462-1w as template, L. monocytogenes partial plcA gene for PI-PLC from 
Tyr-30 was amplified by PCR using primers 5’-
ggtggttGCTCTTCcaactattcgcttaataactggaataag-3’ and 5’-
ttgtaggaataaGAATTCttagttgaatttattgttttttatg-3’. The 30 cycle PCR product was doubly 
digested with SapI and EcoRI and ligated to SapI-EcoRI digested pTYB11. The entire 
DNA sequence of inserted target gene was sequenced with Intein forward primer, G74 
and T7 terminator reverse primer and compared with pBS1462 (to check for PCR-
induced errors). 
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The cells continued to grow at 15°C overnight. Cell extract supernatants, solubilized cell 
debris, and concentrated culture media were then analyzed for PI-PLC activity. This time, 
the reaction mixture did become turbid immediately after adding the cell extract 
supernatants of ER2566 transformed with IMPACT-Y. It took much longer time (several 
hours) for the turbidity to show up when adding the same volume of cell extract 
supernatants of ER2566 harboring IMPACT-F. This turbidity is caused by the insoluble 
DAG released from PI by PI-PLC. PI-PLC hydrolysis activities were detected by NMR in 
the supernatants of both kinds of ER2566 cells, but not in their culture media and the 
solubilized cell debris. However, there was still no obvious overexpressed protein band 
corresponding to a MW of 88 kDa on SDS-PAGE gel of lysed cell supernatants and 
solubilized cell debris. Purification of the protein was achieved by elution of the 
supernatant on a chitin column. After loading supernatant (0.5 ml/min), the chitin column 
was washed with high salt column buffer and then DTT containing cleavage buffer at 
flow rate of 1 ml/min. The on-column cleavage of the fusion protein was carried at room 
temperature for 20 hours to ensure a sufficient yield of L. monocytogenes PI-PLC (this 
protein was reported to be stable at room temperature for several days (Goldfine and 
Knob, 1992)). The target protein, released from the precursor, was eluted from the 
column with dialysis buffer the next day. DTT and the co-eluted small peptide (1.6 kDa) 
were removed by dialysis at 4°C. Protein was then concentrated and analyzed by SDS-
PAGE. For ER2566 harboring IMPACT-F, very little PI-PLC was purified; it could be 
detected with NMR by its activity but was not detected by SDS-PAGE. Recombinant PI-
PLC in milligram amounts was obtained from the ER2566 with IMPACT-Y (Figure 
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3-11). It is unlikely that the much higher protein yield of PI-PLC (starting from Tyr-30) is 
caused only by a higher level of expression, since even the expression of PI-PLC (starting 
from Tyr-30) is very poor. It is more reasonable to assume that fusion precursor with the 
extra 7 amino acids at the N-terminus of PI-PLC was folded improperly since very little 
activity was observed in cell extract supernatants. Misfolded protein precursor may 
aggregate into inclusion bodies leading to the low yield. These results strongly indicate 
that Tyr-30, not Phe-23, is the first amino acid for mature PI-PLC (Goldfine and Knob, 
1992; Ryan et al., 2002). We thus abandoned the further attempts on generating PI-PLC 
starting from Phe-23. 
Conditions for optimizing recombinant PI-PLC yield were explored in some depth 
and the following observations were made. (1) The OD600 range for optimum induction of 
the cell cultures is 0.7-0.8. (2) A higher IPTG concentration (0.8 mM) is preferred as the 
T7/lac promoter is used in the IMPACT system to control the expression of the fusion 
gene. (3) Several induction conditions including 30°C for 6 hours or 15-25°C overnight 
were tested. After induction, incubation at a lower temperature (16°C) for longer time (20 
hours) should be used to help folding of the fusion precursor. (4) A slower flow rate (0.4 
ml/min) is best for loading the cell extract supernatant on the chitin column. (5) Faster 
washing and elution rates (2 ml/min) can be used without impairing the column binding 
of fusion protein. With these modified conditions, the best yield for recombinant L. 
monocytogenes PI-PLC was about 6 mg/L. 
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Figure 3-11 SDS-PAGE showing overexpression and purification of recombinant L. 
monocytogenes PI-PLC cloned in the IMPACT purification system (IMPACT-Y). The 
lanes represent protein content of (1) lysed cell extract, (2) flow through from the chitin 
column when loading, (3) wash from the column after loading, (4) wash from the column 
right before adding DTT, (5) protein eluted after incubation of column with DTT. 
Molecular masses for the standard proteins are 176.5, 113.7, 80.9, 63.8, 49.5, 37.4, and 
26.0 kDa. 
Stds Stds(1) (2) (3) (4) (5)
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III. Summary and Discussion 
We have cloned the L. monocytogenes plcA gene from strain 10403S, in whole or 
truncated forms, into both the pET-23a(+) vector and pTYB11 vector. The attempts to 
overexpress the cloned plcA gene in pET-23a(+) were not successful. The presence of a 
TGA codon for Trp-35, which is a normal terminator codon in E. coli, may account for 
no observed overexpression of the whole plcA gene cloned into pET-23a(+). The failure 
in obtaining PI-PLC with the truncated plcA gene for the mature protein in pET-23a(+), 
however, has another cause since TGA was replaced by TGG, the normal Trp codon in E. 
coli. According to http://www.biotech.ou.edu/, a web server for evaluation of protein 
solubility when it is overexpressed in E. coli, mature L. monocytogenes PI-PLC possesses 
an insolubility probability of 82.5%. The prediction is based on the revised Wilkinson-
Harrison solubility model with two critical parameters, the approximate average charge 
and the turn-forming residue content (Wilkinson and Harrison, 1991; Davis et al., 1999; 
Harrison, 2000). If this is correct, it explains why we could not get recombinant PI-PLC. 
However, the intein tag, the carrier protein used in the IMPACT-CN system, was also 
predicted to be insoluble in E. coli, suggesting the prediction may not be consistent with 
the experimental result. The fact that no PI-PLC activity was found in the crude cell 
extracts is also inconsistent with the insolubility explanation because some proportion of 
the target protein is usually soluble within the cell even when inclusion bodies are formed. 
Except for solubility, the causes reported to prevent efficient heterologous protein 
production in E. coli are biased codon usage, gene product toxicity, mRNA secondary 
structure, and mRNA stability (Kane, 1995). Cloning of the partial L. monocytogenes 
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plcA gene for mature PI-PLC into pTYB11 (IMPACT-Y) enables us to get native target 
protein without any extra N-terminal residues. Although the expression is poor (no 
obvious overexpression band in SDS-PAGE), the yield was still up to 6 mg/L. 
Apparently, the carrier protein does benefit the overexpression of target protein, possibly 
by the use of fusion mRNA or keeping the fusion protein soluble. The extremely low 
yield of PI-PLC produced from the ER2566 carrying IMPACT-F, which differs from 
IMPACT-Y by the extra nucleotide sequence coding for a short peptide from Phe-23 to 
Ala-29, could be caused by a folding problem. Increasing the incubation temperature to 
30°C after induction impaired the PI-PLC activity of supernatant further (longer time 
needed for assay mixture to become turbid).  
An alternative strategy to obtain recombinant L. monocytogenes PI-PLC was to 
use vectors that enable export into the periplasm, which is a more favorable environment 
for folding. In the pET system, several vectors carrying signal peptides can be tried for 
this purpose. Since the amount of PI-PLC produced by IMPACT-Y is enough for the 
following studies, we did not explore this further. Moser et al. (1997) and later Ryan et al. 
(2002) did purify recombinant L. monocytogenes PI-PLC from E. coli periplasmic spaces 
by using the pHS1403 based vectors containing STII signal sequence (Koke et al., 1991). 
The IMPACTTM system (IMPACT-CN and IMPACT-TWIN) regulates the 
expression of target proteins the same way as the pET expression system. The tight 
regulation is obtained by incorporating the T7 promoter into the vector to control the 
transcription of the target gene and introducing the gene for T7 RNA polymerase into the 
host chromosome under the control of IPTG inducible lac operator. The IMPACTTM 
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system contains seven expression vectors for flexible construction of fusion protein 
containing an intein tag. With more than 40 different plasmids, the pET system provides 
various cloning and expression strategies with many more choices than IMPACTTM in the 
fusion partners for purification, detection, solubility, and translocation. However, the use 
of the intein tag of the IMPACTTM system does provide an advantage on releasing the 
target protein without protease, which can be costly and non-specific. In addition to a 
thio-inducible intein tag, IMPACT-TWIN also provides pH and temperature inducible 
intein-tag for proteins sensitive to reducing agents. Also, the ability of IMPACTTM to 
yield purified protein in a single column step enables purification of those poorly 
expressed recombinant proteins, like L. monocytogenes PI-PLC. 
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Chapter 4: 
 
Activation of L. monocytogenes PI-PLC by 
interfaces and salts 
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I. Introduction 
Bacterial PI-PLC catalyzes the calcium-independent hydrolysis of PI in two 
steps: (i) an intramolecular phosphotransferase reaction at a phospholipid aggregate 
surface to produce DAG and water-soluble cIP, followed by (ii) a cyclic 
phosphodiesterase reaction where cIP is hydrolyzed to I-1-P. The second reaction occurs 
with a soluble monomeric substrate and is much slower (with both lower Vmax and 
significant higher Km) than the first one (Volwerk et al., 1990; Zhou et al., 1997a). 
Previous studies of the PI-PLC from Bacillus sp. highlight several kinetic properties 
common to a wide range of phospholipase enzymes. That bacterial PI-PLC exhibits (i) 
“interfacial activation”, an enhanced Vmax/Km, toward aggregated PI compared to 
monomeric PI (Hendrickson et al., 1992; Lewis et al., 1993; Volwerk et al., 1994), (ii) 
“surface dilution inhibition”, a decrease in specific activity as the surface concentration 
of the substrate is diluted with detergents or other phospholipids while keeping the total 
substrate concentration constant (Zhou et al., 1997a), and (iii) “scooting mode catalysis”, 
where enzyme completes several rounds of substrate turnover at the substrate interface 
before dissociating from the particle (Volwerk et al., 1994). The Bacillus sp. PI-PLC is 
also active towards GPI linkages (Low et al., 1988).  
PI-PLC from Listeria monocytogenes, a ubiquitous foodborne intracellular 
pathogen of humans and animals, plays a role as virulence factor for the organism by 
aiding escape of the bacterium from the primary vacuole in macrophages (Camilli et al., 
1993). This phospholipase has been proposed to disrupt the inner membrane of the 
spreading vacuole (Alberti-Segui et al., 2007). L. monocytogenes PI-PLC appears to 
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share the same general base and acid catalysis mechanism as Bacillus sp. PI-PLC 
(Bannam and Goldfine, 1999), and the enzyme has been shown to be activated by short-
chain phosphatidylcholine (PC) molecules as well (Ryan et al., 2002). There are, however, 
several major differences of the L. monocytogenes PI-PLC from Bacillus homologues, 
namely a high pI (above 9), kinetic activation by salts, and relatively weak activity 
toward GPI anchors (Goldfine and Knob, 1992; Hatfield and Diamond, 1993).  
In my work, water-soluble synthetic short chain phosphatidylinositol and cIP 
along with PI/detergent mixed micelles and PI/PC vesicles were used as substrates to 
understand how salts and other phospholipids affect both steps of PI hydrolysis by the L. 
monocytogenes PI-PLC. The results indicate that L. monocytogenes PI-PLC binds tightly 
to anionic phospholipids (e.g., PI, PG) and tends to form aggregated complexes with 
those anionic lipids. The enzymatic activity is much lower for those complexes. The two 
types of activators previously shown for this enzyme work by different mechanisms: (i) 
neutral amphiphiles, which enhance both steps of catalysis regardless of the aggregation 
state of the substrate, bind directly, though weakly, to the protein and enhance its 
catalytic ability (at sufficiently high mole fractions the amphiphiles can prevent the 
enzyme from forming the aggregated complexes), while (ii) moderate ionic strength (e.g., 
salts) only affects the phosphotransferase reaction and then only when an activating 
interface is present. The latter is likely to be the result of altering the surface electrostatics 
and reducing the formation of aggregated complexes, and possibly altering the residence 
time of the enzyme on interfaces. A model rationalizing the role of both types of 
activators in modulating the enzyme activity in situ is presented. 
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II. Specific activity behavior of L. monocytogenes PI-PLC 
A. Dependence of L. monocytogenes PI-PLC specific activity on protein 
concentration 
Previously, the pH behavior for the L. monocytogenes PI-PLC 
phosphotransferase reaction was shown to vary slightly with the detergent matrix for the 
PI. A sharp optimum pH of 7.0 was observed toward PI solubilized in deoxycholate 
micelles with less than 30% activity at pH 6.5 and pH 7.5 (the suspension of PI in 
deoxycholate was no longer clear below pH 6.5), while a broad optimum pH range, from 
5.5 to 6.5, was observed for enzyme acting on PI in TX-100 micelles (Goldfine and Knob, 
1992). For comparison we tested the effect of pH on the phosphodiesterase reaction in the 
absence of detergent. The enzyme was optimally active towards cIP at pH 7.0, with 67% 
and 57% maximum activity at pH 6.5 and 7.5 respectively (Figure 4-1). Thus, pH 7.0 was 
used for both phosphotransferase and cyclic phosphodiesterase kinetic assays. 
PI can be presented to PI-PLC in a range of different matrices – micelles, 
unilamellar vesicles or water/organic solvent co-mixtures (Volwerk et al., 1990; Lewis et 
al., 1993; Zhou et al., 1997a; Zhou and Roberts, 1998; Wehbi et al., 2003a). Differences 
in PI-PLC activity toward the different types of interfaces can often provide insights into 
what factors control the activity of this enzyme. However, L. monocytogenes PI-PLC 
exhibited an added complication that protein concentration also affected enzyme activity. 
Since the assay for phosphotransferase activity is not continuous, we monitored the 
generation of cIP (using 0.02, 0.41, or 1.7 µg/ml PI-PLC) toward PI/TX-100 micelles at  
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Figure 4-1 Dependence of cIP hydrolysis by L. monocytogenes PI-PLC on the pH of the 
solution. Assay conditions included 50 mM imidazole, 10 mM cIP, 3.6 µg/ml enzyme. 
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various time points to avoid the influence of a lag or burst in product formation. The 
specific activities determined for a given sample were all consistent (within 15% errors) 
in the range of 8-20% PI hydrolysis. This suggested that the time scale for PI-PLC 
binding to the substrate PI micelles was relatively short, and that products had little effect 
on enzyme activity. As shown in Figure 4-2, the phosphotransferase activity of L. 
monocytogenes PI-PLC toward PI (8 mM) in TX-100 (32 mM) mixed micelles increased 
dramatically from 147 to 1190 µmol·min-1·mg-1 as protein was diluted from 0.41 to 0.01 
µg/ml. Further dilution of the protein had only a small effect on specific activity. A 
similar dependence of specific activity on protein concentration was also observed with 
PI/diC7PC mixed micelles (Figure 4-2). To rule out any possible inhibitors from the 
expression/purification system, purified recombinant L. monocytogenes PI-PLC was 
further purified with cation exchange or gel filtration (with high salt concentration) 
chromatography, and the concentration dependence of specific activity on enzyme 
concentration still persisted. 
The loss of activity with high enzyme concentration has been discussed by 
Wang (1999) for an association-dissociation enzyme system. PI-PLC could be 
aggregating in solution with the monomer more active than oligomer. Therefore, we tried 
several ways to check the aggregation state of L. monocytogenes PI-PLC in solution. Gel 
filtration was first applied. However the enzyme interacted anomalously with gel 
filtration resins even in the presence of 0.5 M NaCl, so that another method was needed. 
Native gel electrophoresis can often be used to measure the native molecular mass of the  
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Figure 4-2 Dependence of L. monocytogenes PI-PLC phosphotransferase activity on 
enzyme concentration (μg/ml). Assay conditions included 50 mM HEPES, pH 7.0, 8 mM 
PI solubilized in either 32 mM TX-100 (ο) or 32 mM diC7PC (•).  
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protein. For an enzyme with a high pI, an acidic buffer system and standard proteins 
carrying positive charges are required. Within the range of acrylamide concentrations 
used (7-15%), only one band was observed for up to 50 µg L. monocytogenes PI-PLC on 
the gel. But with only three commercially available basic proteins as standards, the errors 
in estimating the native molecular weight were too high for a definitive answer. Laser 
light scattering is another method for characterizing the native molecular mass of proteins. 
This measurement on L. monocytogenes PI-PLC was provided by the HHMI Biopolymer 
Facility and W. M. Keck Foundation Biotechnology Resource Laboratory (Yale 
University). The average molecular mass for L. monocytogenes PI-PLC was determined 
as 28.2 kDa at a concentration of 0.14 mg/ml - well above that used in the kinetic assays. 
This is quite close to the predicted molecular weight of 33 kDa determined from the 
sequence. Thus, this PI-PLC exists as a monomer in solution in the absence of detergent. 
If the protein aggregation does account for the dependence of specific activity on protein 
concentration, the oligomerization of PI-PLC must only occur in presence of an interface 
or the anionic substrates. Cross-linking of the protein with EDC, DMS, and APG was 
tried to assess this possibility. However, with EDC and DMS no aggregate states were 
trapped. With APG, enzyme (2 mg/ml) aggregates were detected (Figure 4-3). At protein 
concentrations used in assays such oligomerization is unlikely to occur unless it is 
catalyzed by interfaces.  
The phosphodiesterase activity of L. monocytogenes PI-PLC toward 5 to 40 mM 
cIP without detergent was investigated at two different protein concentrations. Because  
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Figure 4-3 SDS-PAGE of APG cross-linking assays: lane 1, MW markers; lane 2, pure 
PI-PLC; lane 3, APG crosslinked PI-PLC. For assay, 2 mg/ml PI-PLC was incubated in 
the dark with 2.4 mM of APG in 20 mM sodium phosphate, pH 7.5, for 6 h at room 
temperature; the subsequent photoactivation was performed with a 254 nm UV light 
source for 15 min at room temperature. Upon completion, the reaction mixture was 
dialyzed in the dark to get rid of the excess APG and checked with SDS-PAGE. 
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cIP is a poorer substrate than PI, considerably higher enzyme concentrations (3.6 or 7.2 
µg/ml) were needed. In this high range of enzyme concentration, the activity is low and 
varies little between these two protein concentrations. However, there is a very 
significant difference in kinetic parameters extracted for the two different enzyme 
concentrations (Figure 4-4). In both cases, the data could be fit to the Michaelis-Menten 
equation: Vmax=0.7±0.1 µmol·min-1·mg-1 and Km=12.5±5.0 mM at the lower PI-PLC 
concentration (3.6 µg/ml), and Vmax=2.0±1.0 µmol·min-1·mg-1 with Km=100±62 mM at 
double the enzyme concentration. Although the errors in Vmax and Km are large, the major 
effect of the higher enzyme concentration appears to be an increase in ‘Km’ for water-
soluble substrate cIP. Although L. monocytogenes PI-PLC exists as monomer in solution 
as shown by the laser light scattering measurement, variations in enzyme concentration 
show different extents of activation for cIP cleavage, indicating that the enzyme may 
aggregate with the substrate present (in this case soluble cIP).  
B. Effect of detergent or vesicle interface on PLC activities 
The Bacillus sp. PI-PLC enzymes exhibits a specific activation of both 
phosphotransferase and phosphodiesterase steps by interfaces containing 
phosphatidylcholine (or phosphatidylethanolamine) (Zhou et al., 1997a). It has been 
suggested that such an activation also occurs for the L. monocytogenes PI-PLC (Goldfine 
and Knob, 1992). Therefore, we examined the effect of micelle matrix on the 
phosphotransferase activity of recombinant L. monocytogenes PI-PLC toward PI 
dispersed in TX-100. The enzyme concentration, as well as detergent, was varied (0.02,  
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Figure 4-4 Effect of cIP concentration on L. monocytogenes PI-PLC phosphodiesterase 
activity: (ο) 3.6 µg/ml, and (•) 7.2 µg/ml PI-PLC. Assay conditions included 50 mM 
imidazole, pH 7.0, and variable cIP concentration. 
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0.2, or 0.4 µg/ml protein). TX-100 is a nonionic detergent that clarifies PI bilayers at >2:1 
TX-100/PI (Zhou et al., 1997a). If the surface concentration of PI is important for L. 
monocytogenes PI-PLC activity, then increasing TX-100 at fixed PI (8 mM) will 
eventually “inhibit” the enzyme leading to lower specific activity. Such surface dilution 
inhibition has been documented for the B. thuringiensis PI-PLC (Zhou et al., 1997a). 
However, in our hands, L. monocytogenes PI-PLC presented different kinetic patterns 
depending on the protein concentration (Figure 4-5A). For 0.4 µg/ml enzyme, the enzyme 
exhibited no decrease in activity up to Xdet = 0.94 (16:1 TX-100/PI). In fact, the enzyme 
phosphotransferase activity increased dramatically as the surface concentration of the 
detergent increased above 0.90. The same amount of PI-PLC exhibited the same specific 
activities towards PI presented in diC7PC micelles. A similar trend, but with higher 
specific activities, was observed when the protein concentration in the assay was 
decreased two-fold.  
At a much more dilute concentration, 0.02 µg/ml, a more typical ‘surface 
dilution curve’ was observed with the maximum phosphotransferase activity around 3.5:1 
TX-100/PI. This detergent/substrate ratio for optimal activity is higher than what is 
needed to minimally solubilize PI (2:1 TX-100/PI). It has been reported that PI in 
predominantly PC bilayers is partially demixed (Redfern and Gericke, 2004). A similar 
demixing in mixed micelles could occur unless an excess of detergent is used. 
Alternatively, this could reflect a distinct activation by the detergent. At the very low 
concentration of this PI-PLC, the specific activity of L. monocytogenes PI-PLC decreased 
above Xdet= 0.80 as might be expected for a regime where the surface concentration of 
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substrate influences the enzyme action. Comparing the activity curves of three protein 
concentrations in Figure 4-5A shows that significantly increased TX-100 could 
compensate for the lower specific activity at high enzyme concentration, since 
comparable high activities (1155 and 1260 µmol min-1mg-1) were achieved for all the 
protein concentrations examined. If the protein concentration decreased further, a lower 
optimum TX-100/PI ratio would be expected. However, 0.02 µg/ml is the limit of our 
assay system. Using [3H]PI as substrate, the phosphotransferase activity of PI-PLC was 
previously measured at 0.003 µg/ml enzyme. The optimal L. monocytogenes PI-PLC 
specific activity (~2900 µmol·min-1·mg-1) toward 0.08 mM PI micelles dispersed in TX-
100 or deoxycholate was reported at a ratio of 10:1 TX-100/PI or 30:1 deoxycholate/PI 
(Goldfine and Knob, 1992). The higher specific activity than what we observe with low 
PI-PLC or moderate PI-PLC with high mole fractions of detergent (Xdet) is likely due to 
the addition of moderate salt, ammonium sulfate, in the previous report 
We checked the effect of diC7PC (a zwitterionic synthetic short-chain 
phosphatidylcholine that forms micelles) on PI cleavage by L. monocytogenes PI-PLC. 
As shown in Figure 4-5A, the data for PI dispersed in diC7PC agrees well with that for 
PI/TX-100 mixed micelles at the same enzyme concentration (0.4 µg/ml), although there 
was a slightly lower specific activity at relatively high mole fraction of detergent. The 
similarity in the effects of various detergents on the phosphotransferase activity of PI-
PLC is not observed for Bacillus sp. homologs. For B. thuringiensis PI-PLC, a higher 
ratio of detergent to PI was required for the maximal activity using diC7PC compared to 
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TX-100 (6:1 for diC7PC/PI versus 2:1 for TX-100/PI). The specific activity with the 
short-chain PC micelles was also increased 3.5-fold (Zhou et al., 1997a).  
The activity of L. monocytogenes PI-PLC toward a fixed bulk concentration of 
PI (8 mM) diluted in a POPC vesicle matrix was also studied. Compared with PI/TX-100 
micelles, unilamellar vesicles of long-chain PI are poor substrates for PI-PLC from L. 
monocytogenes, necessitating high protein concentrations for these assays. At a protein 
concentration of 1.6 µg/ml, the enzyme phosphotransferase activity increased about 2-
fold as the mole fraction of POPC increased from 0 to 0.2. A slightly larger activation 
(2.5-3-fold) at 0.2 mole fraction POPC was reported for B. thuringiensis PI-PLC (Pu et 
al., 2008a). Once the POPC mole fraction was greater than 0.2 (at fixed PI), the L. 
monocytogenes PI-PLC specific activity stayed constant until a POPC mole fraction of 
0.5 and then decreased as the mole fraction increased further to 0.8 (Figure 4-5B). This 
behavior is consistent with the weak surface dilution inhibition observed in the PI micelle 
system. Similar to PI/TX-100 micelles, higher activities toward PI/POPC SUVs were also 
observed at a lower enzyme concentration (0.4 µg/ml) except for PI pure SUVs where the 
specific activities were 1.3 and 3.7 µmol·min-1·mg-1 for 0.4 and 1.6 µg/ml enzyme, 
respectively. The effect of 0.2 mole fraction POPC is unlikely to be the result of a 
specific interaction of the enzyme with that zwitterionic phospholipid since the presence 
of POPC could not compensate for the activity loss at higher protein concentration 
(Figure 4-5B).  
Examining amphiphile effects with monomeric substrate, in this case cIP, is one  
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Figure 4-5 (A) Dependence of L. monocytogenes PI-PLC phosphotransferase activity on 
mole fraction of detergent: 0.4 µg/ml PI-PLC with 8 mM PI solubilized in TX-100 (Δ) or 
diC7PC (Χ); 0.02 µg/ml (ο) or 0.2 µg/ml (•) PI-PLC with PI solubilized in TX-100. (B) 
Dependence of phosphotransferase activity on mole fraction of POPC in PI (8 
mM)/POPC SUVs with 0.4 µg/ml (ο) or 1.6 µg/ml (•) enzyme. Reactions were carried 
out with 8 mM PI and the indicated amphiphile dispersed in 50 mM HEPES, pH 7.0. 
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way of separating activator effects that alter the substrate versus those that alter the 
enzyme. With cIP at a fixed concentration, we can screen different additives for their 
effect on L. monocytogenes PI-PLC activity towards this monomeric substrate. Ryan and 
coworkers (2002) have shown that diC6PC at concentrations below its CMC activate this 
enzyme with respect to non-natural water-soluble PI substrates. In our system, the plot of 
phosphodiesterase specific activity of L. monocytogenes PI-PLC versus diC6PC 
concentration was biphasic (Figure 4-6A). Below the CMC of diC6PC (14 mM), there 
was a 12-fold increase in activity upon the addition of 5 mM diC6PC followed by a small 
rate drop. A second increase in specific activity was observed around the CMC of diC6PC, 
with PI-PLC activity 20-fold activity higher than for cIP alone. A slightly more 
hydrophobic amphiphile, diC7PC, also enhanced the activity of the enzyme toward the 
natural soluble substrate cIP (Figure 4-6A). With 10 mM cIP (below its Km), there was a 
4-fold increase in L. monocytogenes PI-PLC specific activity upon the addition of 1.5 
mM diC7PC (the CMC of the lipid alone). The L. monocytogenes PI-PLC specific 
activity toward cIP kept increasing as the PC micelle concentration was increased to 32 
mM. The sigmoidal dependence of specific activity on diC7PC concentration is consistent 
with PC surfaces acting as more potent activators than PC monomers. The effective ‘Kd’ 
or S0.5 for this activation occurred at 3.8 mM diC7PC. The requirement for the higher 
amount of diC7PC micelles to activate L. monocytogenes PI-PLC compared to B. 
thuringiensis PI-PLC (Zhou et al., 1997a) suggests a weaker binding of the Listeria 
enzyme to this surface.  
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Figure 4-6 (A) Effect of diC6PC (o) or diC7PC (•) on cIP (10 mM) hydrolysis by 3.6 
µg/ml PI-PLC in 50 mM imidazole, pH 7.0. (B) Effect of POPC SUVs (Δ) on cIP (10 
mM) hydrolysis by 3.6 µg/ml PI-PLC. The X indicates the effect of 2 mM POPC/0.1 mM 
POPS vesicles on cIP hydrolysis. 
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Table 4-1 Effect of different additives on cIP (10 mM) hydrolysis by L. monocytogenes 
PI-PLCa.  
 
 
Assay system 
PI-PLC 
(µg/ml) 
Additive (mM) 
Relative 
activity a 
cIP 7.2 TX-100 3 14.8 
cIP 7.2 diC7PC 5 15.1 
cIP 7.2 POPC 2 4.38 
cIP 7.2 DOPMe 1 <0.1 
cIP 7.2 POPS 1 0.43 
cIP 3.6 POPC 2 7.94 
cIP + 2 mM POPC 3.6 POPS 0.1 0.31 
cIP 7.2 (NH4)2SO4 150 0.65 
cIP + 5 mM diC7PC 7.2 (NH4)2SO4 100 0.83 
 
aAssays measured in 50 mM HEPES, pH 7.0, 25°C. Relative activity is the ratio of the 
specific activity measured with the additive present compared to the activity in the 
absence of that additive (salts or lipids). For 10 mM cIP in the absence of additives, the 
enzyme specific activity was 0.29 µmol·min-1·mg-1 for 3.6 µg/ml protein or 0.16 
µmol·min-1·mg-1 for 7.2 µg/ml protein.  
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POPC SUVs also enhanced cIP hydrolysis (Figure 4-6B and Table 4-1) with an 
S0.5<0.05 mM, although the maximum activity was considerably less than for diC7PC or 
TX-100 activation. SUVs composed of anionic non-substrate phospholipids (POPS and 
DOPMe) strongly inhibited the cIP hydrolysis reaction (Table 4-1). Vesicles with 0.2 
mole fraction POPS disproportionately reduced L. monocytogenes PI-PLC activity 
toward cIP. Therefore, the enzyme must bind to those anionic phospholipids more tightly 
than it binds to POPC. 
Unlike what is observed for B. thuringiensis PI-PLC, TX-100 was also an 
effective activator of cIP hydrolysis by L. monocytogenes PI-PLC. Comparable activities 
were obtained with 3 mM TX-100 or 5 mM diC7PC (Table 4-1). Since the substrate cIP 
is monomeric, the amphiphile must activate L. monocytogenes by a direct interaction. 
However, whether in doing so it disfavors substrate-induced protein aggregation or 
promotes a more active form of the enzyme is not known. 
C. Effect of salts 
Salt activation of PI cleavage by L. monocytogenes PI-PLC has been 
documented previously (Goldfine and Knob, 1992). Although no explanation was 
proposed, it was noted that in the absence of high salt, L. monocytogenes PI-PLC in 
solution behaved as a large aggregate on gel filtration columns, but that 1 M (NH4)2SO4 
attenuated this behavior (Goldfine and Knob, 1992). Salts can enhance hydrophobic 
interactions (e.g., promote insertion of protein hydrophobic side chains into bilayers) as 
well as weaken electrostatic interactions that hold complexes together. With this in mind, 
we examined the effect of several different salts ((NH4)2SO4, NH4Cl, K2SO4, and KCl) on 
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L. monocytogenes PI-PLC cleavage of PI in TX-100 or diC7PC mixed micelles and 
hydrolysis of cIP. As shown in Table 4-2, the ionic strength, and not the salt identity, was 
important for L. monocytogenes PI-PLC activation towards PI in micelles. Two enzyme 
concentrations were examined for PI cleavage. At fixed enzyme concentration and 8 mM 
PI (solubilized in 32 mM TX-100), L. monocytogenes PI-PLC activity displayed a 
hyperbolic dependence on concentration of (NH4)2SO4 (Figure 4-7). For 0.2 µg/ml L. 
monocytogenes PI-PLC, the apparent Vmax was 2022±202 µmol·min-1·mg-1 with an 
apparent Kd for the salt of 38±16 mM; for 1.6 µg/ml L. monocytogenes PI-PLC, the 
apparent Vmax decreased somewhat to 1355±256 µmol·min-1·mg-1 with a comparable Kd 
42±20 mM. The lower Vmax extrapolated from the salt dependence of activity at an 8-fold 
higher L. monocytogenes PI-PLC concentration indicates that the presence of salt does 
not completely eliminate the unfavorable factors associated with high enzyme 
concentration. However, the ratio of specific activity for 0.21 µg/ml PI-PLC compared to 
1.6 µg/ml at 0, 20, and 100 mM (NH4)2SO4, (3.7, 1.6, and 1.5, respectively) decreases 
suggesting that (NH4)2SO4 does partially compensate for the high enzyme concentration. 
The salt effect was also studied with PI presented in vesicles. With 1.6 µg/ml 
enzyme and (NH4)2SO4 (100 mM) added to PI (8 mM) SUVs, the enzyme specific 
activity increased only 1.3-fold (Table 4-3). For comparison, when the PI was co-
sonicated with 8 mM POPC (0.5 mole fraction PI vesicles), enzyme activity increased 
about 2.4 fold compared to pure PI SUVs. If salt was added to the cosonicated PI/POPC 
(1:1) SUVs, the increase in PI-PLC specific activity was much more dramatic – about a  
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Table 4-2 Effect of 0.30 OsM salts on the specific activity of L. monocytogenes PI-PLC 
toward PI solubilized in 32 mM TX-100. Assays used 0.2 µg/ml PI-PLC in 50 mM 
HEPES, pH 7.0. 
 
Salt (M) Specific Activity (µmol·min-1·mg-1) 
- 0.00 274 
(NH4)2SO4 0.10 1431 
NH4Cl 0.15 936 
K2SO4 0.10 1120 
KCl 0.15 1034 
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Figure 4-7 Effect of (NH4)2SO4 on the rate of cleavage of PI (8 mM) solubilized in 32 
mM TX-100: (•) 0.2 µg/ml and (ο) 1.6 µg/ml PI-PLC.  
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Table 4-3 Effect of (NH4)2SO4 on L. monocytogenes PI-PLC (1.6 µg/ml) cleavage of PI 
(8 mM) vesicles and PI/PC (1:1) cosonicated vesicles.  
 
 
POPC (8 Mm) (NH4)2SO4 (100 mM) Specific Activity (µmol·min-1·mg-1) 
- - 3.8 
- + 4.8 
+ - 9.0 
+ + 127 
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34-fold increase. To see if a zwitterionic / neutral amphiphile is critical for the large salt 
activation shown in PI/detergent assays, we checked the effect of salt on the activity of L. 
monocytogenes PI-PLC toward pure PI SUVs. Surprisingly, the activity increased in a 
sigmoidal fashion from 6 µmol·min-1·mg-1 with 100 mM KCl to 330 µmol·min-1·mg-1 
with 200 mM KCl in the absence of other amphiphiles (Figure 4-8). With 300 to 1500 
mM KCl, the activity remained around 500 µmol·min-1·mg-1, comparable to that toward 
0.08 mole fraction PI dispersed in TX-100 (or diC7PC) micelles for the same enzyme 
concentration. 
In contrast to its activation of PI cleavage by L. monocytogenes PI-PLC, 
(NH4)2SO4 (as well as other salts) inhibited cIP hydrolysis whether diC7PC was present 
or not (Table 4-1). These results make it unlikely that salts biases the enzyme toward a 
more active conformation, otherwise, it should have enhanced cIP hydrolysis as well as 
PI cleavage. The added salt could alter the properties of substrate interfaces making them 
more susceptible to L. monocytogenes PI-PLC or it could alter the interaction of the 
enzyme with the interface. One way of testing these explanations is to examine the effect 
of salts and amphiphiles on cleavage of diC4PI, a soluble phosphodiesterase substrate 
with no tendency to partition into aggregates as long as the substrate concentration is low 
(the CMC for this lipid is likely to be >150 mM since diC4PC has a CMC of 250 mM 
(Bian and Roberts, 1992) and other short-chain PI species exhibit CMC values 
comparable to the same chain length PC compound (Garigapati and Roberts, 1993)). As a 
way of ruling out any aggregation of the diC4PI induced by the amphiphile or salt, the 31P  
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Figure 4-8 Effect of KCl on L. monocytogenes PI-PLC (0.4 µg/ml) cleavage of PI (8 mM) 
vesicles. 
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linewidth of 2 mM diC4PI was measured in buffer in the absence and presence of 100 
mM KCl, 100 mM TX-100, and then both components. The linewidth, 1.6±0.1 Hz, was 
unchanged with the additives.  
Keeping the diC4PI concentration at 2 mM, we measured the effect of KCl and 
TX-100 on L. monocytogenes PI-PLC activity towards the soluble substrate (Figure 4-9). 
With either 75 mM KCl or 32 mM TX-100 only, the specific activity of L. 
monocytogenes PI-PLC toward diC4PI increased slightly (about 1.6-fold). However, if 
both salt and TX-100 were present, there was ~14-fold increase in L. monocytogenes PI-
PLC toward diC4PI. A similar synergistic effect was observed with monomeric diC6PC 
added – a much larger activation was seen with both KCl and amphiphile present. This 
synergistic effect cannot reflect altering the substrate interface because the substrate is 
monomeric. This suggests that for the phosphotransferase reaction, the presence of an 
amphiphile, regardless of its aggregation state, is important for the kinetic activation 
observed with moderate ion strength. KCl (0.1 M) could lower the CMC of diC6PC 
slightly, but the effect in the absence of enzyme is not significant (Lin et al., 1986). 
However, the decrease in activity toward cIP with monomeric diC6PC for L. 
monocytogenes PI-PLC (Figure 4-6A and Ryan et al., 2002) may suggest that the enzyme 
itself could nucleate ‘mini’-micelle formation when it binds a diC6PC molecule. Studies 
of B. thuringiensis PI-PLC showed that monomeric diC6PC can bind to the protein, at a 
site distinct from the catalytic site, and activate the enzyme (Zhou et al., 1997b). DiC4PI 
is a poor substrate for L. monocytogenes PI-PLC, necessitating long incubation time (2 to  
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Figure 4-9 Synergistic effect of salts and amphiphiles on the phosphotransferase activity 
of L. monocytogenes PI-PLC toward: ( ) PI/POPC cosonicated SUVs; ( ) diC4PI/TX-
100; ( ) diC4PI/diC6PC. 
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aAssays measured in 50 mM HEPES, pH 7.0 with 1.6 µg/ml enzyme. Relative activity is 
the ratio of the specific activity measured with the additive present compared to that in 
the absence of that additive (salts or amphiphiles). 
bThe control enzyme activity is 3.8, 0.7, and 1.2 µmol·min-1·mg-1 for PI/POPC (8 mM: 8 
mM) cosonicated vesicle, diC4PI/TX-100 (2 mM: 32 mM), and diC4PC/diC6PC (2 mM:5 
mM). 
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5 h) if the same enzyme concentration is to be used in the absence and presence of salts 
and amphiphiles. With TX-100 present, final products included both cIP and I-1-P for 
incubation times longer than 1 h. However, if diC6PC was used as the amphiphile, cIP 
was the only product even after 2 h. There is a difference when the L. monocytogenes PI-
PLC interacts with TX-100 versus a short-chain PC molecule such that binding of 
diC6PC to the protein promoted cIP release from active site. 
III. Binding PI-PLC to interfaces 
Short-chain PC molecules activate the L. monocytogenes PI-PLC toward cIP in 
the absence of salt, so there must be a direct interaction of the enzyme with the PC 
molecules. This was probed by 31P NMR linewidth studies as has been done previously 
for the B. thuringiensis PI-PLC (Zhou et al., 1997b). As shown in Figure 4-10A, a 
threshold of PC (≥1 mM) was needed before significant broadening (0.8 Hz maximum 
under the conditions used) was detected. As more PC was added, the linewidth difference 
in the presence and absence of L. monocytogenes PI-PLC decreased. This type of profile 
is typical for multiple PC molecules interacting with the enzyme (and occupation of all 
these sites needed before the measured spectral change occurs). As shown in Figure 
4-10B, the linewidth difference for diC7PC caused by the presence of L. monocytogenes 
PI-PLC (2 mg/ml) was consistent with a n value of 3-4, (Δυb-Δυ0) = 5.5±0.6 Hz, and KD 
= 1.5±0.6 mM. The analysis with diC6PC binding to L. monocytogenes PI-PLC yielded 
the same n, (Δυb-Δυ0) = 3.3±0.8 Hz, and KD = 17±10 mM (data not shown). In both cases,  
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Figure 4-10 (A) 31P linewidth (Hz) of diC7PC in the absence (♦) and presence (■) of L. 
monocytogenes PI-PLC. The dotted line indicates the CMC of pure diC7PC. (B) Increase 
in linewidth (Hz) for diC7PC induced by the inclusion of 2 mg/ml PI-PLC (differences in 
linewidth in (A)). The line represents the optimized fit to (Δυobs-Δυ0)=nET[PC]Tn-1((Δυb-
Δυ0)/{KD + [PC]Tn} as described in the methods section. 
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the ‘KD’ describing the interaction was essentially at the CMC of the short-chain PC. The 
linewidth for bound PC would suggest significant mobility consistent with a small 
aggregate or mini-micelle interacting loosely with the protein.  
L. monocytogenes PI-PLC binding to SUVs of POPC or DOPMe was also 
examined using a filtration / centrifugation binding assay (Wehbi et al., 2003b). As 
shown in Figure 4-11A, L. monocytogenes PI-PLC (30 µg/ml or 0.9 µM) had weak 
affinity for POPC SUVs – essentially >90% of the protein was eluted through the filter 
upon centrifugation even after incubation with 5 mM POPC SUVs. In contrast, this 
bacterial PI-PLC bound very tightly to anionic phospholipid SUVs regardless of 
headgroup. For DOPMe concentrations above 10 µM, essentially all the protein was 
bound to the phospholipids and none passed through the filter upon centrifugation. Thus, 
L. monocytogenes PI-PLC binds very tightly to anionic bilayers (PMe, PG, and by 
inference substrate PI); the interaction of this concentration of L. monocytogenes PI-PLC 
with PC bilayers was much weaker (too weak to quantify an apparent Kd by this vesicle 
binding assay). Yet low concentrations of POPC SUVs (0.5 mM) do activate the enzyme 
toward cIP. At higher protein and anionic phospholipid concentration, we observed an 
anionic lipid-induced precipitation of protein (Figure 4-11B). POPG vesicles (0.5 mM) 
precipitated all the protein in this experiment (1.2 mg/ml or 36 µM). If using PC SUVs, 
very little protein was present in the SDS-PAGE gel of precipitate. This very small 
amount of L. monocytogenes PI-PLC could just come from the solution (precipitates were 
dissolved in the same tube used to mix vesicles and enzyme) instead of the precipitate  
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Figure 4-11 Binding of L. monocytogenes PI-PLC to SUVs checked by SDS-PAGE. (A) 
Free enzyme (30 µg/ml) in filtrate through 100 KDa cut-off filter. (B) PG induced 
precipitation of enzyme (1.2 mg/ml, 36 μM). The numbers below each lane indicate mM 
concentration of PG or PC in SUVs added to the sample. 
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since the optical density at 350 nm (OD350) of the PC solution was unchanged upon the 
addition of enzyme. With 0.02 mM POPG and this higher concentration of protein, 
protein was found in both the filtrate and the precipitate. Increasing the concentration of 
POPG SUVs increased the fraction of PI-PLC in the precipitate. If the SUVs used had an 
excess of POPC (0.02 mM POPG/0.5 mM POPC), precipitation of the protein was 
dramatically reduced. If micelles as opposed to vesicles were examined, more PG was 
needed to precipitate the protein. The amount of each lipid in the precipitate (extracted 
with methanol/chloroform) was measured with 31P NMR, and the lipid composition in the 
precipitate for PG/PC SUVs or micelles was very similar to that in solution. Therefore, 
increasing PI-PLC specific activity as detergent or PC in SUV system is increased is 
likely to reflect (at least in part) disruption of this large, nonproductive aggregated 
complex that sequesters the enzyme from the bulk of the substrate.  
The progress of precipitation was monitored by looking at OD350 with 
continuously stirring (Figure 4-12A). After adding L. monocytogenes PI-PLC to 
DOPMe/POPC (1:3.6) SUVs, an instant and very dramatic increase in optical density, 
corresponding to the formation of the precipitate, was observed. Similar behavior was 
also observed for POPG/POPC SUVs, but not for pure PC vesicles. The initial large 
structures eventually reorganize to smaller ones, but they are still larger than SUVs since 
the limiting OD350 was greater than the OD350 of the SUVs in the absence of protein. 
Since the precipitation could be dispersed by salt (at concentrations comparable to those 
used in the kinetics), it can not be related to vesicle fusion. 
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The release of vesicle-entrapped carboxyfluorescein upon the addition of 
protein was monitored to check the stability of vesicles in the presence of PI-PLC (Figure 
4-12B). L. monocytogenes PI-PLC caused <25% carboxyfluorescein leakage (compared 
to total leakage from TX-100) within 2 hours (the reaction time course used for most 
assays) for three vesicle systems (POPC, POPC with KCl, and DOPMe). The initial 
release rate of carboxyfluorescein increased in the order of the affinity of enzyme for the 
interface (DOPMe > POPC > POPC+KCl), but the total carboxyfluorescein leakage level 
increased in the reverse order (POPC+KCl > POPC > DOPMe). These results indicate 
that the carboxyfluorescein released from SUVs is most likely related to perturbing the 
interface upon binding of enzyme, not pore formation or vesicle lysis. The higher the 
binding affinity, the faster the enzyme finds the interface, which in turn, leads to a higher 
initial rate of release rate of carboxyfluorescein. The more tightly the enzyme binds to a 
given vesicle surface, the longer the enzyme stays on that structure and less chance it will 
dissociate and bind to another vesicle.  
The fluorescence spectrum of Pyr-PG is characterized by an excimer band at 
480 nm and monomer bands at 375-395 nm (Figure 4-13A). By introducing a small 
amount of pyrene labeled PC to POPG / diC7PC micelles or POPG/POPC SUVs, the ratio 
of intensity of monomer at 385 nm to that of excimer at 480 nm should be changed upon 
the addition of enzyme if L. monocytogenes PI-PLC perturbs the lateral distribution of 
Pyr-PG. As shown in Figure 4-13B, no such perturbation was oberserved. Clearly, L. 
monocytogenes PI-PLC does not induce the lateral distribution change of anionic lipids in 
micelles or vesicles if the surface concentration is sufficiently dilute. 
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Figure 4-12 (A) Turbidity changes of 0.86 mM DOPMe / 3.1 mM POPC co-sonicated 
SUVs upon the addition (at 10 min) of 0.15 mg/ml (ο), 0.75 mg/ml (●), and 1.5 mg/ml (Δ) 
PI-PLC measured at OD350. (B) Carboxyfluorescein released from 20 mM POPC (ο), 20 
mM POPC+150 mM KCl (●), and 20 mM DOPMe (Δ) vesicles mediated by L. 
monocytogenes PI-PLC (0.5 mg/ml). TX-100 was used to release all entrapped 
carboxyfluorescein. 
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Figure 4-13 (A) Fluorescence emission spectrum of pyrene-labeled PG. (B) Effect of L. 
monocytogenes PI-PLC on the ratio of monomer (385 nm) and excimer band (480 nm) of 
(ο) 20 µM pyrene-labeled PG / 3 mM diC7PC micelles and (□) 100 µM pyrene-labeled 
PG with 100 µM unlabeled POPG / 2 mM POPC SUVs. 
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Monolayer studies provide more insight into how PC (and likely other neutral 
amphiphiles) contributes to the kinetic activation of the enzyme. L. monocytogenes PI-
PLC binds tightly to anionic monolayers of DOPMe (Figure 4-14A), and πC, the 
threshold pressure above which the enzyme cannot insert into the membrane, is high (46 
dyne/cm) for this protein under these conditions. The strong interaction with an anionic 
surface may not be surprising given the high pI for this protein and the potent inhibition 
of cIP hydrolysis by anionic phospholipids vesicles (Table 4-1). The addition of KCl at a 
concentration comparable to the KD observed for KCl kinetic activation (0.16 M) had 
little effect on πC for the enzyme binding to a DOPMe monolayer, indicating binding and 
insertion in the anionic interface were not dramatically affected by this concentration of 
salt (Table 4-4 and Figure 4-14B). The slope of the plot decreased suggesting that the 
portion of protein maximally inserted into a membrane had decreased in the higher ionic 
salt solution (Table 4-4 and Figure 4-14). Binding of L. monocytogenes PI-PLC to POPC 
membranes was characterized by a considerably smaller πC (31 dyne/cm) that was further 
reduced in the presence of 0.16 M KCl (to 23 dyne/cm), confirming that the binding of L. 
monocytogenes PI-PLC to PC interfaces has a smaller electrostatic component compared 
to binding to anionic phospholipid bilayers. Binding of L. monocytogenes PI-PLC to a 
mixed monolayer of 70 mol% PC and 30 mol % DOPMe in the absence of KCl 
resembled the binding curve to a pure DOPMe monolayer (Figure 4-14A, Table 4-4); πC 
was unaltered while the maximum Δπ extrapolated decreased reflecting the PC content 
(24 versus 32 dyne/cm). The addition of 0.16 M KCl to this mixed monolayer had a  
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Figure 4-14 Effect of L. monocytogenes PI-PLC on the surface pressure of DOPMe (ο), 
POPC (•), and POPC/DOPMe (7:3) (■) monolayers in the (A) absence and (B) presence 
of 0.16 M KCl. 
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Table 4-4 Effect of KCl on the ability of L. monocytogenes PI-PLC to penetrate DOPMe 
and POPC monolayers.  
 
 
Phospholipid KCl (M) πc (dyne/cm) Δπmax 
DOPMe 0 45 32 
DOPMe 0.16 44 28 
POPC 0 31 16 
POPC 0.16 23 19 
DOPMe/POPC (3:7) 0 46 24 
DOPMe/POPC (3:7) 0.16 37 19 
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pronounced effect on L. monocytogenes PI-PLC binding. πC was decreased to 37 dyne/cm 
while Δπ was the same as that extrapolated from L. monocytogenes PI-PLC binding to a 
PC monolayer. When the KCl in the solution was increased to 0.5 M, the protein showed 
very minimal binding irrespective of any lipid composition indicating the driving force 
for the L. monocytogenes PI-PLC to bind to the lipid surface has a large electrostatic 
component. The presence of PC in an interface together with 0.16 M KCl reduced 
enzyme penetration of the monolayer. The synergistic effect of PC and KCl in reducing 
the interaction of L. monocytogenes PI-PLC with the monolayer correlates with higher 
enzymatic activity observed with PI/PC SUVs upon the addition of KCl (Table 4-3). 
IV. Carbamylation of PI-PLC 
The high pI for L. monocytogenes PI-PLC coupled with the monolayer results 
suggested that strong interactions with anionic phospholipids can be detrimental to 
enzyme action. Citraconic anhydride was used to modify a portion of the Lys residues on 
the protein surface (Figure 2-6) to see if surface charge had a dominant effect on the 
kinetic behavior. This reagent converts surface Lys residues to amides with a terminal 
carboxylate. For each Lys modified the charge is decreased by 2. The pI of two separate 
batches of modified enzyme were checked by 2D gel (Figure 4-15). Two distinct spots 
were detected with the pI between pH 7 and 9. Given the 28 Lys in the protein this shift is 
consistent with ~5-7 Lys modified (estimated by changing the Lys to a Glu and 
computing the pI). A kinetic analysis of PI cleavage in the TX-100 mixed micelle system 
(Table 4-5) showed that modified enzyme still could be activated by salt and amphiphiles.  
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Figure 4-15 2D gel of (A) unmodified L. monocytogenes PI-PLC migrated as a single 
peak at pH 9-10 region (note the high pI ∼10), and (B) citraconic anhydride modified L. 
monocytogenes PI-PLC migrated as two distinct peaks between pH 7-9.  
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Table 4-5 Effect of citraconic anhydride modification on the kinetic activity. 
 
 
 Relative activity b 
 Unmodified Modified-1c Modified-2c 
Control a 1 1 1 
8-fold increase in [E] 0.2 0.5 0.3 
3-fold increase in TX-100 3.8 0.8 4.9 
+150 mM KCl 3.4 6.0 3.7 
 
a Control condition is 0.2 µg/ml enzyme, 8 mM PI in 32 mM TX-100. 
b The control activity is 303 µmol·min-1·mg-1 for unmodified enzyme, 165 µmol·min-
1·mg-1 for modified-1, 109 µmol·min-1·mg-1 for modified-2.  
c Same amount of citraconic anhydride were used for Modified-1 and Modified-2, ~5-7 
lysine residues were modified according to 2D gels. 
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However, the effect of protein concentration was diminished compared to the control 
enzyme suggesting that the high cationic character of the protein is a major factor in the 
unusual dependence of specific activity on enzyme concentration. The smaller effect on 
salt and amphiphile activation indicates that either (i) Arg and/or remaining unmodified 
Lys residues account for this kinetic activation, or (ii) a hydrophobic interaction with the 
L. monocytogenes PI-PLC is also a major component of the activation by salts and 
amphiphiles. 
V. Discussion 
A. Model for the activation of L. monocytogenes PI-PLC 
Activation of the B. thuringiensis PI-PLC by phosphatidylcholine interfaces has 
been studied in detail (Zhou et al., 1997a, Zhou et al., 1997b; Zhou and Roberts, 1998; 
Feng et al., 2002; Wehbi et al., 2003a; Wehbi et al., 2003b). In the case of B. 
thuringiensis PI-PLC, the binding to PC interfaces, which appears to have a strong 
hydrophobic component (Wehbi et al., 2003b), alters the enzyme conformation so that it 
is a better catalyst in both phosphotransferase and cyclic phosphodiesterase reactions. 
The activation is relatively specific for zwitterionic phospholipids (Zhou et al., 1997a). 
The L. monocytogenes PI-PLC has a similar structure to the B. cereus enzyme (Moser et 
al., 1997), which might suggest very similar catalytic and possibly regulatory behavior. 
While the catalytic mechanism may be essentially the same (Bannam and Goldfine, 
1999), the regulation of activity by amphiphiles and ionic strength is quite different for 
this more cationic protein.  
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Activators for L. monocytogenes PI-PLC exist in two classes: (i) neutral 
amphiphiles (PC and TX-100) and (ii) moderate salt concentrations. The first of these 
directly bind to the enzyme (e.g., diC7PC binding to L. monocytogenes PI-PLC as 
monitored by 31P linewidth changes) and alter the enzyme conformation so that it clearly 
becomes a more efficient catalyst for diC4PI cleavage and cIP hydrolysis. As with B. 
thuringiensis PI-PLC, a micellar activator is more effective than a monomeric activator 
(Lewis et al., 1993). However, unlike B. thuringiensis PI-PLC, the mechanism for 
activation of L. monocytogenes PI-PLC could have a contribution from shifting the 
monomer/aggregate equilibrium (which itself appear to depend on the presence of 
substrates) towards monomeric protein. A major difference between L. monocytogenes 
PI-PLC and B. thuringiensis PI-PLC is that the binding affinity of the former is high to 
anionic lipids, but very low to zwitterionic lipids. Furthermore, the L. monocytogenes PI-
PLC tends to form large aggregates with anionic lipids. As revealed from its crystal 
structure (Moser et al., 1997), there are many basic residues clustered on the sides and 
bottom side of the TIM-barrel which are far away from the rather hydrophobic opening to 
the positively charged active site. With PI dispersed in a variety of aggregates (mixed 
micelles or vesicles), the electrostatic interaction between the positive residues of enzyme 
and anionic substrate drives the enzyme to the interface where it can bind tightly in an 
unproductive orientation (A in Figure 4-16). Even if the protein is in the ‘right’ 
orientation, the basic residues on the opposite face of the protein will cause the clustering 
of nearby negatively charge lipid surfaces, forming a precipitate - in essence sequestering  
 
 Figure 4-16 Proposed model for diverse interactions of L. monocytogenes PI-PLC with mixed phospholipid interfaces (red is 
an anionic phospholipid such as PI substrate, yellow is a neutral lipid). 
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enzyme from interacting with other substrate particles and dramatically decreasing 
specific activity (B in Figure 4-16). An increased surface concentration of zwitterionic / 
neutral amphiphiles along with the salt disperses the anionic substrate, and shields 
charges on the protein and lipid surface. It also appears to reduce the hydrophobic 
interaction between enzyme and anionic surface. This enhances productive encounters of 
the protein with substrate molecules and hence the increases in activity (C in Figure 4-16). 
However, in the experiments presented, the contribution of an activator-induced 
conformational change separate from enzyme aggregates dissociation is difficult to 
quantify.  
While PI/detergent micelle and cIP kinetics could be consistent with an 
explanation where diC7PC and Triton X-100 primarily activate L. monocytogenes PI-PLC 
by promoting enzyme to a more active state (both conformational change and preventing 
formation of the aggregate complex), the kinetics with diC4PI as a monomeric substrate 
for the phosphotransferase reaction are not consistent with this explanation at first glance. 
DiC4PI cleavage is not dramatically enhanced by L. monocytogenes PI-PLC binding to 
the same concentration of diC6PC or TX-100 micelles as used in cIP assays. A large 
increase in the enzyme specific activity is only observed with both an amphiphile and 
moderate (0.075 M) KCl. The difference between diC4PI and cIP is that the first has acyl 
chains, short but with some hydrophobic character. There are multiple cationic sites on 
the enzyme that could bind this anionic phospholipid leading to inhibited enzyme. cIP, 
with no acyl chains, may have a much weaker affinity for these secondary sites. 
Amphiphile alone may not compete well at these secondary sites, so that activation by 
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amphiphile at low ionic strength is small. Increased salt alone (0.1-0.2 M) may not 
displace these molecules from the protein if there is a moderate hydrophobic interaction. 
However, the presence of an activating amphiphile and added salt might be more 
effective at weakening the interactions of diC4PI with secondary sites and allowing the 
enzyme with bound substrate to bind to the activating amphiphile surface. This would 
lead to high specific activity toward diC4PI only observed in the presence of both 
amphiphile and salt. In contrast, the enzyme would be adequately activated by 
amphiphile toward cIP because this molecule does not interact with other sites on the 
enzyme. As for long-chain PI cleavage, this is consistent with PI molecules acting to 
promote/stabilize L. monocytogenes PI-PLC aggregation. 
The kinetic and biophysical studies presented here show that increased ionic 
strength alters the way L. monocytogenes PI-PLC binds to interfaces. Increased KCl (or 
other salts) could (i) enhance PLC binding to surfaces if the driving force is hydrophobic 
(and possibly promote scooting mode kinetics), (ii) weaken electrostatic interactions of 
the enzyme with the surface (which might enhance productive binding of substrate to the 
enzyme or might enhance product release), (iii) alter substrate partitioning, conformation, 
or dynamics in the bilayer (for example, PI lateral diffusion could be reduced when the 
enzyme is present but this could be overcome with high salt). The monolayer studies 
strongly rule out the first possibility and support the idea that KCl weakens the 
interaction of the protein with surfaces. Increased ionic strength reduces the maximum 
penetration (Δπ) of the enzyme and πC to a greater extent when PC is present in the 
interface. These results are critical in explaining the synergistic effects of POPC and KCl 
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on PI-PLC cleavage of PI in vesicles. KCl at moderate concentration (100-150 mM) had 
little effect on L. monocytogenes PI-PLC cleavage of PI in pure PI vesicles but was a 
strong activator for cleavage of the substrate in mixed PI/PC vesicles. PI-PLC binding to 
the POPC/DOPMe (7:3) monolayer exhibited a πC similar to a pure DOPMe monolayer. 
However, the addition of KCl lowered this value dramatically as well as reduced Δπ to 
the value seen with a pure POPC monolayer. Clearly, a high πC and Δπ correlate with 
lower activity of L. monocytogenes PI-PLC. The significant activation in activity toward 
PI SUVs by high salt concentration is consistent with the reduced binding of enzyme to 
the surface at 0.5 M KCl. The inhibition of salts on the hydrolysis of cIP is likely due to 
weakened electrostatic interactions between the enzyme and monomeric cIP in the 
presence of salts. 
B. Biological relevance of amphiphile regulation of L. monocytogenes PI-PLC 
activity? 
Several bacteria, both pathogenic and non-pathogenic, secrete PI-PLC enzymes 
into the media. The biological role of this enzyme, along with other nonspecific 
phospholipases, is to aid in survival of the organism, particularly as it infects mammalian 
cells. Those PI-PLC that cleave GPI-anchored proteins, such as the PI-PLC secreted by B. 
thuringiensis, B. cereus, and Staphylococcus aureus, are well poised to target those 
membrane components in the extracellular leaflet of the plasma membrane, which is rich 
in the zwitterionic lipids PC and sphingomyelin. However, secreted PI-PLC enzymes 
whose targets are PI and not GPI-anchors, must have a different role in bacterial survival 
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since PI is not found in the external leaflet of most organisms. L. monocytogenes is 
capable of hydrolyzing PI from outside mammalian cells. It appears to gain access to 
intracellular PI by means of pores produced by listeriolysin O (Goldfine et al., 1995; 
Sibelius et al., 1996a; Sibelius et al., 1996b; Sibelius et al., 1999; Wadsworth and 
Goldfine, 1999; Goldfine et al., 2000; Wadsworth and Goldfine, 2002). In macrophages, 
L. monocytogenes is internalized and both listeriolysin O and L. monocytogenes PI-PLC 
expression are upregulated in the phagosome (Vazquez-Boland et al., 2001). From the 
phagosome, L. monocytogenes PI-PLC presumably gains access to host PI by means of 
phagosomal permeabilization and eventual destruction. Activation of host PKCβ by 
means of DAG generated from intracellular PI and elevated intracellular calcium appears 
to play a significant role in escape from the phagosome (Wadsworth and Goldfine, 1999; 
Wadsworth and Goldfine, 2002). The inner leaflet of the vacuole membrane is 
presumably like the external leaflet of the plasma membrane – rich in PC or 
sphingomyelin with a low content of anionic phospholipids. If the L. monocytogenes PI-
PLC has weak affinity for PC (and presumably for sphingomyelin and PE as well) under 
the moderate ionic strengths in cells, it will stay in the vacuolar fluid and be easily 
dispersed into the cytoplasm. Once there it will partition with the negatively charged 
components of the target membrane. It should be noted that intracellular concentrations 
of a typical mammalian cell are 5 to 15 mM NaCl, 140 mM KCl, 0.5 mM Mg2+, and 0.1 
mM Ca2+ (Alberts et al., 2002), an ionic strength similar to what optimally activates L. 
monocytogenes PI-PLC. As long as there are some zwitterionic / neutral lipids around, it 
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is likely the enzyme can bind and partially insert into the bilayer in a way that allows it to 
effectively hydrolyze PI and generate DAG. 
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Chapter 5: 
 
L. monocytogenes PI-PLC surface mutants 
 – testing the model 
 168
I. Introduction 
For PI-PLCs, both phosphotransferase and phosphodiesterase activities are 
affected by the presence of non-substrate surfaces, exploring the interfacial binding 
should be important to understanding the regulation of their activities. In the previous 
chapter, binding of L. monocytogenes PI-PLC to interfaces was investigated. The binding 
behavior of L. monocytogenes PI-PLC to interfaces, as that of the homologous B. 
thuringiensis enzyme, is consistent with a two-stage binding model (Wallace and Janes, 
1999; Stahelin and Cho, 2001; Wehbi et al., 2003b), where PI-PLC would first be driven 
to the lipid surface by electrostatic forces followed by formation of tight membrane-
protein complexes that are stabilized by hydrophobic and/or electrostatic interactions and 
hydrogen bondings. However, there is a clear distinction in the binding patterns to 
interfaces of the two bacterial PI-PLC enzymes. L. monocytogenes PI-PLC binds more 
tightly to inhibitory anionic surfaces but more loosely to activating zwitterionic surfaces 
while B. thuringiensis PI-PLC exhibits the reverse behavior. Monolayer studies also 
showed that L. monocytogenes PI-PLC penetrated deeper into both anionic and 
zwitterionic surfaces than B. thuringiensis enzyme. Moreover, L. monocytogenes PI-PLC, 
in contrast to B. thuringiensis enzyme, exhibited more insertion into anionic versus 
zwitterionic surfaces. These differences in the interfacial binding, induced by both 
electrostatic and hydrophobic interactions, may contribute to the unusual kinetics of L. 
monocytogenes PI-PLC. 
Chemical modification of lysine residues in L. monocytogenes PI-PLC with 
citraconic anhydride did affect enzyme activity, but the dependence of activity on the 
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enzyme concentration, amphiphiles and salts was still persisted. As there are 37 total 
basic residues (Arg + Lys), it would be time consuming to screen out the effect of 
electrostatic interactions. The crystal structure of PI-PLC from L. monocytogenes shows a 
close topological similarity to PI-PLC from B. thuringiensis, despite a low level of 
sequence homology (∼24% sequence identity) (Moser et al., 1997). The similarity in 
tertiary structures between L. monocytogenes and B. cereus PI-PLCs enable us to target 
specific regions for the hydrophobic contribution to the interfacial binding based on what 
we know about the Bacillus sp. enzymes (98% sequence identity among Bacillus sp. PI-
PLCs).  
Both L. monocytogenes and Bacillus sp. PI-PLCs are composed of a single 
distorted (βα)8-barrel domain with the active site located at the C-terminal side of the β–
barrel (Heinz et al., 1996; Moser et al., 1997). For Bacillus sp. PI-PLCs, several 
hydrophobic amino acid residues from short α-helix B and some loops, arranged in a 
semicircle around the active site cleft, form a relatively mobile hydrophobic ridge fully 
exposed to solvent. Among the exposed residues, two tryptophans, Trp-47 in α-helix B 
(PIKQVWG) and Trp-242 in one particular loop (SGGTAWN), were reported important 
for the enzyme to bind to both activating zwitterionic and substrate anionic interfaces 
(Feng et al., 2002). The structure of L. monocytogenes PI-PLC also consists of α-helix B 
and an analogous loop. Although the sequence similarity is low for these two regions, the 
structure-based sequence alignment of L. monocytogenes versus B. cereus PI-PLC did 
provide us two candidates, Trp-49 in α-helix B (ITWTLTKP) and Phe-237 in the loop 
(SATSLTF), to start with. Other residues in each structural feature were also mutated to 
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assess their contributions to surface binding and PI-PLC kinetics (Figure 5-1). The results 
suggest both α-helix B and the loop are kinetically important. Removal of just a single 
hydrophobic residue in these regions (Leu-51, Leu-235, and Phe-237) altered the unusual 
kinetic profile of L. monocytogenes PI-PLC in that none of the mutant enzymes showed 
the dramatically increased specific activity with decreasing enzyme concentration or 
increasing TX-100 above Xdet=0.8 as did the wild type recombinant PI-PLC.  
II. Trp-49 and Phe-237 mutants 
A. Intrinsic fluorescence of wild type and mutant L. monocytogenes PI-PLCs 
Protein fluorescence is a mixture of the fluorescence from two aromatic amino 
acids - tryptophan and tyrosine. With relatively (compared to tyrosine) high quantum 
yield, short lifetime, low content in most proteins, and sensitivity to environmental 
factors, tryptophan is the most extensively used amino acid for intrinsic fluorescence 
analysis of protein. When both fluorescent amino acids are present in a protein, pure 
emission from tryptophan can be obtained by excitation at wavelengths above 295 nm 
(Eftink, 1991).  
Compared to seven tryptophan residues in B. thuringiensis enzyme, L. 
monocytogenes PI-PLC has only three tryptophan residues, Trp-6 (too flexible to be 
traced in the electron density map), Trp-19 in α-helix A (comparable to Trp-13 of B. 
thuringiensis PI-PLC), and Trp-49 at α-helix B (comparable to Trp-47 of B. thuringiensis 
PI-PLC) (Figure 5-2). The excitation wavelength chosen was 290 nm in an attempt to  
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Figure 5-1 Model of L. monocytogenes PI-PLC showing the location of the mutants with 
bound myo-inositol (labeled as INS). 
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Figure 5-2 The location of Trp-19 and Trp-49 in L. monocytogenes PI-PLC. The side 
chains of both residues are in red. The bound myo-inositol is labeled as INS. Trp-6 at N 
terminal is too flexible to be traced in the electron density map.  
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primarily excite tryptophan residues with a smaller effect on the many tyrosine residues 
of the protein. The L. monocytogenes PI-PLC fluorescence emission appeared as a broad 
spectrum with a shoulder at 337 nm in addition to the 323 nm main peak (Figure 5-3). 
The intensity of shoulder peak was about 93% that of the 323 nm peak. There are two 
discrete transition bands for the indole ring that contribute to the tryptophan fluorescence 
and can give rise to this type of spectral profile if the major fluorophore(s) is in a 
hydrophobic environment (Callis, 1997). For B. thuringiensis enzymes (both WT and Trp 
mutants), only one single peak with a fluorescence maximum ~340 nm peak was 
observed (Volwerk et al., 1994; Feng et al., 2002). Trp-242 of B. thuringiensis PI-PLC 
was reported as the major fluorophore responding to micelle binding (Feng et al., 2002). 
Thus, the unusual intrinsic fluorescence spectrum for the L. monocytogenes PI-PLC is 
likely to reflect a different environment from that in the B. thuringiensis homologue. 
Of the three Trp residues in the L. monocytogenes PI-PLC, only Trp-19 and 
Trp-49 might be in hydrophobic environments. Trp-19 is buried in the protein while Trp-
49 is closer to the surface. We changed Trp-49 to an alanine to see whether this residue 
had a significant contribution to the protein intrinsic fluorescence in solution. Substitution 
of Trp-49 with alanine did not change the 323 nm fluorescence emission maximum 
wavelength of WT, but significantly decreased the overall intensity, about 43-48% at 
both 323 nm and 337 nm (Figure 5-3). There might be some tyrosine residues excited at 
290 nm, however the reduction in emission suggests that Trp-49 must be contributing to 
the overall the emission spectrum. W49A fluorescence allows us to separate any effects 
on this fluorophore from WT which has both Trp-19 as well as Trp-49. 
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The differences in the intrinsic fluorescence spectrum of the two bacterial PI-
PLC enzymes motivated us to introduce a Trp in the surface loop to see if it would be 
sensitive to the protein binding to different surfaces as is the B. thuringiensis enzyme. We 
thus replaced the Phe-237, which aligns well with B. thuringiensis Trp-242. For F237W 
in solution, the intrinsic fluorescence profile (λex=290 nm) changed significantly in both 
shape and intensity so that the maximum was now shifted to ~340 nm, indicative of a 
moderately polar environment (Figure 5-3). The fluorescence emission maximum of 
F237W was now closer to that of B. thuringiensis PI-PLC, although a shoulder at 237 
still remained. The intensity increased 6% and 28% at 323 nm and 337 nm, respectively. 
Those changes in the fluorescence of F237W suggested that Trp-237 is a major 
contributor to the fluorescence spectrum at 340 nm.  
Several other mutants were made to use for fluorescence experiments: F237A 
(to see if removing a hydrophobic group at this position affected surface binding), and 
W49A/F237A (which we originally thought would emulate W47A/W242A of B. 
thuringiensis PI-PLC and bind very poorly to surfaces). The emission spectra of F237A 
and W49A/F237A were comparable to WT and W49A, respectively (Figure 5-3). What 
the intrinsic fluorescence spectra of these mutants suggest is that F237W may be a good 
probe of interfacial binding by the L. monocytogenes PI-PLC while comparing WT and 
W49A may provide information on differentiating effects on Trp-19 versus Trp-49.  
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Figure 5-3 Intrinsic fluorescence profiles of L. monocytogenes PI-PLC Trp-49 and Phe-
237 mutants: WT (+), F237W (•), F237A (ο), W49A (Δ), and W49A/F237A (▲). 
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Table 5-1 Comparison of secondary structure content of WT, W49 mutants, and F237 
mutants calculated from 200-260 nm CD spectra. In wavelength scan experiments, 0.2-
0.3 mg/ml protein in 10 mM borate buffer (pH 7.0) was used to collect CD spectrum. 
Thermal stability of protein (0.02 mg/ml) was assessed using CD by following ellipticity 
changes at 222 nm. 
 
 
Enzyme % Secondary structure 
 α-helix β-sheet β-turn Random 
coil 
Tm (°C) 
WT 30.3 18.9 17.6 33.2 44.2 
F237W 30.2 19.0 17.6 33.1 43.8 
F237A 29.0 19.8 18.0 33.2 44.0 
W49A 29.2 19.7 17.9 33.2 43.4 
W49A/F237A 29.6 19.4 17.8 33.2 42.0 
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B. Secondary structure and thermal stability of wild type and mutant L. 
monocytogenes PI-PLCs 
CD spectra of WT and mutant PI-PLC proteins were acquired to check for 
overall structural elements. As shown in Table 5-1, estimates of WT secondary structure 
calculated from the CD wavelength spectra by CDNN (Böhm et al., 1992; Andrade et al., 
1993; Waterhous and Johnson, 1994) agreed moderately well with the secondary 
structure elements in the crystal structure (Moser et al., 1997). All the mutants had 
essentially the same proportion of secondary structure elements as WT (29.7±0.6 % α-
helix, 19.4±0.4 % β-sheet, 17.8±0.2 % β-turn, and 33.2±0.1 % random coil). They also 
had very similar thermal denaturation temperatures (43.8±0.3oC for WT and the single 
mutant proteins with a slightly lower value, 42oC, for W49A/F237A) measured by 
monitoring the loss of secondary structure with temperature.  
C. Effect of PC, PMe, and myo-inositol on the intrinsic fluorescence of wild type and 
mutant L. monocytogenes PI-PLCs 
As with recombinant PI-PLC (WT), interfacial binding of these L. monocytogenes PI-
PLC mutants, either too tight to the anionic surfaces or too weak to the activators, could 
not be quantified with the filtration / centrifugation / SDS-PAGE assay. Previous studies 
have shown that intrinsic fluorescence spectrum of Bacillus sp. PI-PLC is sensitive to the 
interfacial binding, with intensity increasing upon the binding of PC activator micelles or 
vesicles (Hendrickson et al., 1992; Volwerk et al., 1994; Zhou et al., 1997b) and 
decreasing upon the binding of molecules to the active site (PA, PMe, PG) (Volwerk et 
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al., 1994; Zhou and Roberts, 1998). Replacing the tryptophan that is responsible for 
spectral change upon interfacial binding with alanine removed this fluorescence 
sensitivity (Feng et al., 2002). We thus examined the intrinsic fluorescence of F237W, 
F237A, W49A, W49A/F237A as a function of added PC, PMe, myo-inositol and 
compared with that of WT PI-PLC. The emission maximum, 337 nm for F237W and 323 
nm for others, was unshifted by those additives (up to 5 mM diC7PC, or 35 mM diC6PC, 
or 1 mM SUVs, or 100 mM myo-inositol). However, intensity changes were observed. 
The relative intensity changes for each mutant were similar to WT suggesting that 
interfacial binding was more or less the same for these mutants. 
For B. thuringiensis PI-PLC, short-chain PCs (diC7PC and diC6PC) had similar 
effects on the fluorescence intensities of WT and W47A, a small increase in emission (5-
10%) with monomeric PC and much larger increase (30-35%) with micellar PC. This 
sensitivity to micelle PC binding was reduced significantly for W242A, indicating that 
the 242 position was much more sensitive to surface binding (Feng et al., 2002). For L. 
monocytogenes PI-PLCs, the response to PC monomer and micelle binding depended on 
the mutant. As shown in Figure 5-4A, the fluorescence intensity of F237W increased 
slightly (∼5%) with monomer diC7PC, and showed an additional ∼4% increase upon 
binding diC7PC micelles. For WT and F237A, any initial increase in the intensities with 
monomer diC7PC was abolished. Instead, F237A showed a 5% decrease in the intensity. 
If Trp-19 is the major contributor to the emission maximum at 323 nm in WT, then its 
lack of response to monomeric diC7PC suggests that monomer binding does not perturb 
the environment of that residue or Trp49. The decrease in fluorescence for F237A is 
 179
interesting and could suggest that monomeric PC binds differently to this mutant 
compared to WT – perhaps it binds at or near the active site. Both of these PI-PLC 
mutant proteins still showed an increase in fluorescence intensities once diC7PC micelles 
were added. It is interesting that ∼8% drop in fluorescence intensity was observed for 
W49A/F237A at the presence of diC7PC micelles (Figure 5-4B). Comparing the changes 
in fluorescence intensity of F237W to that of F237A and WT, clearly indicates that Trp-
237 is the major fluorophore and, in particular, that it must be proximal to ‘monomeric’ 
diC7PC binding (i.e., when monomer PC is added, although small aggregates of the PC 
could form with this region of the protein). Trp-49, on the contrary, showed no sensitivity 
to monomeric diC7PC binding. All mutants showed an increase in fluorescence with 
micellar diC7PC added (i.e., comparing 1 mM to 3 mM) or roughly the same magnitude 
(4-5%).  
DiC6PC had a more pronounced effect on the fluorescence intensities of L. 
monocytogenes PI-PLCs than diC7PC (Figure 5-5). As with diC7PC, monomeric PC had 
little effect at concentrations well below the CMC (which may be reduced by the 
presence of the protein) on F237A or W49A/F237A fluorescence. There is a more 
gradual increase in fluorescence as the CMC is approached, particularly for F237A and 
W49A. If ‘monomer’ diC6PC does bind to the proteins its binding is associated with 
nearing the CMC. This might indeed suggest that small PC aggregates are needed for  
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Figure 5-4 Fluorescence intensities of L. monocytogenes PI-PLCs as a function of added 
diC7PC: (A) wild type recombinant PI-PLC (+), F237A (ο), and F237W (•) mutant 
proteins; (B) W49A (Δ) and W49A/F237A (▲) compared to wild type PI-PLC (+). 
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Figure 5-5 Fluorescence intensities of L. monocytogenes PI-PLCs as a function of added 
diC6PC: (A) wild type recombinant PI-PLC (+), F237A (ο), and F237W (•) mutant 
proteins; (B) W49A (Δ) and W49A/F237A (▲) compared to wild type PI-PLC (+). 
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appreciable binding to the L. monocytogenes PI-PLC. It is hard to quantify the extent of 
increase with diC6PC micelle binding, but the overall intensity increase appears larger 
than for diC7PC binding. 
Considering the salt activation of the phosphotransferase step with detergent 
present, the effects of diC7PC on the fluorescence intensity of WT and F237W were also 
checked with KCl present. As shown in Figure 5-6, 0.16 M KCl did perturb their 
responses to diC7PC in the similar way in that the fluorescence intensities of both 
enzymes were less sensitive to diC7PC, particularly as the CMC was approached. For 
F237W, the fluorescence intensity increase below 1 mM diC7PC in the absence of KCl 
could be fit with a hyperbolic binding equation; the second increase in fluorescence as 
micelles form followed a second hyperbolic profile. This treatment generated a 
Kd=0.04±0.01 mM for monomeric diC7PC and an apparent Kd=1.19±0.04 mM for 
micellar diC7PC which is right around the CMC of the lipid. With KCl present, there is a 
reproducible decrease as the CMC is approached. Since this behavior is also seen with 
WT in the presence of KCl, it suggests that the salt (generic ionic interactions since salt 
identity is not important) must alter the protein conformation such that a different 
fluorophore from Trp237, possibly Trp19 is affected. Micellar PC binding still results in 
an increase in fluorescence. What the salt results do is emphasize that there must be a 
discrete conformational change in the protein when moderate salt is present. This change 
may be weakening the interaction of the protein with monomeric PC such that micelle 
formation competes favorably with the protein for PC monomers. It is this change that is 
linked to enhanced activity when amphiphiles are present as well. 
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Figure 5-6 Changes in the intrinsic fluorescence of L. monocytogenes PI-PLC wild type 
(■,□) and F237W (♦,◊) binding to diC7PC in the absence (filled symbols) or presence 
(open symbols) of 0.16 M KCl. 
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Myo-inositol, a poor competitive inhibitor of PI-PLC (Shashidhar et al., 1990), 
was reported to cause a decrease in fluorescence intensity of B. thuringiensis PI-PLC 
when binding to the PI-PLC active site (Feng et al., 2002). As shown in Figure 5-7, myo-
inositol caused 4-6% decrease in the fluorescence intensity of L. monocytogenes PI-PLC 
WT and F237W, a much smaller decrease (~ 2%) for F237A, basically no change for 
W49A, or W49A/F237A (the 2-3% increase is likely caused by a weakly fluorescing 
impurity in the protein solution). Because myo-inositol has no tendency to form interfaces, 
the decrease in protein intrinsic fluorescence is correlated with binding of this molecule 
to the active site. For those mutants that do not exhibit the decrease shown in WT it 
would suggest that inositol affinity has been altered, unless the fluorophore sensing this 
change has been removed. The interesting mutant here is W49A since it is basically 
insensitive to myo-inositol. Either this residue is a key reporter of substrate binding, or 
this mutant is impaired in binding substrate-like molecules.  
DOPMe SUVs inhibit PI-PLC in both cleavage of PI and hydrolysis of cIP. 
Binding of DOPMe at low concentration (<20 µM in our conditions) induced ∼25% 
increase in WT, F237W and F237A fluorescence; when higher concentrations of DOPMe 
SUVs were present, the intrinsic fluorescence decreased (Figure 5-8). The initial steep 
increase in fluorescence intensity of WT and Phe-237 mutants is consistent with the 
observed tight binding of proteins to anionic interfaces. The smaller fluorescence increase 
for W49A may correspond to an impaired ability to bind anionic substrate or reduced 
sensitivity, consistent with the fluorescence results with myo-inositol. For comparison,  
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Figure 5-7 Intrinsic fluorescence intensities of L. monocytogenes PI-PLC proteins as a 
function of added myo-inositol: WT (+), F237A (ο), F237W (•), W49A (Δ) and 
W49A/F237A (▲). 
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Figure 5-8 Fluorescence intensities of L. monocytogenes PI-PLCs as a function of added 
SUVs: wild type recombinant PI-PLC (+), F237A (ο), F237W (•), W49A (Δ) and 
W49A/F237A (▲) with the addition of DOPMe; F237W (X) with the addition of POPC 
SUVs. 
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POPC SUVs, binding loosely to L. monocytogenes PI-PLCs, lead to a smaller increase 
(~8%) in intensity of F237W and no subsequent decrease. Since the response of the 
protein to POPC was stable, the decrease in intensity from a maximum with anionic 
phospholipid vesicles is likely to result from aggregation of a large PMe/PI-PLC complex 
that is no longer soluble. The different mutants might have different time scales for 
aggregation and precipitation. With this small amount protein we would not easily be 
able to detect aggregation, so this aspect of the interaction can not be easily examined.  
D. Catalytic properties of Trp-49 and Phe-237 mutants 
The potential roles of Trp-49 and Phe-237 in the kinetic behavior of L. 
monocytogenes PI-PLC were examined. As summarized in Table 5-2, no significant 
cyclic phosphodiesterase activity was observed for Trp-49 mutants. Even in the presence 
of 5 mM TX-100, incubating 7.2 µg/ml W49A or W49A/F237A with 10 mM cIP for 24 h 
did not generate any I-1-P detectable in the 31P NMR spectrum. Removal of Trp-49 also 
dramatically decreased the phosphotransferase activity. At a concentration of 0.82 µg/ml, 
the specific activity of W49A toward PI was only 2% that of WT. With this low activity, 
high protein concentrations were used to check the effect of enzyme concentration, 
amphiphile, and salt on the PI cleavage. No WT data was available for comparison at this 
high enzyme concentration. The phosphotransferase activities of both Trp-49 mutants 
were slightly affected by enzyme concentrations, but specific activities decreased as the 
protein concentrations decreased, in contrast to WT enzyme. At a concentration of 7.2 
µg/ml, increasing the amount of TX-100 had no effect on either mutant enzyme, whereas  
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Table 5-2 Kinetic behavior of W49A and W49A/F237A mutants. 
 
 
Effect of enzyme concentration on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt W49A W49A/F237A 
0.21 N/A N/A 
0.82 1.68  
3.60 2.07 1.85 
7.20 4.09 1.95 
14.90 5.30 3.35 
29.80 
0.80 - 
 3.31 
Effect of detergent mole fraction on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt W49A W49A/F237A 
0.80 4.09 1.95 
7.2 
0.92 
- 
4.54 1.84 
Effect of salt on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 
KCl 
(150 mM) W49A W49A/F237A 
- 4.09 1.95 
7.2 0.80 
+ 7.26 1.88 
phosphodiesterase activity 
PI-PLC (µg/ml) W49A W49A/F237A 
7.2 N/A N/A 
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this has a large effect on WT. Adding KCl to the PI/TX-100 assay system slightly 
increased W49A specific activity, but not that of W49A/F237A. At 0.21 µg/ml 
W49A/F237A, generation of cIP was not detected with 31P NMR under the control assay 
condition (8 mM PI, 32 mM TX-100, 20 h), but a small amount of cIP was generated if 
KCl or TX-100 were increased (200 mM KCl or 64 mM TX-100). In any case, the 
specific activity of these two mutants was very low. 
Unlike the Trp-49 mutant proteins, Phe-237 mutant proteins were active and 
comparisons with WT show interesting trends (Table 5-3). Substitution of Phe-237 with 
alanine reduced the PI-PLC specific activity toward cIP to 19% of WT. Although it is a 
less efficient enzyme, F237A can still be activated by amphiphiles. The ratio of specific 
activity of F237A for cIP hydrolysis with and without 3 mM TX-100, 13:1, is essentially 
comparable to that of WT PI-PLC (14.8:1). F237W showed similar phosphodiesterase 
activity as WT, but with a higher increase in activity (25-fold) than WT (15-fold) upon 
the addition of 3 mM TX-100.  
Under the control phosphotransferase assay condition (0.21 µg/ml enzyme, 8 
mM PI, 32 mM TX-100), the activities of F237A and F237W toward PI cleavage were 
97% and 400% of WT, respectively. Compared to WT, both Phe-237 mutants lost the 
steep increase in phosphotransferase activity as enzyme concentration decreased from 
0.82 to 0.02 µg/ml. Instead, F237W specific activity decreased ~30% when comparing 
assays with 0.02 versus 0.2 µg/ml enzyme added. F237A exhibited a 1.7-fold increase in 
specific activity with that 10-fold dilution, still very different from the 3.9-fold increase  
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Table 5-3 Comparison of specific activity behavior of L. monocytogenes PI-PLC WT 
versus Phe-237 mutants. 
 
 
Effect of enzyme concentration on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt WT F237W F237A 
0.02 1068.79 713.30 446.02 
0.21 274.27 1097.00 264.90 
0.41 147.72  193.99 
0.82 
0.80 - 
90.21 1099.20 170.96 
Effect of detergent mole fraction on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt WT F237W F237A 
0.67  37.70 2.17 
0.75  563.30 42.40 
0.80 274.27 1097.00 264.90 
0.89 368.30 1113.00 257.50 
0.92 1155.30 1201.85 267.74 
0.21 
0.94 
- 
  180.08 
Effect of salt on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 
KCl 
(150 mM) WT F237W F237A 
- 274.27 1097.00 264.90 
0.21 0.80 
+ 1033.54 2788.70 983.46 
Effect of TX-100 on phosphodiesterase activity 
PI-PLC 
(µg/ml) TX-100 (3 mM) WT F237W F237A 
- 0.16 0.18 0.03 
7.2 
+ 2.37 4.52 0.39 
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exhibited by WT. The surface dilution behavior of these mutant enzymes was also 
significantly altered. At the concentration of 0.21 µg/ml, WT specific activity increased 
4.2-fold as the TX-100 increased from 32 to 96 mM (Xdet increasing from 0.80 to 0.92). 
F237A in the same range showed constant specific activity (Table 5-3), while F237W 
showed a 1.1-fold increase (likely within the errors in determining activity). Both Phe-
237 mutants still exhibited activation of PI cleavage by salt. Under the assay conditions 
used, the optimal phosphotransferase activity of F237A responding to enzyme 
concentration or amphiphiles was slightly lower than that of WT. Adding KCl 
significantly enhanced the specific activity of F237W so that it was much higher than for 
WT under the same assay conditions.  
III. Other possible interfacial mutants of PI-PLC 
Modification of either Trp-49 or Phe-237 in L. monocytogenes PI-PLC had very 
pronounced effects on the unusual kinetic behavior (increases upon dilution of the 
enzyme, increased mole fraction of detergent, or addition of moderate salt) of this 
enzyme. Since these are two positions where a hydrophobic side chain is at/near the 
surface of the protein, we decided to alter other residues in this region. Both helix B and 
the surface loop each have a leucine residue that could be involved in interfacial effects, 
and so each was mutated to alanine. The two surface structural elements also have a 
threonine residue. Each of these were also chosen for mutation, initially as a way of 
potentially introducing an extrinsic fluorophore for more detailed and site-specific 
fluorescence studies. 
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A. Catalytic properties of L51A and L235A 
Mutation of Phe-237 and Trp-49 was originally undertaken to explore the 
interfacial binding behavior of L. monocytogenes PI-PLC. Our results showed that while 
Phe-237 is likely to contribute to surface binding of this PI-PLC, Trp-49 would appear to 
be more involved with catalysis. Two hydrophobic residues near each of the first 
mutagenesis targets, Leu-51 in α-helix B and Leu-235 in the loop, were mutated to 
alanine. Unlike W49A or F237A, both L51A and L235A retained activities toward water-
soluble cIP substrate in the absence and presence of TX-100 that were comparable to WT 
enzyme (Table 5-4). Detergent enhanced cIP hydrolysis to the same extent as for WT. 
However, modulating enzyme or amphiphile concentration had a much smaller impact on 
the phosphotransferase activities of both L51A and L235A (Table 5-4). No dramatic 
changes in activity were observed for both mutants within the enzyme concentration 
range examined (0.02-3.60 µg/ml). As the mole fraction of TX-100 in TX-100/PI 
micelles increased from 0.80 to 0.92, L51A displayed no surface dilution inhibition while 
L235A showed a decrease in activity. The activities of both mutants toward PI cleavage 
could also be activated by salts, but not to the extent of WT. Clearly, removal of either 
hydrophobic residue Leu-51 or Leu-235 altered the unusual kinetic profile of this PI-PLC. 
B. Catalytic properties of T50C and T236C 
According to the Wimley and White hydrophobic scale (Wimley et al., 1996; 
Wimley and White, 1996; White, 2003), amino acids containing moderately polar side  
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Table 5-4 Comparison of specific activity behavior of L. monocytogenes PI-PLC WT 
versus L51A and L235A mutants. 
 
 
Effect of enzyme concentration on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt WT L51A L235A 
0.02 1068.79 196.23 195.49 
0.21 274.27 265.01 427.03 
0.82 90.21 244.40 258.69 
3.60 
0.80 - 
54.38 254.51 253.12 
Effect of detergent mole fraction on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 Salt WT L51A L235A 
0.67  23.33 18.32 
0.75  80.51 385.97 
0.80 274.27 265.01 427.03 
0.89 368.30   
0.21 
0.92 
- 
1155.30 238.21 179.18 
Effect of salt on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction of 
TX-100 
KCl 
(150 mM) WT L51A L235A 
- 274.27 265.01 427.03 
0.21 0.80 
+ 1033.54 412.12 586.50 
Effect of TX-100 on phosphodiesterase activity 
PI-PLC 
(µg/ml) TX-100 (3 mM) WT L51A L235A 
- 0.16 0.11 0.14 
7.2 
+ 2.37 2.12 2.45 
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chains, like threonine, serine, and cysteine, prefer the interfacial region of membrane. 
There are several polar residues (Thr+Ser) in α-helix B (ITWTLTKP) and the loop 
(SATSLTF) of L. monocytogenes PI-PLC. From the previous results, Trp-49, Leu-51, 
Leu-235, and Phe-237 are involved in regulating the unusual kinetic behavior of this 
enzyme. It is likely that Thr-50 and Thr-236, which are flanked by those residues, also 
play roles. We thus replaced Thr-50 or Thr-236 with cysteine to enable the introduction 
of a thio-reactive probe as there are no other cysteine residues in the enzyme.  
As shown in Table 5-5, cysteine substitution at Thr-50 or Thr-236 had 
unexpected and dramatic effects on the enzyme activities. Compared to WT, the 
phosphodiesterase activity was higher (2-fold and 3-fold for T50C and T236C, 
respectively) but exhibited about the same specific activity as WT when diC7PC was 
added. Most strikingly, both enzymes were much more active than WT under standard 
conditions (0.21 μg/ml enzyme, 8 mM PI, 32 mM TX-100, no added KCl). The enzyme 
specific activities no decreased with protein dilution and increased mole fraction of 
detergent at high and low protein concentrations. At the lowest PI-PLC concentration 
(0.02 µg/ml) and 0.8 mole fraction TX-100, the specific activities of both mutants were 
comparable to that of WT. Both T50C and T236C exhibited obvious surface dilution 
inhibition at high TX-100 mole fraction (0.80 versus 0.92). Salt could enhance the 
phosphotransferase activity of both mutants except when extremely high activity was 
already achieved. 
One possible rationale for the very high activity of the cysteine mutants is that  
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Table 5-5 Comparison of specific activity behavior of L. monocytogenes PI-PLC WT 
versus T50C and T236C mutants. 
 
 
Effect of enzyme concentration on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction 
of TX-100 Salt WT T50C T236C 
0.02 1068.79 910.47 748.66 
0.21 
0.80 - 
274.27 8347.96 4806.39 
Effect of detergent mole fraction on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction 
of TX-100 Salt WT T50C T236C 
0.80 1068.79 910.47 748.66 
0.02 
0.92 
- 
301.23 410.47 280.11 
0.80 274.27 8347.96 4806.39 
0.21 
0.92 
- 
1155.30 3416.12 2461.03 
Effect of salt on phosphotransferase activity 
PI-PLC 
(µg/ml) 
Mole fraction 
of TX-100 
KCl 
(150 mM) WT T50C T236C 
- 1068.79 910.47 748.66 
0.02 
+ 1718.01 3598.70 2547.90 
- 274.27 8347.96 4806.39 
0.21 
0.80 
+ 1033.54 7334.12 7302.92 
Effect of TX-100 on phosphodiesterase activity 
PI-PLC 
(µg/ml) TX-100 (3 mM) WT T50C T236C 
- 0.16 0.31 0.41 
7.2 
+ 2.37 1.90 1.93 
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covalent dimmers might for at PI –containing interfaces. However, the proteins were 
stored with DTT in the buffer and upon dilution into the assay mixture there was still 
DTT present. Also given the short incubation times for these assays, disulfide formation 
is highly unlikely. There must be another cause of the very high specific activities of 
these mutant enzymes. 
C. Use of coumarin/BODIPY FRET to probe the interfacial binding of T50C and 
T236C to POPG/POPC SUVs 
The L. monocytogenes PI-PLC T50C and T236C enzymes were used to explore 
the binding of the protein to POPG/POPC SUVs via a coumarin/BODIPY FRET pair. 
BODIPY-labeled lipid was used as the acceptor with CPM attached to the cysteine 
residue of T50C or T236C via a maleimide as the donor (Keller et al., 1995). BODIPY 
FL is relatively environment insensitive and is fluorescent in both aqueous and lipid 
environment. The Förster energy transfer radius (Ro) was reported ∼50Å for coumarin-β-
BODIPY FL C12-HPC pair. PC labeled with BODIPY connected to a shorter acyl chain 
(C5) instead of C12 was used in our experiments to keep the BODIPY label in the 
hydrophobic region of vesicles but not too far from the interface. In the absence of POPG 
in the vesicle, there was no quenching of coumarin fluorescence indicating that the 
protein did not bind to the vesicles under these conditions (10 µg/ml labeled protein and 
100 µM POPC containing 2.5% BODIPY labeled PC). The filtration/centrifugation 
binding studies with PI-PLC and POPC SUVs (Chapter 4) suggested that most of the 
protein would be free in solution under these conditions. As shown in Figure 5-9, the 
fluorescence of CPM-T50C and CPM-T236C was increasingly quenched upon the 
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addition of vesicles containing β-BODIPY FL C5-HPC as the POPG mole fraction 
increased, confirming that the presence of anionic surface induced the insertion of 
enzyme into the membrane. The fluorophore at T236C is more effectively quenched than 
that at T50C by binding to SUVs containing low amounts of PG. For T236C-CPM the 
mole fraction PI for half of the maximum quenching (57±3%) is 0.007±0.002. Quenching 
of T50C-CPM was much less efficient – at XPG = 0.5, only 20% of the CPM fluorescence 
was quenched. The BODIPY-PC in these experiments shows behavior that is not quite 
complementary. For T236C-CPM binding, the BODIPY probe intensity increases by 
16±2% and reaches half of this value at XPG = 0.08±0.03; for T50C-CPM, the BODIPY 
emission increases a comparable amount (by 13±1%) but requiring more PG (XPG = 
0.19±0.01 for half the increase). The similarly increased BODIPY fluorescence suggests 
by XPG = 0.5 all the protein is bound under these conditions. The more dramatic loss of 
fluorescence by the T236C-CPM compared to T50C-CPM implies that the smaller 
amount of quenching of the T50C-CPM could suggest that the T236-CPM site is closer to 
the BODIPY on the phospholipids. Perhaps, the coumarin attached to T236C inserts into 
the bilayer while the probe on T50C does not. 
The quenching of CPM fluorescence and the increase of β-BODIPY FL C5-
HPC fluorescence with vesicles containing 0.5 mole fraction POPG were also checked at 
various KCl concentrations. As shown in Figure 5-10, the observation that FRET 
between the coumarin/BODIPY pair decreased (meaning the CPM fluorescence 
increased) as the concentration of KCl increased. This observation is in agreement with  
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Figure 5-9 (A) Quenching of CPM fluorescence or (B) increasement of β-BODIPY FL 
C5-HPC fluorescence due to FRET between coumarin labeled protein, T50C-CPM (•) or 
T236C-CPM (ο), and BODIPY labeled lipid. 10 µg/ml labeled protein and 100 µM total 
phospholipids (containing 2.5% BODIPY labeled lipids) were used. 
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Figure 5-10 The effect of increasing KCl on the FRET between PI-PLC-CPM and β-
BODIPY FL C5-HPC initially bound to SUVs containing PC (0.05 mM) / PG (0.05 mM). 
(A) Increase in Donor (PI-PLC-CPM) fluorescence with added salt; (B) decrease in 
Acceptor (β-BODIPY FL C5-HPC) fluorescence with added KCl. The labeled enzymes 
are T50C (•) and T236C (ο). 
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the monolayer penetration result that the driving force for the L. monocytogenes PI-PLC 
to bind to the lipid surface has a large electrostatic component. The binding of T50C-
CPM to the vesicles is considerably weaker than T236C-CPM since it can be washed off 
with 200 mM KCl. Compared to the cysteine in α-helix B, the CPM on Cys-236 is less 
sensitive to the effect of KCl. Assuming the addition of the CPM does not dramatically 
alter the activity of the PI-PLC, these FRET results, consistent with the kinetic data, 
suggest that weaker interfacial binding of T50C may be the key to its higher activity as 
compared to T236C.  
IV. The effect of F237W on plaque formation 
All the PI-PLC mutants exhibit some type of altered kinetics, and vesicle 
binding and kinetics do not necessarily show simple connections. However, the activities 
of F237W are comparable to that of WT, but the response of this mutant enzyme to 
amphiphiles and ionic strength is radically different from WT (Table 5-3). Therefore, we 
decided to check if these different kinetic behaviors affect the biological activity of L. 
monocytogenes. For this we monitored, using the plaque assay, the cell-to-cell spread of 
L. monocytogenes in L2 fibroblasts. The gene for WT or F237W PI-PLC was inserted 
into the pAM401 plasmid which contains the plcA gene promoter with the L. 
monocytogenes PI-PLC original signal peptide sequence. These pAM401 plasmids 
containing either WT or F237W genes were electroporated into strain DP-L1552 (ΔplcA, 
no L. monocytogenes PI-PLC expression). The modified L. monocytogenes strains were 
then used to infect monolayer cultures of mouse fibroblast L2 cells. As shown in Figure 
5-11, infection with DP-L1559, L. monocytogenes containing no chromosomal PI-PLC 
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gene but with the plasmid containing the WT gene, results in decreased plaque size as 
reported previously (Camilli et al., 1993) when compared to 10403S (the L. 
monocytogenes WT strain where the PI-PLC gene is chromosomal) (Bishop and Hinrichs, 
1987). The bigger the plaque the more effective the L. monocytogenes was at colonizing 
the fibroblasts. Interestingly, the L. monocytogenes strain containing the plasmid with the 
F237W gene produced even smaller plaques than those by L. monocytogenes with the 
WT PI-PLC gene located on the plasmid. This result indicates that PI-PLC with the 
F237W mutation had a negative effect over WT for cell-to-cell spread.  
V. Discussion 
A. Trp-49 and Phe-237 may play dual roles in adopting ‘active’ PI-PLC 
conformation and keeping PI-PLC in the ‘right’ orientation on the membrane  
Although the secondary structures of Trp-49 and Phe-237 mutants calculated 
from their CD spectra are similar to that of WT, Trp-49 and Phe-237 clearly play roles in 
helping enzyme to adopt an ‘active’ conformation because the cyclic phosphodiesterase 
activities of both W49A and F237A toward water soluble cIP at the absence of 
amphiphiles are significantly lower than that of WT (Table 5-2 and Table 5-3). In the 
crystal structure of B. thuringiensis W47A/W242A, an interfacially impaired mutant, α-
helix B has switched to a loop structure, presumably due to loss of hydrophobic stacking 
interaction between Ile-43 and Trp-47 (Shao et al., 2007). This hydrophobic stacking 
partner is not found for L. monocytogenes PI-PLC. Instead the side chain of Trp-49 in α- 
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Figure 5-11 Cell-to-cell spread in murine L2 fibroblasts, as indicated by plaque size. 
10403S is the L. monocytogenes WT strain where the PI-PLC gene is chromosomal. DP-
L1559 (pAM401::plcA) and F237W (pAM401::F237W) were inserted into the DP-
L1552 (ΔplcA, no L. monocytogenes PI-PLC expression) background. 
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helix B points inward (Figure 5-1) where it may be involved in interacting with substrates. 
Replacement of the bulky, hydrophobic tryptophan side chain with a methyl group may 
disorder this short helix and impair both phosphotransferase and phosphodiesterase 
activities. Substitution of Phe-237 in the surface the loop with alanine still shows reduced 
activities but not to the same extent as W49A. The specific activities of F237A for cIP 
hydrolysis and PI cleavage (0.21 µg/ml enzyme, 8 mM PI, 32 mM TX-100) are 19% and 
97% that of WT. However, a hydrophobic group located at residue 237 appears important 
for the ‘active’ conformation that leads to optimal PI-PLC specific activity. F237W, but 
not F237A, has maximum phosphodiesterase activity comparable to WT enzyme. 
Mutant intrinsic fluorescence and FRET assays between β-BODIPY FL C5-
HPC and CPM labeled T50C or T236C further explore these regions of the protein. The 
larger changes in the intrinsic fluorescence intensity of F237W upon binding to PC 
micelles compared to the other mutant proteins suggests that the side chain at 237 is 
likely to insert into the phospholipid aggregate. A fluorophore at this position is also 
sensitive to ‘monomeric’ PC binding. The changes in F237W intrinsic fluorescence with 
diC7PC are reminiscent of what has been observed with the B. thuringiensis PI-PLC 
(Feng et al., 2002), except that the increase with monomeric PC is much larger for 
F237W. The differences between WT and F237A intrinsic fluorescent profiles are also 
notable. Replacement of Phe-237 with alanine does not alter the number or placement of 
fluorophores in these experiments. However, what it does is generate a protein whose 
fluorophores are now sensitive to monomer PC binding. Not only does this mutant 
exhibit changes in intensity below 1 mM diC7PC (while WT and W49A, containing the 
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same fluorophores, do not), but the decrease in fluorescence detected is consistent with 
what is seen with a molecule, myo-inositol, that binds to the active site. F237A is not as 
active as WT or F237W and the lower activity could be reflected in the altered 
fluorescence behavior of Trp-19 or Trp-49 observed with monomeric PC. 
Both W49A and W49A/F237A are poor PI-PLC enzymes containing the same 
two Trp residues. The difference in intrinsic fluorescence with micellar diC7PC (Figure 
5-3B) suggests that when both these hydrophobic side chains are removed, the remaining 
fluorophores sense a very different conformational change. In the crystal structure of L. 
monocytogenes PI-PLC, there are many solvent accessible basic residues as well as 
several tyrosine and phenylalanine residues at the bottom and side of the TIM-barrel. 
These may provide some non-productive interfacial binding sites competing with α-helix 
B and the loop for lipids. By removing both Trp-49 and Phe-237, the chances for enzyme 
binding to those regions may greatly increase. The tryptophan residues of W49A/F237A, 
Trp-6 and Trp-19, are located at the N-terminus of the enzyme. Trp-19 in α-helix A has 
limited solvent accessibility while Trp-6 is thought to be flexible. Perhaps the latter 
segment is involved in “non-productive” interfacial binding with micellar diC7PC. Trp-6 
and “non-productive” interfacial binding could also account for the monotonic increases 
in the intrinsic fluorescence changes of L. monocytogenes PI-PLCs upon binding micellar 
diC6PC above 20 mM. 
B. L. monocytogenes PI-PLC – could it dimerize on surfaces?  
PI-PLC dimerization on phospholipid interfaces, mediated by helix B residues, 
the 240’s loop and a strip of tyrosine residues on the surface of the barrel, has been 
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suggested as a major factor in enhancing the activity of that enzyme. Given the overall 
structural similarity of the L. monocytogenes to that PI-PLC, it is worth examining 
evidence for similar dimerization. In B. thuringiensis PI-PLC, α-helix B tilts at a small 
angle relative to the axis of TIM-barrel, and Trp-47, at the C-terminus of α-helix B, 
points outward into solution. For the B. thuringiensis enzyme, the interaction of Trp-47 
with the membrane is critical for dimerization. Trp-47 and helix B form a sort of plug 
that prevents the close approach of Tyr-246, Tyr-247, Tyr-248, and Tyr-251, residues that 
form the core of the homodimer. The flexibility of the 240’s loop also places Trp-242 
near Trp-47 upon binding to interfaces in the homodimer model of the activated enzyme. 
In the L. monocytogenes PI-PLC, helix B is almost perpendicular to the axis of TIM-
barrel, and Trp-49, in the middle of the α-helix, points inward (not into solution). This 
orientational change makes it difficult to see how Trp-49 might initiate tight membrane 
binding by inserting into a PC rich bilayer. It also makes it impossible to place Phe-237 
near Trp-49. This change in the orientation of helix B may be the reason for much weaker 
binding of the Listeria enzyme to PC interfaces compared to the B. thuringiensis PI-PLC. 
Furthermore, there are no counterparts to the residues that form the dimer in the B. 
thuringiensis PI-PLC. There is no region rich in Tyr residues to form the herringbone 
pattern observed in the W47A/W242A dimmer (Shao et al., 2007). If the L. 
monocytogenes PI-PLC were to dimerize on membrane surfaces it would need a radically 
different dimer interface.  
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C. Residues in helix B and the rim loop are important in regulating the enzyme 
kinetic behavior  
In our model, the binding pattern of L. monocytogenes PI-PLC, tight to anionic 
surfaces but weaker to zwitterionic surfaces, is correlated with the unusual kinetics of the 
enzyme. If this is the case, any perturbation of the binding behavior should moderate the 
unusual kinetics. We constructed several mutants at α-helix B and the loop to test their 
catalytic properties. Substitution of Leu-51, Phe-237, and Leu-235 with the less 
hydrophobic alanine residue does moderate the unusual kinetics of WT. Replacing Phe-
237 with tryptophan also has a similar effect on the kinetic behavior as the alanine 
substitution. The results of F237W, at first glance, conflict with that of F237A because 
tryptophan is more hydrophobic than phenylalanine according to the Wimley and White 
hydrophobic scale (Wimley et al., 1996; Wimley and White, 1996; White, 2003). 
Transfer free energies measured with small peptides indicate that tryptophan favors 
inserting into the interfacial region of the bilayer over aqueous solvent – this orientation 
is favored more strongly than for any other natural amino acid (White and Wimley, 1999). 
In contrast, insertion of phenylalanine into a bilayer would favor interior regions over the 
interface. Studies of benzene partitioning in bilayers indicate it is distributed throughout 
the lipid bilayer, with the hydrocarbon core as the most stable position (Norman and 
Nymeyer, 2006). Phenylalanine, instead of tryptophan at residue 237, may facilitate deep 
penetration of WT PI-PLC into the bilayer. This tight anchoring of the protein might keep 
the protein anchored on a surface and minimize release into solution where it might 
surface denature at the air-water interface. Tight binding of this PI-PLC to an anion-rich 
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membrane would also promote aggregation of vesicles at high protein concentrations, 
given the very high cationic character of the protein. That such a mechanism is 
operational might be supported by the surface dilution kinetics with the F237W mutant 
where very dilute protein leads to lower specific activity. A major problem with 
understanding these results is that we do not have a good assay for quantitative surface 
binding of the different mutants, in part because of the aggregation of the protein bound 
to vesicles to generate a precipitate. A better method to quantify L. monocytogenes PI-
PLC binding to vesicles as a function of composition is needed. FCS, fluorescence 
correlation spectroscopy, may be such a technique since it can use very low protein 
concentrations (3-4 nM, which translates to 0.1-0.2 μg/ml and is the amount used in 
kinetics for this PI-PLC) (Pu et al., 2008a; Pu et al., 2008b). This will require attaching a 
fluorophore to the protein on a segment far away form the surface binding regions. 
However, it would allow us a better handle on the protein/vesicles aggregation and what 
happens as the vesicle composition changes. 
It was unexpected by us that replacement of Thr-50 and Thr-236 with cysteine 
also dramatically changed the kinetic behavior of WT. This may suggest that hydrogen 
bonding also contributes to the complex kinetics of L. monocytogenes PI-PLC. Lacking a 
way to quantify the interfacial binding affinities of mutants to various lipid surfaces 
prevents us from looking further into this issue at this time. However, another 
interpretation of the kinetics for these mutants is possible. These two mutant enzymes are 
much more active at higher protein concentrations than WT, while at the lowest enzyme 
concentration, 0.02 μg/ml, they are comparable to WT. It is possible that the Cys residues 
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on the surface of these proteins form disulfides when proteins are bound to vesicles. 
Covalent dimers might increase specific activity because scooting mode catalysis is 
enhanced. This very high activity is only observed in the phosphotransferase step. 
 
 209
Chapter 6: 
 
Effect of deoxy-PI compounds on activities of  
PI-PLC and PI3K enzymes 
 210
I. Introduction 
The phosphatidylinositol 3-kinase (PI3K) / Akt (or PKB) signaling pathway is 
crucial to many aspects of cell growth, survival and apoptosis (Brazil et al., 2004; Hanada 
et al., 2004) and upregulated in a variety of human cancer cell lines (Vivanco and 
Sawyers, 2002) and solid tumors (Seufferlein, 2002; Ghosh et al., 2003; Barnett et al., 
2005). A key step in this pathway is the specific phosphorylation of the 3-hydroxyl group 
of the inositol ring in phosphoinositides by PI3K enzymes (Qiao et al., 1998; Kandel and 
Hay, 1999; Meuillet et al., 2003).  
Attempts to inhibit the PI3K/Akt pathway led to the synthesis of D-3-deoxy-
phosphatidylinositol molecules that can no longer be phosphorylated by PI3K (Gills and 
Dennis, 2004). Many of these molecules have antiproliferative properties (Kozikowski et 
al., 1995; Kozikowski et al., 2003). The first of these, 3-deoxy-dipalmitoyl-PI, was 
shown to inhibit cancer cell (HT-29 human colon carcinoma) growth in vitro with an IC50 
of 35 μM (Kozikowski et al., 1995). Recent syntheses of ether linked rather than ester 
linked alkyl chains, e.g., D-3-deoxy-myo-inositol 1-[(R)-3-(hexadecyloxy)-2-
hydroxypropyl hydrogen phosphate], have generated a newer class of PI analogues that 
should have higher stability in vivo and may also have slightly better delivery properties 
since they are more like lyso-phospholipids (Andresen et al., 2004). 3-Deoxy-PIs have 
also been shown to reduce drug resistance in human leukemia cell lines (Tabellini et al., 
2004). Thus, these PI analogues may have a future in treatment of a variety of cancers.  
A series of 3-deoxy-dioctanoyl phosphatidylinositol (3-deoxy-diC8PI) 
derivatives (Figure 6-1) that can exist as monomers below 0.5 mM were synthesized by 
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the group of Scott Miller. We decided to explore the interactions of these lipids with 
different enzymes in the PI3K/Akt pathway. Part of this study was to examine the 
susceptibility of these short-chain PIs to phospholipase C cleavage and their effects on 
the catalytic activity of PI3K. Under the assay conditions, these compounds were poor 
substrates and not inhibitors of the PLC. There was also little inhibition of PI3K observed 
except for 3-deoxy-diC8PI enantiomers, suggesting that the 3-deoxy-diC8PI molecules are 
unlikely to have a significant effect on PI3K in vivo. 
II. Results and Discussion 
A. Effect of phospholipase C enzymes on 3-deoxy-diC8PI molecules 
PI-PLC plays a key role in the metabolism of membrane phospholipids by 
hydrolyzing PI(4,5)P2 to second messengers, I (1,4,5)P3 and DAG (Berridge and Irvine, 
1989). The initial 3-deoxy-PI studied as a cell growth inhibitor, D-3-deoxy-dipalmitoyl-PI, 
did not appear to be a substrate for PLC (although in vivo potency of the drug was 
dramatically improved when the acyl linkages were replaced by ether linkages). However, 
that phospholipid has a high gel-to-liquid-crystalline phase transition temperature and 
may not have been presented in structures accessible to phospholipases. By using D-
diC8PI as the standard substrate, we can quantify the relative cleavage of the 3-deoxy-
diC8PIs substrates as well as examine their ability to inhibit the enzyme, which reflects 
their ability to bind to PLC active sites. 
We examined the 3-deoxy-PI molecules as substrates and inhibitors of two  
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Figure 6-1 Structures of 3-deoxy-dioctanoylphosphatidylinositol (3-deoxy-diC8PI) 
compounds synthesized. 
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different phosphatidylinositol-specific PLC enzymes – a Ca2+-dependent mammalian 
PLCδ1 (this is a chimera of the –δ1 catalytic domain and the –β1 PH domain and was 
chosen because it has moderately high activity in vitro (Barnett et al., 1995)) and a Ca2+-
independent bacterial PLC. Mechanistically, PI cleavage occurs in a similar fashion in 
both types of enzymes except that an Arg replaces the active site Ca2+ in the bacterial 
enzyme (Bian and Roberts, 1992; Lewis et al., 1993). As seen in Table 6-1, removal of 
the hydroxyl group at C3 generated a very poor substrate for the PLCδ1 enzyme with PI 
cleavage occurring at 0.5 to 1% that of diC8PI. However, in the context of a cell and over 
the time course of several days, these lipids are likely to be hydrolyzed by the 
endogenous PLC enzymes.  
These compounds were also not very good inhibitors of this PLCδ1. The ratio 
of cIP to the final water-soluble product I-1-P reflects how well the intermediate is bound 
to the enzyme. A tighter binding cIP generated in situ translates to a lower ratio of cIP/I-
1-P (Lowry et al., 1951, Shi et al., 2007). As hydroxyl groups are removed from the 
inositol ring, the intermediate cIP analogue becomes more hydrophobic and its release is 
slow compared to attack by water and production of I-1-P (Table 6-1). With D-3,5-
dideoxy-diC8PI, no cIP was observed suggesting that the enzyme must hold the cyclic 
intermediate sufficiently long that it is always hydrolyzed (but very slowly). Addition of 
a phosphate to C(5) to produce D-3-deoxy-diC8PI(5)P did not generate a better substrate 
but it did bias the enzyme so that now cIP was the dominant product. This is an 
interesting contrast to how the enzyme hydrolyzed phosphorylated glycerol- 
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Table 6-1 Recombinant PLC-δ1 activity toward diC8PI and deoxy-diC8PI lipids 
 
 
Substrate a Inhibitor (mM) b 
P-1-I
cIP Specific Activity
 c 
(µmol·min-1·mg-1) 
Relative 
Activity 
D-diC8PI  0.93 3.68 1.00 
D-3-deoxy-diC8PI  0.22 0.039 0.011 
D-3,5-dideoxy-diC8PI  0.00 0.018 0.005 
D-3-deoxy- diC8PI(5)P  3.01 0.022 0.006 
D-diC8PI D-3-deoxy-diC8PI  (2) 1.99 3.01 0.82 
D-diC8PI D-3-deoxy-diC8PI5P  (6) 1.29 4.81 1.31 
D-diC8PI D-3,5-dideoxy-diC8PI  (2) 1.77 3.25 0.88 
D-diC8PI D-3,5-dideoxy-diC8PI  (6) 0.99 3.93 1.07 
D-diC8PI L-diC8PI  (2) 1.02 3.08 0.84 
 
aSubstrates present at 2 mM. 
bThe value in parentheses represents the concentration of inhibitor used in these assays. 
cErrors in specific activity typically <20%.  
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phosphoinositols (Lowry et al., 1951), where a phosphorylated substrate was more 
efficiently hydrolyzed and I-1-P became the major product. It strongly indicates that the 
3-hydroxy group of the inositol ring must make important hydrogen bond contacts with 
the enzyme that stabilize binding of PI analogues to the protein but not in an optimal 
configuration for PI cleavage. 
Mammalian PLC enzymes have multiple domains that could complicate / mask 
effects of the deoxy-diC8PI compounds. Therefore, for comparison we also examined the 
effect of these compounds on the PLC from L. monocytogenes. This bacterial PLC is 
essentially the catalytic domain of the mammalian enzymes and serves to assess the 
effects of the deoxy-PI compounds on catalysis only. The 3-deoxy-diC8PI compounds 
were also poor substrates and poor inhibitors for L. monocytogenes PLC (Table 6-2). The 
specific activities toward D-3-deoxy-diC8PI and D-3,5-dideoxy-diC8PI were 1.3 and 
0.037% that toward diC8PI, respectively. Addition of 2 to 6 mM deoxy-PI compounds 
had only minor effects on the activity of L. monocytogenes PLC toward 2 mM D-diC8PI. 
For all the deoxy-compounds, the decrease in specific activity was less than 10%, 
comparable to the effect of L-diC8PI. As with the mammalian enzyme, removal of the 3-
hydroxyl group generates a compound that binds very poorly to PLC and does not 
compete well with substrate.  
B. Effect of 3-deoxy-diC8PI molecules on PI3K activity  
Removal of the 3-hydroxyl group from PI generates a molecule that should 
inhibit PI3K. Previous work (Meuillet et al., 2003) has suggested that the 3-deoxy-PI  
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Table 6-2 Recombinant L. monocytogenes. PI-PLC activity toward 1D-diC8PI and 
deoxy-diC8PI lipids. 
 
 
Substrate a Inhibitor (mM) 
Specific Activity b 
(μmol min-1 mg-1) 
Relative 
Activity 
D-diC8PI  489 1.00 
D-3-deoxy-diC8PI  6.44 0.013 
D-3,5-dideoxy-diC8PI  0.18 3.7x10-4 
D-diC8PI D-3-deoxy-diC8PI  (2) 522 1.07 
D-diC8PI D-3-deoxy-diC8PI(5)P  (6) 452 0.92 
D-diC8PI D-3,5-dideoxy-diC8PI  (2) 522 1.07 
D-diC8PI D-3,5-dideoxy-diC8PI  (6) 539 1.10 
D-diC8PI L-diC8PI  (2) 441 0.90 
 
aSubstrates present at 2 mM with the indicated concentration of inhibitor molecule. 
bThe value in parentheses represents the concentration of inhibitor used in these assays. 
cErrors in specific activity were ≤15%. 
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species are not very potent inhibitors of PI3K, although this can be misleading if 
substrate and inhibitor have different chain lengths or solubilities. In an attempt to keep 
substrate and inhibitors in the same physical state we investigated the activity of the 
p110α/p85α complex towards 1 mM D-diC8PI in the absence and presence of 1 or 3 mM 
3-deoxy-diC8PI analogs. Since PI3K prefers interfacial PI substrate (Wu et al., 1997), the 
concentrations of PIs were chosen so that substrate was micellar. As shown in Table 6-3, 
only 3-deoxy-diC8PI inhibited the phosphorylation of diC8PI; removing a second 
hydroxyl group (data not shown) or adding a phosphate to the 5-hydroxyl group reduced 
the potency of these compounds as inhibitors so that no inhibition was observed under 
these conditions. Interestingly, both 3-deoxy-diC8PI enantiomers were equally effective 
at inhibiting PI3K. Assuming the 3-deoxy-diC8PI compound is a competitive inhibitor of 
diC8PI and the Km<3 mM (likely given kinetics with longer chain substrates), the Ki/Km 
is likely to be 0.5 for D-3-deoxy-diC8PI and 0.6 for L-3-deoxy-diC8PI. For comparison, 
we also examined the inhibitory effect of L-diC8PI on p110α/p85α activity toward D-
diC8PI. The substrate enantiomer had no effect on D-diC8PI phosphorylation. The 
replacement of the 3-hydroxyl of inositol ring of diC8PI with hydrogen not only 
improved the binding of 3-deoxy-diC8PI compounds to PI3K (compared to diC8PI) but 
also eliminated the inositol ring stereoisomer selectivity for ligand binding. A 
phosphorylated 3-deoxy-diC8PI (D-3-diC8PI(5)P at 1 and 3 mM) was also examined for 
inhibition of diC8PI phosphorylation by PI3K. Enzyme activity increased slightly with 
1:1 substrate/inhibitor and decreased only 20% with an excess of D-3-diC8PI(5)P. Adding  
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Table 6-3 Recombinant PI3K (P110α/ P85α) activity toward 1 mM diC8PI and inhibition 
by deoxy-diC8PI lipids.a 
 
 
Inhibitor (mM) 
Specific Activity b 
(μmol min-1 mg-1) Relative Activity
 –   0.60 1.00 
D-3-deoxy-diC8PI 3 0.09 0.15 
D-3-deoxy-diC8PI(5)P 1 0.66 1.10 
 3 0.49 0.81 
L-diC8PI 3 0.60 1.00 
L-3-deoxy-diC8PI 3 0.11 0.18 
 
aAssay conditions included 1 mM D-diC8PI and 2 mM ATP as substrates, 5 mM Mg2+, in 
50 mM Tris-HCl, pH 7.5, with 3 mM of the deoxy-PI analogs. 
bFor several of the samples run in duplicate, the error in determining the specific activity 
was <10% 
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a phosphate to the C5 of inositol did not improve the ability of this compound to interact 
with the enzyme, although this could also reflect the fact that the CMC for this 
phospholipid is notably higher than for the 3-deoxy-diC8PI compounds. These in vitro 
assays suggest that the 3-deoxy-diC8PI molecules are unlikely to have a significant effect 
on PI3K in vivo. They also suggest that if PI3K is involved, both D- and L-3-deoxy-
diC8PI should have similar effects. 
Our results of PLC and PI3K suggested that removal of the 3-hydroxyl group 
generates a serious of compounds unlikely to have a significant effect on both PLC and 
PI3K in vivo. Under the assay conditions, these compounds were poor substrates and not 
inhibitors of the PLC. There was also little inhibition of PI3K observed except for 3-
deoxy-diC8PI enantiomers. 
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Chapter 7: 
 
Future studies 
 221
The work in this thesis aimed to explore the kinetic profile of L. monocytogenes 
PI-PLC and its biological relevance. Compared to its Bacillus sp. PI-PLC counterpart, L. 
monocytogenes PI-PLC exhibits several different kinetic properties, including 
dependence of activity on enzyme concentration, lacking of surface dilution inhibition at 
high mole fraction of amphiphiles, and salt activation. Our results indicate those kinetic 
behaviors are tuned by the distinct binding abilities of this enzyme to anionic substrates 
versus zwitterionic or neutral amphiphiles. The binding assays used for Bacillus sp. PI-
PLC (centrifugation, gel filtration, fluorescence, and NMR), however, are not sensitive 
enough to quantify surface binding of L. monocytogenes PI-PLC (binding either too 
loosely to zwitterionic or neutral amphiphiles or too tightly to anionic substrates). The 
protein/vesicle aggregation induced by L. monocytogenes PI-PLC in the presence of 
anionic lipids complicates the binding studies. Therefore, a good assay for quantitative 
surface binding of L. monocytogenes PI-PLC is needed to further understand these results. 
Fluorescence correlation spectroscopy (FCS) may be such a technique. In contrast to 
other fluorescence techniques, FCS monitors minute spontaneous intensity fluctuations 
for information rather than just the steady-state emission intensity. To obtain good signal-
to-noise, researchers use femtoliter detection volume and nanomolar protein 
concentration (comparable to the amount used in kinetics for PI-PLC) for optimal FCS 
measurements. With a fluorophore attached to a region far away from the surface binding 
areas (it is easy to introduce a fluorophore at a specific position since there is no Cys for 
wild type L. monocytogenes PI-PLC), fluorescence cross-correlation spectroscopy (FCCS) 
may allow us a better handle on the protein/vesicles aggregation and what happens under 
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different conditions (vesicle composition, salt, enzyme mutants). By introducing a 
fluorophore at different regions of enzyme, FRET-FCS may also be helpful to probe the 
binding of these regions to the interface (non-productive binding). 
Some of the interesting surface mutants we already have generated should also 
be checked for their effect on plaque formation when L. monocytogenes infects 
fibroblasts. Almost all the mutant proteins we generated have kinetic parameters more 
like the B. thuringiensis PI-PLC. For instance, the two surface Cys mutants, T50C and 
T236C, were extremely active in our in vitro assays. However, these enzymes show little 
kinetic sensitivity to decreasing protein concentration or increasing Xdet. It would be 
particularly interesting to see how these affect L. monocytogenes infection. The enhanced 
catalytic activity might lead to enhanced infection. Alternatively, if the high activity if the 
wild type PI-PLC at very low concentrations is really critical, perhaps these mutant 
enzymes will be less infective. 
The results obtained in this first round of mutagenesis suggest we should 
examine surface regions for other interesting changes in kinetics. In particular, the helix 
B moiety has other residues that may aid in surface binding of the PI-PLC. Thr-48 is 
certainly worth examining (either converting it to Cys or to Ala). In the same vein, we 
need to prepare T50A and T236A to see if the high activity is solely associated with the 
cysteine side chain. If it is, the question becomes what causes this change? Also the lone 
cationic residue in this structural unit, Lys-53, may be important in binding to anionic 
surfaces. It would be interesting to convert it to Ala or to reverse the charge to Glu to see 
how binding and enzyme kinetics are affected. 
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Once we have a better idea of how the enzyme binds to surfaces, we may have a 
better chance at developing selective inhibitors that could be used to reduce L. 
monocytogenes infections. 
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